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Abstract 
Chromatin is the complex of DNA, histones and non-histone proteins that make up 
chromosomes and the region of dispersed chromosomes during the interphases and 
S phase of the cell cycle. It is found inside cell nuclei in eukaryotic cells. There are 
many important proteins in the nuclei which are involved in DNA replication, gene 
expression, DNA repair, etc. Core histones, linker histones and HMGs are the most 
important proteins in this group. In this thesis, a new, quick and efficient method is 
developed, to extract and purify proteins from cell nuclei, which is named "forward 
technology". 
By using the "forward technology", ultra-pure native core histone octamers, dimers 
and tetramers were extracted from chick erythrocytes. By using the pure histone 
dimers and tetramers, the complexes of NAP1-dimer and NAP1-tetramer were 
obtained in collaboration with others. Crystals of pure histone octamers with a higher 
resolution than before were produced (Chapter 2). 
A low KCI/phosphate wash of chick erythrocyte nuclei removed up to 1g of proteins 
without nuclei lysis (cePNE1 proteins). The high KCI/phosphate soluble fraction of 
the cePNE1 is rich in HMG proteins, peptidyl-prolyl isomerases (FKBP3) and 
heatshock protein 70 which were fractionated by cation-exchange chromatography 
and anion-exchange chromatography (Chapter 3). 
Valuable (in terms of function) high-molecular-weight proteins were enriched, and 
another group of nucleoproteins called cePNE5 is fractionated by the "forward 
technology" from chick erythrocyte nuclei. It was confirmed that HMGB proteins 
prefer to bind to core histone H2A-H2B dimers (Chapter 4). 
It has proved possible to fractionate HMG-rich PNE1 proteins separate from a linker- 
histone rich nucleoprotein extract, separate from pure core histones (not as 
octamers) from human tissue culture cells. The method has been applied to human 
leukocytes obtained from the National Blood Service. This enrichment of particular 
groups of proteins will be useful for proteomic studies (Chapter 5). 
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Chapter 1 
Introduction 
1.1 Chromatin 
Chromatin is the complex of DNA, histones and non-histone proteins that make 
up chromosomes (Figure 1.1) and the region of dispersed chromosomes during the 
interphases and S phase of the cell cycle. Chromosomes were considered to 
determine inherited characteristics in the end of the nineteenth century. Studies 
carried out during that time were mainly based on cytological observations with the 
light microscope. At the same time RNA (first identified as yeast nucleic acid), DNA 
(nucleic acid) and histones were all discovered as parts of genes (Johns, 1964). 
Investigators first considered that proteins in chromatin were the major component of 
the genes, until the double helical structure of DNA with its immediate implications 
for self-duplication was discovered by Watson and Crick in 1953 (Watson and Crick, 
1953), followed soon after by deciphering the genetic code (Crick, et al., 1961). 
Nowadays we recognise DNA as containing genetic information, but how this 
information is controlled was not fully understood. 
In eukaryotes, chromatin is found inside the nuclei of eukaryotic cells, whereas in 
prokaryotes, the chromatin is held within the nucleoid. The main function of 
chromatin structure is to pack very long DNA strands into small nuclei. For example, 
the human genome of 3x109 base pairs (bp) would extend over a metre if unravelled, 
but actually this is compacted into a nucleus of less than 10"5 m in diameter. 
In most major types of eukaryotic cells the main proteins involved in this DNA- 
protein complex are the histone proteins. B-form DNA surrounds the core histone to 
form a nucleosome core particle. Then, by adding linker histones and 20 to 60 base 
pairs of linker DNA (species dependent) whole nucleosomes are formed. The 
nucleosomes form chain-like beads on a string and they zig zag from one 
nucleosome to the next. The nucleosomes pack more tightly to form the 30 nm fibre. 
By adding some further scaffold proteins, chromosomes are formed. (Figure 1.1) 
(Wolffe, 1999) 
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Figure 1.1 The structure of chromatin 
The major structures in DNA compaction: DNA, the nucleosome, the 10 nm "beads- 
on-a-string" fibre, the 30nm fibre and the metaphase chromosome 
(http: //en. wikipedia. org/wiki/Chromatin). 
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1.2 Nucleosome 
In the 1970s, based on the development of a series of technologies including 
nuclease digestion (Newish and Burgoyne, 1973), protein-protein cross-linking 
(Kornherg and Thomas, 1974), electron microscopy (Olins and Olins, 1974), neutron 
scattering (Baldwin et al., 1975; Suau et al., 1979) and sedimentation analysis, it was 
discovered that chromatin is built up with a repetitive fundamental nucleoprotein 
complex which was then named the nucleosome (Newish and Burgoyne, 1973; Olins 
and Olins, 1974; Kornherg and Thomas, 1974; Baldwin, et al., 1975; Suau, et al., 
1979). Structure studies of nucleosomes were carried out continuously to the present 
time (Baldwin et al., 1973; Pardon et al., 1972; Richmond et al., 1984; Luger et al., 
1997; Moudrianakis et al., 1985). Researchers now have realised that the 
nucleosome is the basic structural unit of chromatin (Luger et al., 1997). In most 
types of eukaryotic cells, 146 base pairs of DNA are wrapped around a core-histone 
octamer plus a single molecule of linker histone to form a nucleosome. Nucleosomes 
play three major roles within the cell nucleus. First, they provide the lowest level of 
compaction which is required to fit double stranded B-form DNA into the cell nucleus. 
Secondly, they are important in the regulation of transcription by preventing RNA 
polymerase from unnecessarily accessing the promoter regions of genes which are 
not needed by the cell. Thirdly, remodelling of nucleosomes is necessary for all the 
processes of the cell cycle. When gene expression is required, special enzymes 
known as remodelling factors can remodel the nucleosomes in the region of a gene 
to allow access to the DNA (Kornberg, 1974; Allis et al., 2007; Turner et al., 1991; 
Kouzarides, 2007). 
The first break through in development of nucleosome structure was the nuclease 
digestion experiment. DNA in chromatin was digested into a regular size of 
fragments length 180-200 bp (Williamson, 1970; Hewish and Burgoyne, 1973). By 
analytical ultracentrifuge technology, these fragments were separated and measured 
to have a mass about 20,000 Da which contain about 11,000 Da of proteins. Then 
electron microscopic analysis was introduced and the micrographs showed a 'beads 
on a string' structure of these repeating units. Each repeating particle was 
approximately 10 nm in diameter (Thoma, Koller and Klug, 1979). From all these 
observations, Kornberg suggested a nucleosome model that each particle consisted 
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of DNA and histones. DNA is wrapped around a core histone octamer consisting of a 
histone (H3-H4)2 tetramer and two histone H2A-H2B dimers (Kornberg, 1974; 
Kornberg and Thomas, 1974). Micrococcal nuclease cleavage experiments indicated 
that 146 bp of DNA interacted very strongly with core histones, while the DNA in 
between nucleosome core particles (which was lost in separating nucleosomes 
during nuclease cleavage) is called linker DNA (Figure 1.2). The scaling of the 
components of the nucleosome, the DNA being on the outside of the histone core 
was proved by contrast variation in neutron scattering from nucleosome core 
particles (Suau et al., 1979). 
Later, by using native-gel electrophoresis technology, Simpson isolated a protein- 
DNA complex from chromatin called chromatosome which contains a histone 
octamer, a linker histone H1 and about 160 bp of DNA (Simpson, 1978). Studies of 
these chromatosomes and comparing them with H1-depleted particles showed that 
linker histone H1 not only interacts with linker DNA but also plays very important 
roles in stabilising DNA with core histones (Simpson, 1978). Researchers also found 
that linker histone H1 may influence the formation of the chromatin fibre (Figure 1.1) 
and the interaction of trans-acting factors with DNA, which are factors from outside 
the structure as opposed to cis-acting factors from within the structure. 
The structure with DNA wrapped around the outside of the core histone octamer 
was determined first by neutron-scattering and shortly after by DNase I digestion 
experiments. Investigators found that the DNA with core histones was nicked by 
DNase I once per 10-11 bp for the entire 146 bp in nucleosomes (Lutter, 1978). This 
indirectly revealed that the whole 146 bp of DNA must lie on the surface of core 
histones. Evidence was given by neutron and X-ray crystallography of the 
nucleosome core particles. The nucleosome core particles in aqueous solutions, 
DNA has a larger radius of gyration than the protein component which indicated DNA 
was wrapped around the histones. Further structure studies were carried out by Klug 
and colleagues who analysed the crystals to 7A resolution and discovered the disc- 
like shape of nucleosome. The disc was 11 nm in diameter and 5.6 nm in height, 
DNA was wrapped in 1.75 turns of a left handed double helix around the histone core 
(Figure 1.3) (Wolffe, 1999). It was originally thought that the bending of the DNA 
around the histone core was not uniform because of the difference in DNA sequence, 
4 
but later high-resolution X-ray studies of the nucleosome core particle and histone 
octamer in KCI/phosphate (Luger et al., 1997; Chantalat et al., 2003) showed it to be 
an exuberant structure that (except in some cases) was not dependent on DNA 
sequence. There were very sharp bends approximately one and four helical turns to 
either side away from the centre of the nucleosomal DNA. 
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Figure 1.2 The organization of nucleosome core particle and the position of linker 
DNA 
The structure of nucleosome core particle, DNA wrapped around core histone and 
located as a 'zig zag' shape in chromatin (Thomas, Koller and Klug, 1979). Linker 
histone is shown as the black molecule stabilising the nucleosome core particle and 
interacting with linker DNA in between two nucleosomes (Wolfe, 1999). 
6 
Figure 1.3 The organization of DNA in the nucleosome 
In this diagram A shows the 'disc' shape of a nucleosome core particle, where the 
hatched cylinder is the core histone octamer and the open tube is DNA. B shows one 
turn of DNA wrapped around the histone octamer, the number refers to turns of the 
DNA helix away from the dyad axis. C shows that the pathway for transcription 
factors (big circles) to access the DNA (small circles) is restricted by core histones 
(hatched square) (Wolffe, 1999). 
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1.3 Histone proteins 
Histone proteins (Johns, 1964) are the major proteins involved in the DNA- 
protein complex of chromatin. Core histones pack DNA into nucleosomes; linker 
histone and linker DNA connect nucleosomes together to form a further tightly- 
packed structure in order to form chromatin as described. Apart from associating with 
DNA, histone proteins also undertake protein-protein interactions between 
themselves and other proteins. These interactions contribute to maintain their high 
degree of evolutionary conservation and also allow them to carry out the function of 
regulating gene expression. 
Although histone proteins are highly conserved in different species, not all 
eukaryotic cells pack their DNA with histone. For example, dinoflagellates are 
reported to package the majority of their DNA with small basic proteins completely 
unlike histones (Vernet et al., 1990); and in spermatozoa of mammalian species DNA 
is packed with basic molecules known as protamines. 
There are five major histone classes which are known as histone H1, H2A, H2B, 
H3 and H4. The core histone octamer is formed by a (H3-H4)2 tetramer and a pair of 
(H2A-H2B) dimers. DNA wraps around the core histone octamer in a left-handed 
superhelix to form a nucleosome (Figure 1.4). The major interactions between core 
histones and DNA are electrostatic forces binding positively charged lysines and 
arginines on the histones to negatively charged phosphates on DNA. Core histones 
can be separated from DNA by high salt concentrations. By increasing the salt 
concentration, histones H2A and H2B are removed from the nucleosome structure 
first and then followed by H3 and H4. In the absence of DNA, histones H2A and H2B 
form stable dimers; two pairs of histones H3 and H4 dimers form a stable tetramer 
(Kornberg, 1974; Kornberg and Thomas, 1974). The core histone proteins are small 
basic proteins containing large amounts of lysine and arginine (more than 20% of the 
total amino acids). Histones H2A (13,960 Da) and H2B (13,774 Da) contain more 
lysine, and histones H3 (15,273 Da) and H4 (11,236 Da) contain more arginine. 
Histones are very highly conserved proteins, in core histone octamers, H3 and H4 
are the most conserved based on their important roles in the structure and function 
of nucleosomes. Histones H2A and H2B are slightly less conserved compared with 
H3 and H4 but still highly conserved compared with many other proteins. The four 
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core histones all consist of a C-terminal histone-fold domain containing three a- 
helices and an N-terminal charged tail rich in lysine residues. These N-terminal 
charged tails are involved with many histone post-translational modifications (see 
section 1.4). The reason for the C-terminal histone-fold domain to be highly 
conserved might be their central structural roles in a nucleosome; for the N-terminal 
tails it might be because of their roles in post-translational modifications and 
interactions with other proteins that organize higher-order chromatin structures. 
The structure of the central histone-fold domain of four histones is very similar. 
Each of them contain three a-helices; the central long a-helix is connected to two 
short a-helices by loop segments. These loop segments have some 13-strand 
structure. The four histones form heterodimers with each other (H2A-H2B, H3-H4) by 
a `hand-shake' model where their central a-helix acts as the interface (Figure 1.4). 
These heterodimers then interact with each other to form the octamer. Two H3-H4 
dimers bind together to form a tetramer and each of them bind to a H2A-H2B dimer 
to finally give the octamer. The interface between two H3-H4 dimers is less extensive 
compared with the interface between the H3-H4 dimer and the H2A-H2B dimer, but 
the latter is more accessible to solvent and is consequently less stable (Eickbusch 
and Moudrianakis, 1978; Karantza et al., 1996) (Figure 1.4). Also this is confirmed by 
higher-resolution crystallography of nucleosome core particles (1.9A structure, 
Davey, 2002) and histone octamers (Chantalat et al., 2003; Wood et al., 2005) 
Each nucleosome is attatched to a linker histone and between two nucleosomes 
there is a region of DNA called linker DNA to which the linker histone binds (Figure 
1.5) (Turner, 2001). Compared with highly conversed core histones, linker histones 
are much more variable. The most common linker histone is histone H1, in some 
species linker histone variants exist such as histone H5 in chick erythrocyte cells. 
Linker histones are also highly basic proteins, rich in lysine residues and slightly 
larger than core histones (>20,000 Da) (Wolffe, 1999). Linker histones contain a 
central domain which consists of three a-helices attached to a three stranded 13- 
sheet and highly basic charged tails rich in lysine residues at both the N-terminal and 
C-terminal regions (Figure 1.6). The central domain plays important roles in 
stabilising the nucleosome structure and the tails interact with the linker DNA 
between nucleosomes. 
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Figure 1.4 The structure of core histone octamer 
The structure and formation of core histone octamer histone H3 and H4 form dimers, 
H2A and H2B form another dimer. Then two (H3-H4) dimer form a tetramer, a 
tetramer binds to two (H2A-H2B) dimers to form a histone octamer (Wheeler, 2005). 
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Figure 1.5 The structure and function of linker histones 
One model for poly-nucleosome chain is where linker histones bind to the entry/exit 
sites of nucleosomes to pack nucleosomes more tightly. They also interact with linker 
DNA to package nucleosomes into 30 nm fibre, the structure of which, including the 
location of the linker histone in relation to the nucleosome-core-particle, is still not 
determined in detail(http: //www. cbs. dtu. dk/staff/dave/roanoke/genetics980218. html). 
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Figure 1.6 The structure of linker histone H5 
The structure of linker histone H5, the core particle domain consists of three a- 
helices and ß-sheets. Two highly basic charged tails are found at both N- and C- 
terminal regions (Wolfe, 1999). 
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1.4 Nucleosome remodelling 
Because the DNA double strands are very tightly packed in the eukaryotic cell 
nuclei by histone proteins, other proteins can not readily interact with DNA under 
these conditions. So when the DNA replication or gene expression needs to take 
place, the DNA needs to be released from the histones first. This can be done by 
nucleosome remodelling. There are three ways in which nucleosomes are 
remodelled to allow access of proteins to access specific regions of the DNA 
sequence (the genome) at specific timings within the cell cycle (Figure 1.7). 
Firstly, the remodelling can be ATP dependent structure changes to the chromatin 
fibre made by groups of enzymes (eg. the SWI/SNFcomplex). This way involves 
histone octamer movements as a whole or movement or depletions of histone 
dimers and tetramers. Our group developed the interactions between two histone 
octamers since we obtained high resolution histone octamer crystals (Wood, et al., 
2005). There is a very strong interaction between the acid rich patch of one octamer 
with the basic lysines and arginines of the next. 
Secondly, histones (probably as whole tetramers or whole dimers), with slightly 
different sequences from the majority in a species and cell type, can be inserted in 
place of the normal proteins. These are called histone variants and they are coded 
by their own separate genes. The variants are correlated with specific function such 
as histone H2A. X (replacing histone H2A). 
Thirdly, the major types of histone post-translational modifications (PTMs) such 
as acetylation, deacetylation, methylation, demethylation, phosphorylation, 
dephosphorylation, ubiquitylation and several more modifications are correlated with 
specific functions (Kouzarides, 2007; Reynolds, 2008). There are more than 60 
different modifications of histone residues which were identified by either specific 
antibodies or by mass spectrometry and this number has a huge potential to be 
increased (Kouzarides, 2007) (Table 1.1 and 1.2). 
Experiments indicated that the level of these post-translational modifications 
change with different phases during the cell cycle (Figure 1.7). During S phase of the 
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cell cycle, all the core histones are acetylated but the key modifications of histones 
H3 and H4 are mono- and diacetylation. In G2 phase, histones H3 and H4 become 
hyperacetylated and in mitosis all four core histones are deacetylated. Histone H2A 
is phosphorylated throughout the cell cycle. Histone H3 is phosphorylated during 
mitosis. Histone H1 phosphorylation occurs in S phase, increases in G2 phase and 
becomes maximal at metaphase. Histone ubiquitylation and ADP-ribosylation occurs 
in S phase and become maximal in G2 phase (Wolffe, 1999). 
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Figure 1.7 The relationship between cell cycle and histone modifications 
This diagram shows the modifications of histones occurring associated with different 
stages in the cell cycle (Wolffe, 1999). 
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Table 1.1 Different Classes of Modifications Identified on Histones 
This table shows the classes of different modifications on histones and their related 
functions (Kouzarides, 2007). 
Keys: ac = acetyl group 
me = methyl group 
ph = phosphroyl group 
ub = ubiquitin 
su=SUMO 
ar = ADP ribose 
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Table 1.2 Histone modification enzymes 
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This table shows more than 60 modifications on histones which have been identified 
and the enzymes that catalyse these modifications in humans and yeast are shown 
(Kouzarides, 2007). 
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1.4.1 Histone variants 
There are many histone variants which are found in different species or in 
different stages during the cell cycle in the same species. These histone variants are 
coded by separate genes, to replace the normal histone proteins in certain regions of 
chromatin to carry out specific functions. 
One of the first examples of histone variant studies is in the sea urchin. The 
sea urchin contains seven different H2A variants expressed separately for the 
cleavage, blastula and gastrula stages of embryogenesis; it also contains four 
different H2B variants which are developmentally regulated as well. Sea urchin 
sperm has an H2B variant containing an N-terminal tail of 21 amino acids extension, 
which may interact with linker DNA to provide special stability for sperm 
nucleosomes (Bavykin et al., 1990; Hill and Thomas, 1990). Studies also show that 
histones H3 and H4 in sea urchin do not have any variants during development 
which indicates the central role of these histones in nucleosome structure and 
chromatin assembly. Variations of histones H2A and H2B can change the 
compaction of DNA in nucleosomes and chromatin fibres by directly influencing the 
nucleosome structure or through changing the binding of histone H1 to the 
nucleosome core particle. 
A highly conserved histone H2A variant known as H2A. Z in mammals (also 
known as H2A. F/Z in chickens, hv1 in Tetrahymena and H2A. vD in Drosophila) is 
found to associate with actively transcribed chromatin. It has an N-terminal tail which 
is post-translationally modified through acetylation to a greater extent than normal 
H2A. Another conserved histone H2A variant called H2A. X contains an extended C- 
terminal tail beyond the histone-fold domain. Wheat H2A1 is another example of an 
H2A variant that has a C-terminal tail with 19 amino acids. Although these histone 
variants have a wide range of different sequences, they form a family of proteins that 
share the histone-fold domain and might be incorporated into a nucleosomal 
structure. 
The histone-fold domain consists of three a-helices, all the core histone 
proteins and their variants are developed from a basic DNA-binding protein 
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containing only a histone-fold domain and lack of any tails which can interact with 
DNA to form a nucleosome-like structure. The tails of different histone variants 
provide them with specific functions. The tails of core histones in eukaryotic nuclei 
give them the ability to interact with other proteins, DNA or complexes. Other 
regulatory proteins with histone-fold domains can replace normal histones in the 
nucleosome to change the nucleosome structure, in order to carry out certain 
functions. 
Some regulatory proteins with histone-fold domains such as CENP-A (found 
at the centromere) and rat macro H2A use their histone-fold domains to confer 
specialised properties on individual nucleosomes through replacing normal histones 
within chromatin. CENP-A is similar to histone H3 but with a very different N-terminal 
tail (Figure 1.8). It is found to form heterodimers with histone H4 in nucleosomes. 
Some other transcriptional regulatory proteins use their histone-fold domains to bind 
the DNA and direct specific protein-protein interactions. This group of histone 
variants including the TATA-binding protein associated factors TAF1140 and TAF1160, 
and CCAAT-box-binding proteins CBF-A, -B and -C and HAP2,3 and 5. TAF1140 and 
TAF60 are related to histones H3 and H4. They replace normal histones H3 and H4 
in the TATA box and maintain the DNA in a semi-compacted state for transcription 
(Kokubo et al., 1993; Nakatani et al., 1996; Xie et al., 1996). CBF-A, B and C and 
HAP2,3 and 5 are evolutionarily related proteins in different species. They are 
transcriptional activators where CBF-A and C, HAP3 and 5 are similar to histones 
H2B and H2A. Together with the third component (CBF-B or HAP2) they can bind to 
the DNA. 
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Figure 1.8 Histones and their variants containing the histone fold domain 
This Figure shows the core histones and their variants which contain histone fold 
domains but with different tail domains. A is showing several histone variants 
compared with original histones. B is showing how histone fold domains bind to each 
other in histones H2A-H2B and H3-H4 dimers (Wolffe, 1999). 
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1.4.2 Histone acetylation and deacetylation 
The acetylation and deacetylation of histones occurs at specific lysine amino- 
acid residues at the N-terminal tails of the histone molecules which are covalently 
bonded to an acetyl group (COCH3). Histone acetylation of the four core histones 
occurs in all animal and plant species examined (Csordas, 1990). These 
modifications lead to a loosening of DNA from the histone proteins to 
activatetranscription. Histone-acetyltransferase and Histonedeacetylase are the 
enzymes which catalyse these reactions (Berg et al., 2002) (Figure 1.9). 
There is a balance of the activities of histone acetyltransferase (HAT) and 
histone deacetylase (HDAC) which together give the final histone acetylation level. 
For example histone H4 with four acetylated lysine residues would be considered as 
hyperacetylated, whereas the protein containing one or no acetylated lysine residues 
is described as hypoacetylated. The acetylated lysines in the histone tails lead to a 
more relaxed chromatin state which gives a higher activity of gene expression. On 
the other hand, the presence of deacetylated lysine residues in histone tails gives a 
tight model of chromatin and is associated with gene silencing. Histone deacetylation 
can increase the ionic interaction between positively charged histone and negatively 
charged DNA which decreases the accessibility of the transcription machinery to the 
DNA. 
The hyperacetylated state of core histones not only increases the accessibility of 
proteins to DNA, but is also significant for protein-protein interactions. Experiments 
show that the N-terminal tails of the core histones are accessible to trypsin, which 
indicates that they are exposed on the outside of the nucleosomal core particle. 
Further studies of cross-linking showed that the N-terminal tail of H2B can have 
weak interactions with linker DNA. Protein NMR experiments also indicate that the 
N-terminal tails of histones H3 and H4 have interactions with the DNA in nucleosome 
core particles (Wolffe, 1999; Bradbury et al., 1974). Researchers proved that 
acetylation or removal of the histone tails can increase the accessibility of trans- 
acting factors to their recognition sites in nucleosomes (Lee et al., 1993; Vettese- 
Dadey et al., 1996). Histone acetylation might have a major regulatory role in 
transcription and this was proved by Hubbes et al. (1988). They used antibodies to 
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acetylated lysines in nucleosomes with immune-precipitation to separate the highly 
acetylated nucleosomes. These were then analysed by removing the histones and 
analysing the DNA sequences. These were shown to be from regions of the genome 
active in transcription in chick erythrocytes (globin genes). This was one of the early 
chromatin immuno-precipitation (ChIP) experiments. The chromatin immune- 
precipitation together with gene array technology (ChIP on CHIP) was applied to 
analyse acetylation and lysine methylation of histones. The results show that these 
modifications are not uniformly distributed in chromatin, acetylation is found to be 
enriched at specific sites in the promoter and 5' end of the coding regions 
(Kouzarides, 2007). 
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Figure 1.9 Histone acetylation and deacetylation 
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This Figure shows the acetylation and deacetylation of the lysine residues. An acetyl 
group is added to or removed from the lysine residue. These reactions are catalysed 
by enzymes called HATs (histoneacetyltransferase) and HDACs (histone 
deacetylase) (Figure produced by the Author). 
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1.4.3 Histone phosphorylation 
Histone phosphorylation occurs at serine and theonine residues on the N- 
terminal tails of histone molecules and is catalysed by a family of kinases (Figure 
1.10). It has mostly the same effect as acetylation. Phosphorylation of serine at a 
certain position can enhance the activity of histone acetyl transferases (called `cross 
talk'). 
The serine residues in the histone H3 basic amino terminal domains are rapidly 
phosphorylated when some extracellular signals such as growth factors or phorbol 
esters stimulate quiescent cells to proliferate (Mahadevan et al., 1991). This 
phosphorylation may lead to conformation changes of nucleosomes or even the 
higher-order structure of chromatin, and the related transcriptional activity would be 
increased. Experiments which introduce phorbol esters to proto-oncogenes c-fos and 
c-jun show that their transcriptional activity level was rapidly increased and 
sulphydryl groups in histone H3 cysteine residues were exposed. Because cysteine 
residues of histone H3 are normally buried inside of nucleosomes, exposure of 
sulphydryl groups of these cysteine residues may indicate that a major disruption of 
nucleosome structure such as dissociation of histones H2A-H2B dimers has 
occurred. These changes might be associated with histone H3 phosphorylation and 
acetylation. 
Phosphorylation also occurson histones H4 and H2A in the cytoplasm shortly 
after histone synthesis (Sung and Dixon, 1970; Ruiz-Carillo et al., 1975; Jackson et 
al., 1976; Dimitrov et al., 1994). Studies show that this phosphorylation together with 
deacetylation of histone H4 may target them to molecular chaperones involved in 
DNA replication and chromatin assembly. Another histone H2A variant, H2A. X, also 
can be phosphorylated. Experiments show that this phosphorylation plays a role in 
nucleosome spacing during chromatin assembly. However, nucleosome spacing 
would not be affected when H2A. X phosphorylation is removed by phosphatases 
(Dimitrov et al., 1994) 
Linker-histone phosphorylation is one of the widely studied post-translational 
modifications of histones. Phosphorylation of histone H1 tails occurs at a highly- 
25 
conserved motif: S/T-P-X-K-R (serine/threonine - proline - any amino acid - lysine- 
arginine). This motif exists several times along the basic charged tails on each side 
of the central globular domain of histones H1and H5 (Snijders et al., 2008). Studies 
of mammalian cell culture discovered that rapidly dividing cells have the highest level 
of histone H1 phosphorylation and the level decreases in non-proliferating cells 
(Wolffe, 1999). During the cell cycle, histone H1 phosphorylation level is lowest in G1 
phase; it increases in S phase and mitosis and reaches the maximum at metaphase. 
This indicates that histone H1 phosphorylation level is increasing when the 
chromosome is getting more condensed, and suggests that there are some 
relationships between histone H1 phosphorylation and chromosome compaction 
(Bradbury et al., 1974). Phosphorylation of histone H1 would weaken the interaction 
between the histone H1 and linker DNA, because of the basic charged tails of 
histone H1 are neutralized. But surprisingly, this modification influences the binding 
of the protein to chromatin more than to DNA (Hill et al., 1991). This may suggest 
that phosphorylation of histone H1 could weaken the interaction between linker 
histone and chromatin therefore allowing other trans-acting factors to bind to DNA or 
the fibre in order to change the chromosomal architecture. 
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Figure 1.10 Histone phosphorylation 
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This Figure shows the phosphorylation of a serine residue. A phosphate group is 
added to and removed from the serine residue by a family of kinases and 
phosphatases respectively (Figure produced by the Author). 
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1.4.4 Histone methylation 
Histone methylation is another possible modification that occurs to control gene 
expression. This may happen by adding a methyl group to a specific lysine or 
arginine residue (Figure 1.11). This modification particularly appears in histone H3 
and H4 and it is catalysed by histone methyltransferases. It has recently been found 
that demethylases are also present to maintain the balance between methylation and 
demethylation (Vargason, 2000). 
The function of histone methylation is not clear yet. Most methylation occurs on 
histone H3 at lysines 9 and 27 and histone H4 at lysine 20. It was found that up to 
three methyl groups can be added to each lysine residues of histone H3; meanwhile 
histone H4 contains maximum two methyl groups. Histone methylation of lysine 
residues occurs after nucleosome assembly. It seems to occur preferentially to the 
histone H3 and H4 which are already acetylated (Kouzarides, 2007). 
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Figure 1.11 Histone methylation 
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This Figure shows the mono methylation of a lysine residue. A methyl group is added 
to the lysine residue by methyl transferase. Methylation can be mono-, di- or tri-. The 
lysines in histone H3 are found can be added with up to three methyl groups, but in 
histone H4 they contain maximally two methyl groups (Figure produced by the 
Author). 
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1.4.5 Histone ubiguitylation 
Ubiquitin is a highly conserved small regulatory protein with 76 amino acids that 
is ubiquitous in eukaryotes. Ubiquitylation refers to the post-translational modification 
of a protein by the covalent attachment of one or more ubiquitin monomers. The 
most prominent function of ubiquitin is labelling proteins for proteasomal degradation. 
So the function of ubiquitylation is to control the stability, function, and intercellular 
localization of a wide variety of proteins. For the histone proteins, ubiquitin may be 
attached to lysine residues of the C-terminal tail of histone H2A and H2B (Figure 
1.12). This modification might be linked to the repression or activation of gene 
expression. For example, ubiquitylation of H2B stimulates gene expression since it 
promotes the methylation of H3 on Lys 4 and Lys 79. Ubiquitylation of histone H2A 
tail domain may disrupt the interaction of linker histones with nucleosomal DNA and 
may also disrupt higher-order chromatin structures by impeding internucleosomal 
interactions (Kouzarides, 2007). 
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Figure 1.12 Histone ubiquitylation 
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This Figure shows that an ubiquitin molecule with 79 residues is added to a lysine 
residue. This is found to occur on the C-terminal tail of histones H2A and H2B 
(Figure produced by the Author). 
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1.4.6 Histone sumoylation 
Sumoylation is a newly identified modification of lysine residues on histone 
tails. It is found to be related with transcriptional repression (Shiio and Eisenman, 
2003). Small ubiquitin-related modifier (SUMO) is a polypeptide that has similar 3D 
structure to ubiquitin (18% of sequence similarity). It is covalently attached to other 
proteins through the activities of an enzyme cascade (E1-E2-E3) similar to that of 
ubiquitylation (Shiio and Eisenman, 2003). SUMO is reported to bind to many 
different proteins; in most of the cases it decreases the transcriptional activity (e. g. 
Elk1, Sp3, c-Myb, and c-Jun) (Verger, et al. ) and represses the gene. Shiio and 
Eisenman's study shows that the sumoylation of histone H4 is correlated to 
transcriptional repression as well. They genetically fused SUMO to histone H4 and 
found that SUMO-H4 associates with chromatin and can be immuno-precipitated 
with endogenous histone deacetylasel (HDAC1) and heterochromatic protein 1 
(HP1). These data indicate that sumoylation of histone H4 is associated with gene 
repression. 
According to Shiio and Eisenman's study, a model of the role of sumoylation 
of histone H4 is given (Nathan et al., 2003). It suggests that once a gene is 
expressed it must then be attenuated and finally repressed. So acetylation itself 
might be a signal for recruiting sumoylation enzymes. Experiments show that H4 
sumoylation increases with increasing H4 acetylation, and then the acetyl group is 
removed by HDAC and gene repression is caused by histone methylation, in order to 
build up chromatin condensation. In this process, sumoylation may actually be the 
signal that initiates a sequence of attenuation followed by repression (Figure 1.13). 
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Figure 1.13 A model of the function of histone H4 sumoylation 
This Figure shows a model of the function of histone H4 sumoylation. SUMO binds 
to histone H4 as a signal to recruit HDAC to deacetylate the protein and in order to 
attenuate and repress the gene (Nathan et al., 2003). 
Keys: Act = activator 
ac = acetyl group 
HAT = histone acetyltransferase 
Rep = repressor 
HDAC = histone deacetylase 
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1.4.7 Histone ADP ribosylation 
ADP ribosylation is a covalent post-translational modification catalysed by 
ADP-ribosyltransferase (Figure 1.14). Poly(ADP-ribose) polymerase 1 
(ARTD1/PARP1) is one of the key enzymes of ADP ribosylation and it is responsible 
for most of the cellular poly(ADP-ribose) formation. ADP ribosylation has been found 
to be related to histone proteins in vivo for many years (Ueda, 1975). Histones 
isolated from rat liver nuclei and HeLa cells treated with radioactive NAD+ indicated 
that all core histones H2A, H2B, H3, H4 and linker histone H1 are ADP ribosylated to 
a variable extent (Otake et al., 1969; Adamietz et al., 1978; Minaga et al., 1979 and 
Ogata et al., 1980). Association of long negatively charged chains of ADP-ribose with 
histones may contribute to the disruption of nucleosomes by exchange of histones to 
this competitor polyanion. ADP-ribosylation may lead to unfolding of the chromatin 
fibre and may play an important role in DNA repair (Wolffe, 1999). It is also involved 
in cell cycle regulation, DNA replication and transcription. ADP-ribosylation can be 
read by the zinc finger motif, in order to regulate chromatin structure and 
transcription (Hoftiger, 2011). Recent studies suggest that lysine residues of all the 
core histones are the acceptor sites of ADP-ribosylation instead of previously 
assumed glutamic acid residues (Messner et al., 2010). 
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Figure 1.14 ADP-ribosylation 
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This diagram shows that how the poly(ADP-ribose) formed and how it is modifying 
the target proteins (Miwa, et al., 2006). 
Keys: PARG = poly(ADP-ribose) glycohydrolase 
PARP = poly(ADP-ribose) polymerase 
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1.4.8 Peptidylprolyl isomerisation 
In drug development studies, several organic molecules (with molecular 
weights far less than those of nearly all proteins) were found empirically to suppress 
immune reactions and therefore to be effective in stopping rejection of human 
transplants. Three immuno-suppressive small drug molecules, FK506, rapamycin 
and cyclosporin are shown in Figure 1.15. These drugs were found to bind to specific 
bio-molecules that inhibit the mechanisms of T-cell and/or B-cell control. These bio- 
molecules belong to a class of enzymes called peptidylprolyl isomerases (PPIs), at 
least some of which (and possibly nearly all) control the immunological processes of 
lymphocytes (in T -cell and B-cell lymphocytes in particular). 
The PPIs that bind to FK506 or rapamycin are called FK506-binding proteins 
abbreviated to FKBPX, where X is the approximate molecular weight of the protein. 
Those binding to cyclosporin are called cyclophilins, mostly A (cypA) or B (cypB). 
The FKBPX family mainly includes FKBP 13 (12a), 25,38,52 and 51. The FKBP 
proteins, in nearly all known cases, consist of the PPI/drug-binding region plus other 
regions specific for a particular FKBP protein. FKBP 12 is called the canonical FKBP 
protein because it contains only the PPI/drug-binding region (Figure 1.16). 
These PPIs change the 3D structure of proteins by targeting very specific 
proline aminoacid residues. This changes the proline from the usual trans 
conformation into its isomeric cis conformation (Figure 1.17). 
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Figure 1.15 Three immune-suppressive molecules, cyclosporin, rapamycin and 
FK506 
This Figure shows the structure of three immune-suppressive small drug molecules 
which A is cyclosporin A, B is rapamycin and C is FK506 (Galat, 1993). 
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Figure 1.16 Topography for different FKBPs 
This Figure shows the topography of different FKBPs. The pink region is the 
canonical region for drug binding (Leclercq et al., 2000). 
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Figure 1.17 Thetrans and cis forms of proline 
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This Figure shows the trans and cis forms of proline. Naturally there are about 6% of 
prolins in cis form and others are in trans form (Galat, 1993). 
Keys: P, = peptide 1 
P2 = peptide 2 
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All the FKBP proteins contain a region where a five-stranded ß sheet has a 
right-handed twist around the only a helix in that part of an FKBP. The structure 
forms a hydrophobic pocket where the drug molecule binds (Figure 1.18). This 
region of the proteins contains the PPI activity and the drug binding site(s) (FK506, 
rapamycin etc). 
Peptidylprolyl isomerisation is a PTM for the target protein at a particular 
proline and it changes the conformation of the protein because of the change in 
trajectory of ensuing amino-acid residues. Therefore it must cause at least local 
changes of protein three-dimensional conformation that results in binding other 
factors and causing function changes. 
Our group is familiar with PTMs of histone proteins and there is one protein 
FPR4 that has some homology with FKBPs. This protein has been found by the 
Kouzaredes's Group to isomerise histone H3 proline 38 that seems to be necessary 
for the recognition and methylation of H3 Lysine 36 via the SET (Su(var) 3-9, 
Enhancer of Zeste, Trithorax domain) methyl transferase (Nelson, et al., 2006). 
Otherwise, until present, the detailed pinpointing of prolines in the targets for the 
FKBPs is not established. Also the mechanisms of the immunophilin function or 
detailed structures of the FKBP proteins complexed with their target proteins remain 
unknown. Even such structures of FPR4 with portions of histone H3 or the methyl 
transferase seem not to have been done and recorded in the RCSB PDB (Research 
Collaboratory for Structural Bioinformatics, Protein-structure Data Bank). 
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Figure 1.18 Structure of the PPI-ß-sheet region 
This Figure shows the structure of the PPI-ß-sheet region of all FKBP family proteins 
(a and b, canonical region which is really the complete FKBP12). The FK506 drug 
molecule is shown bound to the FKBP12 through the yellow region in c and d (Kang 
et al., 2008). 
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1.5 HMG proteins 
High Mobility Group (HMG) proteins are a group of chromosomal proteins that 
help with transcription, replication, recombination and DNA repair. HMG proteins are 
subdivided into three superfamilies which are HMGB (HMG-box) family, HMGN 
(nucleosomal binding domain) family and HMGA (A-T hook motif for binding to DNA) 
family. 
HMGs were first fractionated with linker histone H1 by perchloric acid extraction. 
The proteins soluble in perchloric acid except linker histone H1 were then separated 
by trichloroacetic acid (2%) into an insoluble group of large proteins named low 
mobility group (LMG, determined by gel electrophoresis) proteins and a soluble 
group of small size proteins named high mobility group (HMG) proteins. HMG 
proteins were then subdivided into three classes which were originally called 
HMG1/2, HMG14/17 and HMGI/Y by their size. These classes were then found to 
contain different motifs and renamed as HMGB (HMG1/2, containing HMG-box), 
HMGN (HMG14/17, containing nucleosomal binding domain) and HMGA (HMGI/Y, 
containing A-T hook motif). 
HMGB 
The HMGB proteins are the major family of HMGs. They play important roles in a 
range of chromatin-related processes such as transcription, replication, and they are 
also involved in determining the cell phenotype (Bustin, 1999; Thomas and Travers, 
2001; Agresti and Bianchi, 2003; Bianchi and Agresti, 2005; Hock et al., 2007). They 
also have functions as extracellular signalling molecules (Lotze and Tracey, 2005; 
Bianchi and Manfredi, 2007). Three major variants are involved in this family which 
are HMGB1, HMGB2 and HMGB3. 
HMGB proteins contain a basic N-terminal tail and an acidic C-terminal tail. The 
N-terminal tail contains two HMG-boxes, called HMG box A and HMG box B, which 
are protein domains consisting of three a-helices and creating two independent 
DNA-binding surfaces (Read et al., 1993; Weir et al., 1993; Gerlitz, et al., 2009) 
(Figure 1.19). This structure of multiple DNA-binding sites on the same protein is 
similar to linker histones. Experiments showed that HMGB proteins can replace 
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linker histones in chromatin (Nightingale et al., 1996; Ura et al., 1996). The HMG box 
also provides the binding site for chromatin. 
HMGN 
HMGNs are highly conserved proteins containing N-terminal basic regions. These 
basic regions are believed to interact with nucleosomal DNA. They were examined to 
have higher affinity for nucleosomal DNA than for naked DNA. They may contribute 
to the folding of chromatin and indirectly increase the accessibility of regulatory 
complexes to RNA polymerase. There are five major variants in this family which are 
HMGN1, HMGN2, HMGN3a, HMGN3b and HMGN4. Their sizes are all around 10 
kDa (Bustin, 2001). The proteins in this family all contain a 30 amino acid 
nucleosomal binding domain (NDB). A highly conserved 8 amino acids motif is 
embedded in this domain which is RRSARLSA. The bolded RSRL amino acids in 
this sequence are essential for the specific binding of the HMGN protein to the 
nucleosome core particle (Gerlitzet al., 2009). 
HMGA 
HMGA family proteins contain three conserved AT hook DNA-binding domains 
and all have an acidic C-terminal tail. The AT-hook domain is a small motif containing 
the PRGRP sequence which is flanked by additional positively charged residues 
(Reeves and Nissen, 1990; Huth et al., 1997). The central RGR sequence binds to 
the minor groove of AT base pairs where the arginine residues form electrostatic and 
hydrophobic contacts with the floor of the minor groove DNA (Figure 1.20). After 
binding to the DNA, conformational changes of HMGA proteins take place. This 
gives them the ability to bend the DNA (Reeves and Beckerbauer, 2001). 
HMG proteins are thought to play an important role in many sorts of human 
disorders. Disruptions and rearrangements in the genes coding for some of the HMG 
proteins are related to some common benign tumors. Antibodies to HMG proteins 
are found in patients suffering from autoimmune disease (lannaconeet al., 2007). 
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Figure 1.19 A model for the binding of HMG box A and B to linker DNA and chromatin 
This Figure shows how the HMGB proteins bind to the DNA through HMG boxes A 
and B (Gerlitz, et al., 2009). 
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Figure 1.20 A model showing how AT-hooks might bind to the minor groove in AT rich 
DNA 
This Figure shows that how AT-hooks might bind to the minor groove in AT rich DNA 
(Gerlitz, et al., 2009). 
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1.6Aim of the project 
The need for nucleoproteomics and nucleoprotein purification 
The Association for Clinical Biochemistry (ACB) was founded in 1953, and is 
one of the oldest such Associations in the world. Based in the United Kingdom, it is a 
professional body dedicated to the practice and promotion of clinical science. The 
Association has medical and non-medical members in all major UK healthcare 
laboratories, in many university departments and in several commercial companies. 
The links with its Corporate Members leads to a fruitful relationship with the clinical 
diagnostics industry. The Association liaises with and is consulted by many national 
and international organisations on issues relating to Clinical Biochemistry. 
The ACB has circulated the following statement showing the importance of 
isolating and developing protein extraction procedures (including nucleoproteins), so 
that new protein biomarkers can be developed as a national priority: 
"It is a government priority that NHS research should be directed towards 
more immediate patient benefit and, with the clinical demand for more and better 
markers of disease, Clinical Biochemistry should be ideally placed to play an 
important role in this, particularly in the translation of protein biomarkers into the 
clinic. However, doubts have been raised regarding the capacity and resources of 
hard pressed routine of the Clinic Biochemistry laboratories to do this, and there may 
be a lack of awareness of the ongoing work in clinical proteomics for the discovery of 
new protein biomarkers". 
The above stresses the need for biomarkers for disease. There is also the 
need to understand the mechanisms of all processes of cell cycle control in terms of 
the functions of all the proteins in the cell nucleus. So there is a need for the 
following: 
1. Targeted extraction of all nucleoproteins in normal and disease cells; 
2. Special attention at targeted extraction of those nucleoproteins that are 
closely involved in the primary architecture of chromatin such as core histones, 
linker histones, HMG proteins, so called immunophilins, and molecules 
associated with nuclear scaffold, such as topoisomerases; 
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3. Targeted extraction of proteins with known changes or likely changes 
associated with cancer and other diseases. 
Objectives of this Thesis 
In this thesis, nucleoprotein purification is developed by a cheap integrated 
approach using KCI/phosphate solutions, in order to address the issues of the last 
section. KCI/phosphate is used for the following reasons: 
1. The pH of the extraction solutions can be controlled by changing the ratio of 
K2HPO4/KH2PO4 over a wide range; 
2. The ionic strength of the extracting solutions can be controlled by the 
concentration of KCI and phosphate to values as high as 2M KCI, 2M 
phosphate or higher in the case of KCI. 
Asa result of 1 and 2: 
a. The solution conditions for extracting DNA binding molecules are rich in 
phosphate, simulating the native conditions; 
b. Precipitation of nucleoproteins to separate the soluble from the insoluble is 
possible by varying the ionic strength, while being in control of a very stable 
pH; 
c. Control of low ionic strength KCI/phosphate condition enables the extraction 
of nucleoproteins (that we term cePNE1 proteins and they are rich in high 
mobility group proteins and many others, see later) that diffuse through the 
nuclear membrane into the extraction solution maintaining the protein 
depleted nuclei intact. This was discovered in our laboratory when preparing 
chick erythrocyte nuclei. Use of detergent and nuclei washing solutions in 
dilute KCI-tris, pH 7.5 enabled pure white nuclei to be prepared (see later). 
However, replacing the tris with phosphate at the same pH and ionic strength 
resulted in reddish nuclei because of the passage of haemoglobin from the 
cytoplasm into the nuclei. This indicates that nuclear membranes are 
permeable to proteins in the presence of phosphate. 
d. It is possible to control pH and ionic strength, after the extraction of cePNE1 
proteins, to break (lyse) cell nuclei and extract sequentially DNA binding 
proteins, firstly linker histones preferentially and then, in higher ionic strength, 
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to strip core histones from the DNA into the extraction solution (as opposed to 
acid extraction, see later). 
In the chapters 2,3 and 4 of this thesis, the principles established above are 
used for an integrated series of nucleoprotein extraction procedures using also 
conventional chromatography methods. In each chapter, brief examples of 
procedures used by others are given. Many proteins have been purified in this way 
paying particular attention to histones, HMGs, peptidylprolyl isomerases (PPIs) and 
other nucleoproteins, for example, topoisomerases. 
In the context of nucleoproteins as biomarkers for disease, the methods, having 
been developed for chick erythrocyte nuclei, were applied to human leukocyte nuclei, 
extracted from human bully coats supplied by the National Blood Service (chapter 5). 
These experiments were carried out in national laboratories, formerly the CCLRC 
Daresbury laboratory and latterly the Diamond national X-ray source at the 
Harwell/Rutherford laboratory sites. These laboratories have stringent safety 
procedures in place and national ethics approval was also obtained. 
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1.7 Review: DNA replication and histone chaperones 
1.7.1 DNA replication and chromatin assembly 
DNA replication in part of the cell cycle is a basic process in all living organisms. 
The two strands of B-form DNA hold the same genetic information because both 
strands can serve as templates for the reproduction of the complementary strand. 
During DNA replication, the two strands are separated at specific sites in the genome 
called 'origins' of replication. RNA primers attached to single stranded DNA and the 
enzyme DNA polymerase extends the primers to form new strands of DNA by adding 
nucleotides complementaryto the template strand (Figure 1.21). One DNA 
polymerase produces the leading strand copy; another DNA polymerase binds to the 
lagging strand and makes discontinuous segments called Okazaki fragments. This 
happens because the DNA polymerase can only extend a DNA strand from the 5' 
end to 3' end, and the Okazaki fragments will be linked together by DNA ligase 
afterwards. 
The first step of replication initiation involves the assembly of a pre-replication 
complex (pre-RC) (Sun and Kong, 2010). DNA replication is initiated by the binding 
of the replicator to special regions of DNA known as origins. In prokaryotes, for 
example E. coli, the replication origin named oriC is a DNA sequence of -250 bp. The 
origin-recognition protein DnaA binds to several 9 bp highly-conserved sequences in 
oriC. Beside these 9 bp sequences there is a second conserved AT-rich sequence 
which is the site for opening the duplex for loading DnaB helicase and subsequent 
initiation of DNA synthesis. In eukaryotes, such as budding yeast Saccharomyces 
cerevisiae, the replication origin is a 100-150 bp sequence similar to the structure of 
oriC. These origins contain an essential 11 bp consensus sequence of 5'- 
(A/T)TTTA(T/C)(A/G)TTT(A/T)-3' called the 'A element and a non-conserved B 
region that is also important for origin activity (Marahrens and Stillman, 1992). The 
binding site of the origin-recognition complex (ORC) is located at the A region and 
the A region, together with a part of B region beside it, is used for the assembly of 
pre-RC. 
The pre-RC assembly occurs at the late M and early G1 phase of the cell 
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cycle when the activity of cyclin-dependent kinase (CDK), which phosphorylates pre- 
RC components and inhibits their activity, is low (Nguyen et al., 2001). In budding 
yeast S. cerevisiae, ORC binds to the DNA replication origin first and loads Cdc6 
onto the DNA at the early G1 phase. Following that, ORC and Cdc6 together recruit 
Cdtl-MCM (Mcm2p, Mcm3p, Mcm4p, Mcm5p, Mcm6p and Mcm7p) to origins to 
form a pre-RC (Diffley et al., 1994; Speck et al., 2005; Chen et al., 2007) (Figure 
1.22). 
In the cell cycle, eukaryotic cells must replicate large amounts of genomic DNA 
distributed on all the different chromosomes. In doing that, replication needs to 
initiate throughout S phase at multiple origins along each chromosome (Diffley and 
Labib, 2002). Initiation from those origins must be at the same time so that no region 
of the genome is left unreplicated and no region is replicated more than once. DNA is 
guaranteed to be replicated only once in a cell cycle by a simple mechanism which 
dismantles the pre-RC and destroys or inhibits all its components after the DNA 
replication is initiated (Stillman, 2004). DNA replication must also be coordinated with 
chromosome segregation to ensure that each daughter cell receives a complete and 
unaltered complement of genetic information. Any mistakes made in either DNA 
replication or chromosome segregation can result in loss or duplication of the genetic 
information, and these events can play an important role in the production of cancer 
cells. 
After the assembly and binding of the pre-RC to the origins, DNA replication 
starts at the S phase of the cell cycle. At this stage, the DNA helix has been opened 
and unwound to form "replication forks" (Figure 1.21). In prokaryotes, this is done by 
DnaA when it binds to the origin and initiates DNA replication. In eukaryotes, the 
DNA helix is unwound by an enzyme known as DNA helicase which is a component 
of the pre-RC, but the mechanisms and the exact timing of the melting of the origin 
DNA are not well understood. Some recent structure studies of Cdc6/ORC-double- 
stranded-DNA complexes revealed that the double-stranded DNA was bent but not 
melted. This suggested that the DNA melting may require additional components 
(such as MCM) (Gai et a/., 2010). The pre-RC is assembled on the origin during G1 
phase but activated at the start of S phase. The opened DNA double strands are 
prevented from reannealing by a single strand binding protein known as replication 
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protein A (RPA) in eukaryotes. Then a group of proteins including the most important 
DNA polymerases are recruited to the replication forks, which then move outwards 
from the replication fork in both directions to synthesise new DNA strands by a semi- 
conserved mechanism (Morgan, 2007). 
DNA polymerase can only add new deoxyribonucleotides to the 3' end of a 
previously existing strand that is base-paired with the template strand. So the new 
DNA strand is initiated with a short polynucleotide primer, synthesised by the 
polymerase called primase, which copies a short fragment of the DNA template into 
RNA. Then the primase is replaced by DNA polymerase which completes the new 
DNA strand. In eukaryotes, the primase and DNA polymerase activities are both 
carried out by a protein complex called Pol a-primase. Also the newly synthesised 
nucleotides can only be attached to the 3' end of the new DNA strand. That means in 
the replication fork, only one of the newly synthesised DNA strands can grow from 
the 5' end to the 3'end directly (called leading strand). The other one has to be 
synthesised from the 5' end to the 3' end towards the opposite direction (called 
lagging strand) as a series of discontinuous fragments called Okazaki fragments. 
These fragments can then be linked together by DNA ligase (Figure 1.21). The 
moving of DNA polymerase is controlled by an accessory protein called PCNA in 
eukaryotes (Figure 1.27). It forms a ring around the DNA template strand and can 
move along it freely. It gives the DNA polymerase the ability to continuously 
synthesise long DNA (Morgan, 2007). 
When the DNA replication machine reaches the end of the chromosome in 
eukaryotes, the leading strand can be completed directly but the lagging strand 
cannot, because of the lack of space for the primer of another Okazaki fragment. 
This problem is solved by telomerase. Telomeres are long segments of repeating 
DNA sequences at the end of chromosomes. The enzyme generating these 
telomeres is called telomerase. Telomerase contains an RNA template allowing them 
to add extra DNA repeats on the end of the chromosome. These repeats give space 
for the primer of newly synthesised Okazaki fragments (Morgan, 2007). 
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Figure 1.21 DNA replication 
This diagram shows the model of DNA replication. Two strands are separated and 
form a replication fork. Each strand acts as a template. One DNA polymerase 
produces the leading strand copy; another DNA polymerase binds to the lagging 
strand and makes discontinuous segments called Okazaki fragments 
(http: //www replication fork. com/). 
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Figure 1.22 A model of the assembly of pre-RC in budding yeast S. cerevisiae 
This diagram shows the assembly of the pre-replication complex in budding yeast S. 
cerevisiae. This only occurs at late M phase and early G1 phase when the activity of 
CDK is down-regulated by the anaphase promoting complex (APC). ORC binds to 
the DNA replication origin first and loads Cdc6 onto the DNA at early GI. Following 
that, ORC and Cdc6 together recruit Cdt1-MCM to origins to form a pre-RC. After the 
DNA replication starts, the Cdc6 and Cdt1 are hydrolysed to avoid the DNA being 
replicated more than once in a cell cycle. 
(http: //dnareplication. csc. mrc. ac. uk/research. html) 
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The eukaryotic genome is packaged into a nucleoprotein structure called 
chromatin. The basic repeating unit of chromatin is known as the nucleosome 
(explained in chapter 1), this comprises approximately 1.7 turns (-146 bp) of DNA 
wrapped around two molecules of each of the core histone proteins (H2A, H2B, H3 
and H4) and, as also explained there are varying lengths of linker DNA together with 
linker histones in between each pair of nucleosomes. Highly-condensed metaphase 
chromosomes are formed by multiple folding of the zig-zagging chains of 
nucleosomes. This highly condensed structure provides protection and organization 
of DNA, but also permits rapid access to the DNA during its transcription, replication, 
repair and recombination. These dynamic transitions in the chromatin structure are 
regulated by hundreds of proteins largely organised in groups including histone 
chaperones, non-histone DNA binding proteins, ATP-dependent chromatin 
remodelling complexes and post-translational modification enzymes (Choudhary and 
Varga-Weisz, 2007; Campos and Reibnberg, 2009; Das et al., 2010). During DNA 
replication, DNA must first be loosened from core histones by chromatin disassembly. 
After replication the new DNA strands need to be packed again into chains of 
nucleosomes leading to chromatin reassembly. 
Histone proteins are highly conserved among eukaryotic organisms. Recent 
research has shown that the structure of a yeast nucleosome is similar to a 
metazoan nucleosome (Wolffe, 1999). Even in some archaebacteria their 
nucleosomes contain 80 bp of DNA wrapped around two molecules of each of the 
two archaeal histones. The similarity of nucleosome structures among eukaryotic 
organisms indicates that the mechanism of chromatin assembly is highly conserved 
across all eukaryotes. In our laboratory the histone octamer from chick erythrocytes 
has been crystallised (Chantalat et al., 2003; Wood et al., 2005) and the structure 
solved to a resolution of 1.90 A. This structure is essentially identical to that of the 
octamer in the nucleosome core particle (Luger et al., 1997) made from cloned 
Xenopus histones, even to many bound water molecules. 
Chromatin assembly is not a well understood process in the cell. The majority 
of chromatin assembly occurs immediately after DNA replication, where 
nucleosomes are disrupted by the passage of the replication machinery. The newly 
replicated daughter DNA strand is rapidly assembled into chromatin by a multistep 
54 
process. Firstly, histones H3 and H4 are bound to the DNA, followed by incorporation 
of two histone H2A-H2B dimers to complete the nucleosome (Das et al., 2010) 
(Figure 1.23). The original nucleosomes before replication are disassembled into H3- 
H4 tetramers and H2A-H2B dimers, and then they are randomly distributed to the 
two daughter DNA duplexes by an unknown mechanism. The parental chromatin 
only provides half of the histones which are required, the other half of the histones 
are synthesized during S phase of the cell cycle. 
Newly synthesised core histones enter the nucleus mediated by a network of 
soluble transport receptors called karyopherins that bind to the nuclear localization 
signal in the N-terminal domain of each core histone. Before assembly into 
chromatin, these newly synthesized core histones are acetylated at lysine residues 5 
and 12 of H4, and lysine residue 14 of H3; and then rapidly deacetylated after 
deposition onto newly replicated DNA. The reason why this histone acetylation and 
subsequent deacetylation occurs during chromatin assembly is as yet unknown. In 
vitro, the N-terminal domain of histone H3 and H4 are unnecessary for chromatin 
assembly. The acetylation of histone N-terminal domains is not required in deposition 
of histone onto the DNA but recent studies showed that it facilitates the regular 
spacing of nucleosomes during chromatin assembly in vitro. 
Histone proteins are rich in the positively-charged basic amino acids lysine 
and arginine. This gives them an intrinsic affinity for the negatively-charged 
phosphate groups of DNA in the histone-DNA interactions. In vitro, mixing histones 
and DNA at physiological salt concentration leads to the rapid formation of undefined 
insoluble aggregates (Figure 1.24). Chromatin assembly occurs in a regulated and 
ordered manner by the help of some additional anionic factors which shield the 
charge of the histones from DNA. These additional negatively charged molecules act 
as histone chaperones to allow the H3-H4 tetramers to bind to DNA first because of 
their higher affinity for DNA compared with H2A-H2B dimers. H2A-H2B dimers are 
deposited subsequently, having greater affinity for subnucleosomal particles 
containing DNA and H3-H4 tetramers than for either histone chaperones or DNA. 
These in vitro experiments show that chromatin assembly is mediated by histone 
chaperones. (Figures1.23 and 1.24) 
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Figure 1.23 The mechanism of chromatin assembly and disassembly 
This diagram shows the stepwise assembly and disassembly of nucleosomes 
mediated by histone chaperones. Histone H2A is depicted in yellow, H2B in red, H3 
in blue and H4 in green (Das et al., 2010). In chromatin assembly, it is believed that 
one histone H3-H4 dimer is attached to the DNA strand first, followed by another H3- 
H4 dimer to form a 'tetrasome'. Then a histone H2A-H2B dimer is attached to the 
'tetrasome', and finally another H2A-H2B dimer is recruited to form a nucleosome. 
The chromatin disassembly is progressed in the completely opposite way of 
chromatin assembly. All these processes are mediated by histone chaperones. 
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Figure 1.24 The chromatin assembly is mediated by histone chaperones 
This diagram shows the mechanism of histone assembly (Das et al., 2010). 
A. Directly mixed histone and DNA in vitro will rapidly form insoluble aggregates 
because of the affinity between positively charged histones and negatively 
charged DNA. 
B. Histone chaperones could shield the positive charge of histone proteins and let 
chromatin assembly occur in a regulated manner. 
C. An ATP-dependent chromatin remodelling machine is required in the regulation of 
the space between newly synthesised nucleosomes. 
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1.7.2 Histone chaperones 
Histone chaperones are negatively charged molecules that bind to histone 
proteins and facilitate nucleosome formation (Tyler, 2002). Previously, histone 
chaperones were considered as simple histone binding proteins which were involved 
in histone transport into the nucleus and in nucleosome assembly. Later experiments 
indicated that they help to maintain a delicate balance between nucleosome 
assembly and partial or complete disassembly (Figure 1.25; Table 1.3). Recently, 
histone chaperones have been implicated in histone removal and exchange in 
addition to their traditional role of aiding nucleosome assembly. Their role in 
maintaining chromatin structure and dynamics in non-replicating cells is increasingly 
recognized (Das et al., 2010). 
Many molecules can act as histone chaperones in vitro by shielding the basic 
charge of histone proteins from DNA to mediate the process of chromatin assembly. 
Such molecules include pectin, RNA, polyglutamic acid and even salt. Most of these 
molecules just have a little or even no relevance for the assembly of chromatin in the 
cell. However, some histone chaperones still can be identified by using a cell free 
chromatin assembly system coupled to ongoing DNA replication. Histone 
chaperones have traditionally been grouped into chaperones that are `specific' for 
H2A-H2B (e. g. NAP1, FACT, Chz1, nucleophosmin, nucleoplasmin, nucleolin), or 
H3-H4 (e. g. Asf1, Spt6, HIRA, or CAF1) (Table 1.3). Some chaperones are highly 
specific such as Chzl, which preferentially bind H2A. Z-H2B over H2A-H2B. But 
some other chaperones, like NAP1, bind all histones including H1 with high affinity. 
Many structural studies have been carried out on these histone chaperones, 
mostly not complexed to their target histones. The structure of several variants of 
nucleoplasmin, NAP1 and the related SET/TAF-1 and the H3-H4 chaperone Asf1 are 
now known (Burgess and Zhang, 2010). The structure of HIRA and CAF-1 are also 
predicted through homology modelling (Burgess and Zhang, 2010). The overall 
structures of these chaperones are without similarities. However, a four-stranded 0- 
structure is common in the four types of structures (Figure 1.26). Studies show that 
this region directly interacts with histones in Asf1, and it is also suggested that it 
might be the primary histone-recognition motif for the NAP1 family (Burgess and 
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Zhang, 2010). 
Asf1 (CIA1) is the most conserved histone chaperone in eukaryotes. It has been 
shown to interact with the C-terminal of histone H3 by NMR (Mousson et al., 2005), 
and the later crystallisation studies showed that it binds to histone H3-H4 dimer with 
interactions to both H3 and H4 (English et al., 2006; Natsume et al., 2007; lshikawa 
et al., 2011). Although the exact functions of Asf1 in chromatin disassembly and re- 
assembly are not yet clear, it is believed to play important roles in the deposition of 
H3-H4 tetramers onto DNA during nucleosome assembly. The crystal structure of the 
histone H3-H4-Asfl complex showed that the complex made a mutually exclusive 
interaction to another histone H3-H4 dimer. This indicates that Asf1 may play a role 
in nucleosome disassembly as well (Natsume et al., 2007). Studies by Douglas et al. 
(2011) showed that Asf1 aids both deposition of histone H3-H4 tetramers onto DNA 
and removal of the histone H3-H4 tetramer from DNA. But the latter process needs 
additional factors to go to completion (Douglas et al., 2011). The isolated histone H3- 
H4-Asfl complex was also found to be a CAF-1 stimulator (Natsume et al., 2007). 
Chromatin assembly in vitro from proteins extracted from Xenopus oocytes and 
human cells proceeds in a stepwise manner, similar to the chromatin assembly 
occurring in the cell. A heterotrimeric protein complex termed chromatin assembly 
factor-1 (CAF-1) was extracted and identified from human cells. It acts as a histone 
chaperone to deposit newly synthesised histone H3 and H4 onto newly replicated 
DNA in vitro (Stillman, 1986). 
CAF-1 mediates chromatin assembly by the interactions between CAF-1 and 
the nucleoprotein called "proliferating cell nuclear antigen" or PCNA which is a 
component of the DNA replication machinery. It localises to sites of ongoing DNA 
replication in the cell and is required for efficient chromain-mediated transcriptional 
silencing. However, yeast lacks CAF-1 but can still grow well, so this indicates that 
CAF-1 is not the only histone chaperone in the cell. A novel histone chaperone 
termed "replication-coupling assembly factor" (RCAF), was identified to have an 
ability to facilitate CAF-1-mediated assembly of nucleosomes onto newly replicated 
DNA in vitro (Burgess and Zhang, 2010). RCAF is a complex of the Drosophila 
homologue of the yeast antisilencing function 1 (Asf1) protein and histone H3 and H4. 
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Asf1 appears as a histone chaperone for newly synthesised histones H3 and H4 in 
vitro. The study showed that the function of Asf1 is to bind to CAF-1 to enhance 
chromatin assembly. To do this, CAF-1 targets Asf1 to the DNA replication fork but 
does not directly mediate the process (Figure 1.27). CAF-1 also binds H3-H4 by 
interacting with a component of the DNA replication machinery, PCNA (see above). 
This facilitates nucleosome assembly following DNA replication and repair (Burgess 
and Zhang, 2010). Lack of CAF-1 in yeast cells leads to reduced silencing at 
telomeres and higher sensitivity to DNA damaging agents (Kaufman et al., 1997; 
Linger and Tyler, 2005). 
Nucleosome assembly protein (NAP) is another class of histone chaperone. 
NAP1 and Vps75 are two proteins in this class which have been shown to associate 
with all four core histones(Krogan et al., 2006). NAP1 is reported to have roles in 
transporting histones into the nucleus (Chang et al., 1997; Mosammaparast et al., 
2001) and, together with ATP-dependent chromatin remodelling factors, to play roles 
in disassembly and re-assembly of nucleosomes in vitro (Lorch et al., 2006; Tyler at 
al., 1999). Recently, some studies showed that two histone H3-H4 dimers bind to a 
single NAP1Nps75 dimer (Andrews et al., 2008,2010; Park et al., 2008) which may 
suggest a new model of deposition and removal of histone H3-H4 onto and from the 
DNA as an integrity tetramer rather than split into dimers (Bowman et al., 2011) 
(Figure 1.29). 
It is currently believed that during chromatin assembly after DNA replication, 
H3-H4 or (H3-H4)2 is first deposited to the DNA, followed by the deposition of H2A- 
H2B dimers (Burgess and Zhang, 2010). There are two potential procedures to 
deposit H3-H4 to the DNA. One possible pathway is that two H3-H4 dimers 
sequentially deposit onto the DNA. Another possibility can be that two H3-H4 dimers 
form a tetramer on a histone chaperone before being deposited onto the DNA (Das 
et al., 2010). Studies show that the histone chaperone Asf1 can bind to H3-H4 
dimers through an H3 interface which is involved in the formation of (H3-H4)2 
tetramers (English et al., 2006). However, in this structural study, cloned histones 
were involved and the H3 N terminal helical region was not present. Asf1 was also 
found to be required for acetylation of histone H3 on lysine 56, which is an important 
mark of newly-synthesized histones in DNA replication and repair (Recht et al., 2006; 
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Chen et al., 2008; Li et al., 2008). Rttl06 is another histone H3-H4 chaperone found 
in yeast (Burgess and Zhang, 2010). Studies have shown that Rtt106 is involved in 
DNA replication and repair (Huang et al., 2007; Li et al., 2008). A possible model for 
the deposition of H3-H4 is that H3-H4 dimers are transferred from Asfl-H3-H4 to 
CAF-1 and Rttl06, which in turn deposit H3-H4 onto replicating DNA for nucleosome 
formation (Figure 1.28) (Burgess and Zhang, 2010). 
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Table 1.3 Summary of histone chaperones (Modified from Das et al., 2010) 
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Figure 1.25 A summary of potential histone chaperone functions 
This Figure shows the potential functions of histone chaperones. The functions are 
determined by the affinity between a chaperone and histones compared to the 
affinity between the histone and DNA. These affinities can be controlled by post- 
translational modification of histones or the chaperones (Das et al., 2010). 
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Figure 1.26 The structures of some histone chaperones 
The structures of NAP1, Nucleoplasmin, Asf1 and a homology model of HirA or 
CAF1 is shown. They share a ß-sheet motif, but their overall structures are not 
similar (Das et al., 2010). 
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Figure 1.27 The mechanisms of CAF-1 and ASF1 in the mediation of chromatin 
assembly 
Assembly of newly replicated DNA into chromatin requires both Asf1 and CAF-1 in 
vitro. CAF-1 interacts with the ring-shaped PCNA component of the replication 
machinery and the recently identified interaction between Asf1 and CAF-1 may target 
Asf1 to the DNA replication fork to facilitate the process(Burgess and Zhang, 2010). 
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Figure 1.28 A model of how histone H3-H4 deposits onto DNA 
This diagram shows the coordination of histone chaperones for replication- 
dependent nucleosome assembly. In the replication fork, newly-synthesised H3-H4 is 
deposited onto the DNA first and followed by deposition of H2A-H2B dimers to form 
the nucleosome. The deposition of H3-H4 is mediated by histone chaperones CAF-1, 
Asf1 and Rtt106, but how the Asf-H3-H4 complex interacts with CAF-1 and Rtt106 
and whether CAF-1 and Rtt106 bind to H3-H4 dimers or tetramers still remains 
unknown (Burgess and Zhang, 2010). 
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Figure 1.29 A new model of deposition and removal of histone H3-H4 as an integrity 
tetramer: (H3-H4)2 
This diagram shows an alternative mode of histone H3-H4 to be deposited or 
removed onto or from DNA as an intact tetramer form instead of dimer form 
(Bowman et al., 2011). 
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1.7.3 ATP-dependent chromatin remodelling 
Histone chaperones alone are not enough to generate regular arrays of 
nucleosomes with 180-200 base pair spacing in vitro (Figure 1.24). Research has 
shown that chromatin assembly in crude extracts requires ATP hydrolysis in order to 
generate regular arrays of physiologically spaced nucleosomes. The study of crude 
Drosophila embryos identified a second key component of the chromatin assembly 
machinery which is an ATP-dependent chromatin remodelling factor (ACF) (Steger 
and Workman, 1996). 
Histone chaperones and ACF work together as a combination to generate 
regular arrays of nucleosomes in an ATP-dependent manner. The energy required is 
provided by ATP-hydrolysis which allows the histone octamer to move along the DNA 
until regular spacing between nucleosomes is achieved. 
A similar protein complex to Drosophila ACF has been identified in humans, 
called the remodelling and spacing factor (RSF). Compared with ACF, RSF has more 
functions including both deposition of histones and spacing nucleosomes. The other 
difference between ASF and RSF is that the ASF molecule can assemble multiple 
DNA molecules into chromatin but each RSF only assembles one. This may be due 
to the ability of RSF to bind to histones H3-H4 and act as a histone chaperone and 
also a remodelling factor at the same time (Figure 1.24). 
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1.7.4 Our studies 
As described in this review, many mechanisms in DNA replication are still 
unclear. Some unanswered questions are: How do histone chaperones bind to 
histones? Do histones H3-H4 bind to their chaperones as a dimer or a tetramer? 
How were histones H3-H4 deposited onto the DNA with their chaperones? What 
exactly happens in the replication fork during histone disassembly and re-assembly? 
Purified histone dimers (H2A-H2B) and tetramers (H3-H4)2 with a high yield are 
described in Chapter 2. That gives a great potential to study how histone dimers and 
tetramers interact with their chaperones and DNA by, for example, crosslinking 
experiments (Chapter 3.3). The purification of pure histone octamers, dimers and 
tetramers and the use of them to study the related structures and functions are 
explained in Chapters 2,3,4 and 5. 
In collaboration with Dr. Emily Newman and Dr. John MeGeehan in 
Portsmouth University, we have produced a complex of histone chaperone NAP1 
with our pure native chick histones H3-H4 tetramers and studied the structure of the 
NAP1-(H3-H4)2 tetramer complex. The complex was first successfully obtained by 
using our high yield and high purity native H3-H4 tetramers made in this study and 
their recombinant NAP1. This allowed them to find the correct conditions for forming 
a meaningful structure allowing a whole range of structure studies of the low 
resolution NAP1-(H3-H4)2 tetramer complex. In this work, the histones H3-H4 
tetramers were intact and with all its native post translational modifications. This is 
quite different from other studies (English et al., 2006) when they studied the 
complex of histone H3-H4 tetramers with the histone chaperone Asf1. In the studies 
of English et al., (2006) the a-helix and the whole N-terminal tail of histone H3 were 
not present. Based on these results, the Portsmouth group has produced a complex 
of NAP1 and their recombinant histones H3-H4 tetramers and compared the 
complexes containing native intact histones H3-H4 tetramers and recombinant 
tetramers. These studies are described and discussed in chapter 2. 
In the studies of native nucleoproteins obtained from chick erythrocytes with 
our extraction methods, we found that the linker histone H5 protein co-fractionated 
with histone tetramers under their native, intact states. This may suggest a new 
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model of nucleosome assembly in which the histone H3-H4 tetramers deposit onto 
the DNA first, followed by the deposition of linker histones and nucleosome spacing, 
and finally the deposition of histone H2A-H2B dimers. These studies are described 
and discussed in chapter 4. 
The methods developed and described in this thesis, can be used to extract 
and purify nucleoproteins in their native state in a very quick and efficientmanner. 
This gives a very good opportunity to study histones and their associated proteins, 
such as histone chaperones, and in order to study the mechanisms of chromatin 
disassembly and re-assembly, DNA replication and gene expressionin diseases such 
as cancer. 
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1.8 Materials and methods 
1.8.1 Centrifugation 
Centrifugation is a technique used for the separation of suspensions or even 
macromolecules from solutions according to their size, shape and density by 
centrifugal force. Basically during centrifuging, the more-dense components migrate 
away from the centrifuge axis and the less-dense components migrate toward the 
axis, if they are less dense than the centrifugation medium (Atkinson and Mavituna, 
1983). 
In a laboratory, centrifugations are normally carried out with small volumes 
between 1 to 5,000ml of liquid. A rotor holds a number of tubes of sample balanced 
to pairs, which is placed into the centrifuge machine and an artificial gravitational 
field would be induced by spinning the rotor. Typical rotation speeds of laboratory 
centrifuges, used for centrifuging particles such as cell organelles, range from 1,000 
- 15,000 rpm. Ultracentrifuges are used for biomolecules (Geankoplis, 2003). The 
magnitude of the induced gravitational field is measured in terms of the G value, 
which indicates how many times of gravity is induced into the system. The G value is 
also referred to as the RCF (relative centrifugal force) value which depends on the 
rotation speed and the manner in which the centrifuge tubes are held by the rotor: 
G= rw2/g = 2Trrn2/g 
Where: 
r= distance from the axis of rotation (m) 
w= angular velocity (radians/s) 
g= acceleration due to gravity (m/s2) 
n= rotation speed (revolutions per minute, rpm) 
The distances, r, from the axis of rotation to the top and the bottom of the 
centrifuge tubes are different, so the bottom of the tube has the highest G value and 
the top of the tube has the lowest G value. So as the particles migrate to the bottom 
of the tube they will experience an increasing G value. Normally the average G value 
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(a mean of the maximum and minimum values) is used for nomograms giving the 
relationship between rotation speed and G value which is provided by centrifuge 
manufacturers for each type of rotor. Typical G values range in laboratory centrifuges 
are from 1,000 - 20,000. Ultracentrifuges can provide G values up to 200,000 and 
even higher. 
Because of the time spent on speed up and slow down of the rotor; to accurately 
calculate the complete sedimentation time is almost impossible. Commonly there is 
an empirical correlation which is used to calculate the complete centrifugation time: 
t= k/s 
where: 
t= complete sedimentation time 
k= k-factor of the centrifuge 
S= Svedberg coefficient of the material being precipitated 
One Svedberg unit (S) is equal to 10-13s (sedimentation coefficient). The k-factor 
can be calculated using the empirical correlation: 
k=2 
. 
53x 1 Oll (In(rmax-rmin)/rpmmax2) 
Where: 
rmax 
rmin 
rpmmax 
= radial distance from the axis to the bottom of the tube (cm) 
= radial distance from the axis to the top of the tube (cm) 
= maximum rotation speed (/min) 
An ultracentrifuge which ranges from 30,000 - 100,000 rpm can be used if a 
higher speed separation is required. It is normally used for separating molecules 
such as DNA/RNA or proteins. Because of the very high speed, these special- 
designed devices include provision of vacuum and cooling system to avoid the heat 
generated during the high speed spinning. The centrifuge tubes with sample need to 
be balanced very accurately and carefully, to within 0.01 g (Ghosh, 2006). 
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1.8.2 Dialysis 
Dialysis is a common method to separate molecules in solution by the difference 
in their rates of diffusion through a semipermeable membrane. Typically a solution of 
several types of molecules is placed into a semipermeable dialysis bag, such as a 
cellulose membrane with pores that only molecules smaller than a certain molecular 
weight can pass through. This could typically be 10,000 daltons or, at greater cost, 
as low as 3,000 daltons. Then the sealed dialysis bag is placed in a container 
containing different buffers, or pure water. The pores on the semipermeable 
membrane of the dialysis bag only allow small molecules, often water and salts, to 
pass through. Large molecules like proteins or DNA are retained inside the dialysis 
bag. 
The solution into which the dialysis bag is placed will be changed after several 
hours when the salt concentration in the bag has been changed. The new solution 
changed will lead to a further change of the salt in the protein solution. After several 
changes, the new salt conditions will be fully established. 
This technique is usually used to remove the salt from a protein solution; it will 
not distinguish between proteins effectively. The main applications of dialysis 
technique include: 
1. Remove of acid or alkali from products 
2. Remove of salts and low molecular weight components from solutions of 
macromolecules 
3. Concentration of macromolecules 
4. Haemodialysis 
During dialysis, the solute transport through the dialysis membrane is driven by 
the concentration difference between each side of the membrane. The solute flux J 
can be calculated by: 
J= SDefl(OC/bm) 
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Where: 
S= dimensionless solute partition coefficient (- ) 
Deff = effective diffusivity of solute within the membrane (m2/s) 
bm = membrane thickness (m) 
S, Deff and ism can be combined to calculate the membrane mass transfer 
coefficient which gives: 
J= KMOC = AC/RM 
Where: 
KM = membrane mass transfer coefficient (m/s) 
RM = membrane resistance (s/m) 
The dialysis membrane creates a resistance known as RM which is a constant for 
a particular solute membrane system. Because normally during dialysis both side of 
dialysis membrane are liquids, the liquid boundary layers on either side of the 
membrane also create resistance to solute transport. The total three barriers can be 
added: 
Ro = RM + Ri +R2 
Where: 
Ro = overall resistance (s/m) 
R, = resistance of upstream side boundary layer (s/m) 
R2 = resistance of downstream side boundary layer (s/m) 
This equals to: 
1 /Ko =1 /Km +1 /K1 + 1/K2 
Where: 
Ko = overall mass transfer coefficient (m/s) 
K1 = upstream side mass transfer coefficient (m/s) 
K2 = downstream side mass transfer coefficient (m/s) 
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So the overall solute transport from the upstream to the downstream side can be 
calculated by: 
N= Ko (Cl - C2) 
Where: 
Cl = upstream concentration (kg/m3) 
C2 = downstream concentration (kg/m3) 
The solution outside the dialysis bag is stirred to keep always the maximum 
concentration difference between the inside and outside of the bag. 
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1.8.3 Precipitation 
Precipitation is a traditional purification method which is widely used in 
bioseparations. The basic mechanism of precipitation is to separate the proteins with 
different solubility in the solution. By adding precipitating agent into the solution, the 
components which tend to be insoluble under the new condition will be precipitate 
out from the solution. Then the solid-liquid separation techniques such as 
centrifugation will be used to separate the insoluble components and the soluble 
parts will remain in the supernatant. 
The precipitation factors are mainly including cooling, pH adjustment, addition of 
solvents, addition of anti-chaotropic salts, addition of chaotropic salts and addition of 
biospecific reagents. 
The solubility of proteins in aqueous solutions depends on the temperature, and 
different proteins have different sensitivities to the temperature of their solubility. For 
example, at a certain temperature one protein may largely be precipitated out but 
another protein can be still largely in the solution. 
pH is another key element in protein solubility. The minimum solubility of a protein 
is at its isoelectric point (pl). Different proteins have different pl, so if the solution is 
maintained at the pH equal to the pl of one protein which would largely precipitate 
out, meanwhile other proteins would remain in the solution. However, proteins may 
not precipitate out at solvent pH equal to their pl: it depends on the abundance of 
charged, hydrophilic, amino-acid residues such as lysines, arginines, histidines 
(basic), asparagine-acid and gultamic-acid present. The presence of high solvent 
salts ionic strength therefore promotes precipitation (salting out, see later). 
Some organic solvents such as ethanol or acetone can be added into the solution 
to precipitate out proteins or DNA/RNA. These organic solvents can reduce the 
dielectric constant of the solution and decrease the solubility of the proteins in the 
solution. This can be calculated by: 
In(S/Sw) = (A/RT)(1/ew -1/e) 
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Where: 
S= solubility of the protein in solvent (kg-moles/m3) 
SW = solubility of protein in water (kg-moles/m3) 
A=a constant 
e= dielectric constant of the medium (-) 
eW = dielectric constant of water (-) 
For example, the dielectric constant of water at 25 °C is 78.3 and ethanol at the 
same temperature is 24.3. So when ethanol is added into the solution the solubility of 
the proteins in the solution would be decreased and finally precipitate out. The main 
problem inthe using of this method is that the organic solvents can denature proteins. 
To minimize the denaturation this method is normally carried out at low temperatures 
and the final concentration of the organic solvents in the solution cannot be very high. 
Adding salts to the solution can also reduce the solubility of the proteins in the 
solution. Salts can expose hydrophobic patches on proteins by removing the highly 
structured water layer which covers the patches in solution. This allows the proteins 
to interact with each other causing aggregation and precipitation. Meanwhile salts 
can shield charged groups on proteins which also leads to precipitation. The 
behaviour of proteins is different in salt addition which makes this a successful 
purification method. Salt induced protein precipitation is governed by the Cohn 
equation: 
In(S) =B- KgCs 
Where: 
B=a constant which is the natural log of the theoretical solubility of the protein 
in salt free water. 
K. = salting out constant (m3/kg-moles) 
Cg = salt concentration (kg-moles/m3) 
Step-by-step precipitation is a simple but very useful method in protein 
purification. Careful design of the precipitation methods can allow large amounts of 
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different proteins to be divided into small groups. Even pure single protein can be 
isolated. Crystallization is a special type of precipitation which requires highly 
optimized and carefully controlled conditions. Crystallization is very important 
because the protein crystals can then be analysed by X-ray diffraction to study the 
protein structure (Ladisch, 2001). 
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1.8.4 Size-exclusion chromatography 
Size-exclusion chromatography is a widely used technique to separate proteins 
by their size. It also can be applied to many biological studies such as removal of 
non-protein components (DNA), removal of protein aggregates, the study of 
biological interactions and protein folding (Bailey and Ollis, 1986). 
The mechanism of size-exclusion chromatography is basically using a column 
containing a matrix of porous beads (100-250 pm). When proteins in solution pass 
through the column they will be separated according to their size. Smaller proteins 
would enter the pores of the beads which can delay them in passing through; 
meanwhile larger molecules would directly pass through the column because they 
are not able to enter the pores of the beads. The result ends up with the larger 
proteins being washed out first and smaller proteins later. 
The ability of separation depends on the type of beads. The pore size of the 
beads needs to be closely controlled, and the beads need to have high physical- 
chemical stability. Also the beads need to be hydrophilic and inert, to minimize 
chemical interactions between sample and matrix (Wheelwright, 1991). 
The equipment of size-exclusion chromatography normally includes a pump, a 
sample injector, the column, a detector and a fraction collector. Before use, the 
column should be equilibrated with running buffer for at least 1 column volume. Then 
the protein sample will be applied into the system through the injector. The flow rate 
of size-exclusion chromatography should be carefully controlled, normally between 5 
- 15 cm/h. Too high a flow rate leads to incomplete separation and band spreading. 
Too slow a flow rateleads to diffusion and band spreading. The sample volume has 
to be controlled as well. The loading volume is restricted to <5% (typically 2%) of the 
column volume in order to maximize resolution. Because of that, the protein 
concentration of the sample should be quite high such as 2- 20 mg/ml. The 
solubility depends on the characteristic proteins present so that the sample needs to 
be centrifuged or filtered to remove any precipitations before loading onto the column, 
otherwise the column could be blocked. All the solvents used in size-exclusion 
chromatography need to be degassed while filtering, to reduce the effect of gas 
bubbles. This applies to all chromatographic procedures (Culter, 2004). 
80 
1.8.5 Ion-exchange chromatography 
Ion-exchange chromatography is a technique used to distinguish molecules by 
their net charge. If the pH of the sample is below its pl, the molecules carry a positive 
net charge and will bind to a cation exchange column; if the pH of the sample is 
above its pl, the molecules carry a negative net charge and will bind to an anion 
exchange column. Column contains either cation-exchange resin or anion-exchange 
resin depending on the net charge of the sample. The sample solution will pass 
through the column and the target molecules will bind to the column; other molecules 
will pass through the column with the solution. The target molecule could be washed 
out afterwards (Helfferich, 1962). 
Ion-Exchange Chromatography is based on the interaction between the charged 
molecules in the sample and the matrix contained in the ion-exchange column. 
Proteins contain different charged amino-acid residues. Lysine, arginine and histidine 
have a positive charge at physiological pH; aspartic acid and glutamic acid have a 
negative charge at physiological pH. The net charge of a protein depends on the 
overall chargeof its positively charged amino acid groups and negatively charged 
amino acid groups at physiological pH. The net charge of each charged amino acid 
varies according to the pH of the solution and it will affect the overall charge of a 
protein. Each protein has an isoelectric point (pl) which is a certain pH where the 
protein has a net charge of zero. So if the solution pH is below a protein's pl, the 
protein will has a positive net charge; on the other hand if the solution pH is above a 
protein's pl, the protein will be negatively charged (Belter et al., 1988). 
There are two major types of ion-exchange matrices which are cation-exchange 
resins and anion-exchange resins (Table 1.4). Cation-exchange resins have a 
negatively charged surface and are able to bind to positively charged proteins; 
anion-exchange resins have a positively charged surface and will bind to negatively 
charged proteins. These resins are available as dry granular material or as 
preswollen loose beads, and now prepacked columns are very commonly used. 
An increasing salt (e. g. KCI) solution is passed through or a changing pH in the 
direction of the pl of the protein to be fractionated. In a cation-exchange 
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chromatography, the protein sample is injected to the column. Buffer (called binding 
buffer) with a low pH and low concentration of KCI is passed through the column. 
The proteins with a pI above this pH would be positively charged and bind to the 
column, other proteins would be directly washed out as the non-bind fraction. Then 
an elution buffer with an increased KCI concentration and increased pH is passed 
through the column. The increased positively charged potassium ions, K+, will 
compete with the positively charged proteins for binding to the column; in the 
meanwhile the increased pH towards the pi of the proteins will lower their net 
positive charge and be released from binding to the column and eluted into fraction- 
collector, progressively as the salt in the elution buffer is increased. The elution 
buffer progressive salt increase is produced by control of a mixer device. This mixes 
the high-salt buffer, B, with the binding buffer, A. Similar effects happen in an anion- 
exchange chromatography: the increased negatively charged chloride ion in KCI will 
compete with the negatively charged proteins and the decreased pH will 
lowerproteins' negative charge and in order to be washed out. 
In our group, size-exclusion chromatography and ion-exchange chromatography 
are all carried out by Fast Protein Liquid Chromatography (FPLC) with the AKTA 
system (made by G. E. Healthcare). FPLCis a system developed from High- 
Performance Liquid Chromatography (HPLC), which is designed for a full range of 
chromatography modes such as ion-exchange chromatography, size-exclusion 
chromatography, Affinity Chromatography, etc. 
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Table 1.4 Ion-exchange columns 
Ion-exchange Type Strong exchanger Weak exchanger 
Cation exchangers SP (sulfopropyl) CM (carboxymethyl) 
S (Methyl sulfonate) 
Anion exchangers Q (quaternary ammonium) DEAE (diethylaminoethyl) 
QAE (quaternary aminoethyl) 
The ion-exchange columns used in the Author's experiments are all supplied by G. E. 
Healthcare. 
83 
1.8.6 Gel electrophoresis 
Gel electrophoresis is an analytical technique which separates biomolecules by 
their electrical charge and size. The biomolecules move under the influence of an 
electrical field and migrate through a gel at a rate depending on their size and charge. 
The gel used to separate molecules is usually a crosslinked polymer whose 
composition and porosity is chosen based on the weight and composition of the 
target of the analysis. For proteins or small nucleic acids, the gel is usually made 
with different concentrations of acrylamide and a cross linker, producing different size 
mesh networks of polyacrylamide. For large nucleic acids which have greater than a 
few hundred bases, usually an agarose gel is used. During electrophoresis, a 
voltage across the gel produces an electric-field profile that exerts forces on the 
charged molecules allowing them to migrate to various positions in the gel. 
Molecules move from one end to the other end of the electric field by the net charge 
they contain. Because the gel provides resistance for their movement, the molecules 
with smaller size will move faster than the molecules with larger size. The molecules 
with different sizes and shapes will so be separated (Berg, 2002). 
For protein separation, sodium-dodecyl-sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) is commonly used. The protein solution to be analysed 
is first mixed with SDS, an anionic detergent which denatures secondary and non- 
disulfide-linked tertiary structures and gives a negative charge to each protein in 
proportion to its mass. Without SDS, different proteins with similar molecular weights 
would migrate differently due to differences in folding, as differences in folding 
patterns would cause some proteins to better fit through the gel matrix than others. 
Another treatment of the protein sample, needed to be done before running the 
gel, is to heat the sample to near boiling in the presence (or sometimes absence) of 
a reducing agent such as dithiothreitol (DTT) or 2-mercaptoethanol which further 
denatures the proteins by reducing disulfide linkages. This is known as reducing 
SDS-PAGE. Sometimes non-reducing SDS-PAGE is needed when it is important to 
see if a protein or group of proteins interact via disulphide bridges. PAGE gels can 
be used, without SDS and without boiling a sample, to allow proteins to migrate 
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through the gel, linked acrylamide, according to its native conformation and charge. 
In SDS PAGE, denatured proteins will be loaded onto the gel carefully, mixed with 
"sample buffer" containing glycerol and the reducing agent. This allows the solutions 
to sink to the bottom of the loading pocket formed in the gel. The polyacrylamide gel 
is inside a tank of two slides of glass and submerged in a suitable buffer. An electric 
voltage is applied across the gel; the negatively charged proteins will start to move 
from the top of the gel to the bottom if the bottom electrode is positive. Short proteins 
will more easily flow through the pores in the gel, while larger ones will have more 
difficulty, so the small proteins will move faster than larger ones. Following the 
electrophoresis, the gel may be stained to allow the protein bands to become visible. 
Stain not bound to the SDS-protein bands is removed by washing in a destaining 
solution. In our experiments coomassie stain was used and destaining was in 
distilled water. The recipes and method of SDS-PAGE which were used in our 
experiments are described in Appendix 3. 
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1.8.7 Mass spectrometry 
Mass spectrometry is an analytical technique used to measure the mass-to- 
charge ratio of ions. It is usually used to find the composition of a physical sample by 
generating a mass spectrum representing the masses of sample components. The 
mass spectrum is measured by a mass spectrometer. 
A spectrometer usually involves three main parts which are an ion source, a 
mass analyzer and a detector system. Firstly the mass spectrometer will produce 
ions from the sample; then it separate ions of differing masses; after that it detects 
the number of ions of each mass produced and finally it collects the data and 
generates the mass spectrum. 
This technique could be used to identify unknown compounds by the mass of the 
compound molecules (Bruins, 1991). 
The mass spectrometry might be the most useful technology in proteomics. 
During this process, proteins will be digested by enzyme (typically using trypsin) into 
small peptides, which contain three to eight amino-acids residues. The technology 
produce tiny nanometer-sized droplets, and introduce them so that the peptides are 
in a charged state in the vacuum of an electo-optical system that determines the 
mass of a peptide to an accuracy of better than 0.01% (typically +/- 0.01 to 0.001 
Daltons). Such amazing accuracy easily distinguishes which amino-acid residues are 
present in a peptide and also which amino-acid residues have particular 
modifications, because the options for modifications are limited in number and they 
introduce uniquely-defined changes in molecular weight. Proteins can be identified 
through this technology by matching the observed peptide compositions to proteins 
encoded on the genome map. 
Our group is collaborating with Dr. Mark Dickman of The University of Sheffield 
for the mass spectrometry analysis of proteins separated in SDS-PAGE gels. We 
pre-treat the gel sample in our laboratory and then send them to Sheffield University 
for analysis in their Mass Spectrometer. 
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There are basically five steps in treating the gel sample for mass spectrometry. 
First of all, the SDS-PAGE gel was carefully rinsed with deionised water and the 
bands which were going to be analysed were cut from the gel. Then the bands were 
washed and incubated with ammonium bicarbonate and acetonitrile solution at 37°C 
to remove the commassie blue stain. After that the gel pieces were reduced to break 
disulphide bonds and they were then alkylated to prevent disulphide bonds reforming. 
Then the gel pieces were treated by trypsin digestion which digests the peptides in 
the gel pieces into approximately five amino acidresidues. Finally the peptides were 
extracted from the gel pieces and dried. They were then ready to be sent to Sheffield 
University for mass spectrometry analysis. 
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1.8.8 Lyophilization (Freeze-drying) 
The proteins in solution could suffer from many reactions due to physical, 
chemical and biological factors. Physical reactions such as aggregation and 
precipitation, chemical reactions such as glycation of lysine residues, and biological 
reaction such as degradation by enzymes will affect the further study or analysis of 
the protein. On the other hand, proteins under a dry state could preserve all or most 
of its initial biological activity which offers many advantages for long-term storage. 
Meanwhile to dry the protein sample can be also considered as a concentrating 
process since the protein can be then dissolved into a certain amount of buffer to 
provide a certain concentration. 
Lyophilization, also known as freeze-drying method is a widely used technique to 
dry the protein samples. A freeze-drying machine normally consists of a set of 
shelves, a condenser, and a high performance vacuum pump. The protein sample in 
solution will first be cooled down to about -40°C, meanwhile the condenseris also 
cooled down to usually -60 °C. Then the sample will be placed into a chamber where 
the vacuum pump will reduces the pressure in it. This allows sublimation of the water 
molecules in the sample solution, and the condenser acts as a lower temperature 
trap for the sublimed water to be collected as ice. 
Freeze-drying is quite a time consuming process. Depending on the total volume 
of the sample, process for 72 hours or more is not unusual. 
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Chapter 2 
Extraction and crystallisation of histone octamers, 
dimers and tetramers from chick erythrocyte nuclei 
2.1 Extraction of histone octamers, dimers and tetramers from chick 
erythrocyte nuclei 
Introduction 
The Liverpool John Moores University Chromatin Research Group has 
developed the methods for making pure histone octamers, dimers and tetramers and 
published high resolution histone octamer structure in high KCI/phosphate (1.6 M 
KCI, 0.8 M K2HPO4i 0.8 M KH2PO4) . 
A previous student Dr. Sirirath Sodngam (Sodngam, 2007) has established a 
method of histone octamer purification as a first stage in histone dimers and 
tetramers purification. With her method histone octamers were purified from most of 
the other proteins. She also fractionated histone dimers and tetramers at low ionic 
strength by dialysing histone octamers into 100 mM KCI, 100 mM equimolar 
phosphate to purify them in a S100 size-exclusion column. The tetramers eluted first 
from the column and the dimers afterwards, but the two peaks were not well 
separated. 
My tasks are firstly to produce extra-pure histone octamers and then 
crystallise them and attempt to gain higher resolution structure than 1.9 A already 
achieved by our group (Wood et al., 2005). Also we want to improve on the previous 
student's work by using the extra-pure histone octamers to dialyse against 100mM 
KCI, 100mM equimolar phosphate to extract pure histone dimers and tetramers by 
using cation-exchange chromatography, and try to crystallise these histone dimers 
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and tetramers in order to analyse their structure by X-ray diffraction studies (Chapter 
2.1 & 2.2). Finally we want to use the pure native histone dimers and tetramers in 
collaboration with others in order to produce specific complexes with histone 
chaperones (Chapter 2.3). 
During the course of the work a publication by Santos-Rosa (Santos-Rosaet 
al., 2008) showed that there is a specific endogenous protease that cleaves the core 
histone H3. In my hands the use of benzamidine hydrochloride as an inhibitor of 
proteases in general, and this one in particular, worked well and pure uncleaved 
histone octamers could be produced. Latterly, the inclusion of this protease inhibitor 
in the last gel exclusion chromatography, even though this affected the OD278 
ultraviolet-absorption monitor, gave the final step to fractionate ultra-pure octamers. 
Benzamidine hydrochloride was also effective for pure core histones in tissue-culture 
extracts without the need for extra protease inhibitors, for example the "complete" 
cocktail of inhibitors from the company Merck. 
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Materials and Methods: 
Buffers: 
(add benzamidine hydrochloride freshly, keep in 4 °C before use; all buffers 
were filtered by 0.4 micron filters before use) 
1. Nuclei washing buffer: 1L of 10 mM KCI, 5 mM K2HPO4,5 mM KH2PO4, 
3.5 mM MgCI2,2.5 mM benzamidine hydrochloride. 
2. Nuclei Lysing buffer: 400 ml of 2.5 M KCI, 0.25 M K2HPO4,0.25 M KH2PO4, 
2.5 mM benzamidine hydrochloride. 
3. Histone octamer precipitation buffer: 100 ml of 2M KCI, 1M K2HPO4,1 M 
KH2PO4,2.5 mM benzamidine hydrochloride. 
4. Octamer maintenance buffer: 2L of 2M KCI, 0.2 M K2HP04,0.2 M 
KH2PO4. 
5. Ion-exchange running buffer: 
Buffer A: 1L of 100 mM KCI, 50 mM K2HPO4,50 mM KH2PO4. 
Buffer B: 1L of 2M KCI, 50 mM K2HPO4,50 mM KH2PO4. 
Procedure: 
Four tubes (about 160 ml) of the chick nuclei (prepared as in Appendix 1) 
were thawed in the 4 °C cold room. After thawing, the chick nuclei were partitioned 
into two 50 ml centrifuge tubes, balanced and then centrifuged at 2000 rpm 
(Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) (900 xg) for 20 mintues. This 
speed and time was determined by experiments, if the speed is too high 
centrifugation would cause nuclei lysis. After centrifugation, the supernatant was 
discarded and the nuclei pellets were mixed with equal volume of nuclei washing 
buffer, dispersed by sucking in and out with a submerged Pasteur pipette and made 
up to 160 ml. Then the nuclei sample was centrifuged again at 2000 rpm (Beckman 
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Acanti® J-26 XP centrifuge, JS 13.1 rotor) for 15 mintues and the supernatant was 
discarded, the nuclei pellets were mixed with equal volume of nuclei washing buffer, 
dispersed by sucking in and out with a submerged pipette and made up to 75 ml. 
Then 50 ml of nuclei lysis buffer was put into each of six Ti 45 centrifuge tubes, 12.5 
ml of nuclei sample was carefully layered on top of the nuclei lysis buffer in each of 
six Ti 45 centrifuge tubes and the tubes were balanced in pairs within 0.01 g with 
nuclei washing buffer. The six tubes were quickly shaken to mix the nuclei and lysis 
buffer. The nuclei lysed to form a gel in the centrifuge tubes. The balanced tubes 
were placed into a Beckman Ti 45 rotor to ultra-centrifuge at 35,000 rpm (Beckman 
OPTIMATM L-80 preparative ultracentrifuge, Ti 45 rotor) (100,000 xg) for 16 hours. 
The layering and sudden shaking of the centrifuge tubes were new in my methods, 
since nuclei take a short time before lysing, by which time the mixed conditions (2 M 
KCI, 0.2 M K2HPO4,0.2 M KH2PO4) had been established for each nucleus. 
After ultra-centrifugation, the DNA pellets were kept in the freezer; the 
supernatant was concentrated down to a certain volume V which the concentration 
was 20 mg/ml. There was about 480 mg of total proteins in the supernatant so V=24 
ml this time. A volume of 0.9XV ml (21.6 ml) histone octamer precipitation buffer was 
added dropwise while stirring on ice to the concentrated 24 ml of sample. After 10 
minutes stirring on ice, a light precipitate was formed and the sample was 
centrifuged at 12,000 rpm (Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) for 
30 minutes to separate the supernatant and precipitate. The precipitate was kept as 
a group of proteins we called cePNE2 and further analysis could be done for them. 
The supernatant was collected and a further 1.5xV ml (36 ml) histone octamer 
precipitation buffer was added dropwise while stirring on ice to the centrifuged 
supernatant. After 10 minutes stirring on ice, a heavy precipitate was formed and the 
sample was centrifuged again at 12,000 rpm (Beckman Acanti® J-26 XP centrifuge, 
JS 13.1 rotor) for 30 minutes to separate the supernatant and precipitate. This time a 
dense pellet was formed on top of the supernatant after centrifuging; the supernatant 
containing mainly linker histones was sucked out by a syringe and kept in the freezer. 
The octamer crusts were dissolved in 10 ml of octamer maintenance buffer and 
loaded onto a S100 gel exclusion column to run at 0.6 ml/minute flow rate for 500 ml 
(1.5 column volume) (Figure 2.1). 
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The main peak fractionated from the gel exclusion which contained pure 
histone octamers (Figure 2.1b) was dialysed against cation exchange buffer A (100 
mM KCI, 50 mM K2HPO4,50 mM KH2PO4), then the sample was loaded onto four 
series of 5 ml Sephadex SP columns (high trap, fast flow, GE Healthcare) to run 
cation exchange chromatography with buffer A: 100 mM KCI, 50 mM K2HP04,50 
mM KH2PO4; and buffer B: 2M KCI, 50 mM K2HPO4,50 mM KH2PO4. (Figure 2.2) 
There were two peaks separated from this cation exchange which the first one was 
pure histone dimers and the second one was pure histone tetramers, 20% SDS- 
PAGE was run for pure histone octamers, dimers and tetramers (Figure 2.3 & 2.4). 
Note that this is the reverse order from size-exclusion chromatography where the 
dimers and tetramers were partially separated. This proves that the isolated H3-H4 
complex is definitely in the tetramer form. 
The principle of this method was that the dimers and tetramers were ultra- 
pure because they were prepared from pure histone octamers. Therefore they were 
not contaminated by other proteins which feature in other methods for preparing 
histone dimers and tetramers. 
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Results: 
The chromatograms of the size-exclusion chromatography for purifying 
histone octamers and of the cation-exchange chromatography for histone dimers 
and tetramers are given in Figure 2.1 and 2.2, which are self-explanatory and show 
high-resolution fractionation of the octamers, dimers and tetramers. 
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Figure 2.1 Pure histone octamers fractionated from S100 size exclusion 
chromatography 
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Four tubes of chick nuclei were lysed by nuclei lysis buffer (2.5 M KCI, 0.25 M 
K2HPO4,0.25 M KH2PO4,2.5 mM benzamidine hydrochloride) and ultracentrifuged 
at 100,000 xg in the Beckman Ti 45 rotor for 16 hours. After that the supernatant was 
taken and concentrated down to 20 mg/ml. Then after two steps of precipitation with 
histone octamer precipitation buffer (2 M KCI, 1M K2HPO4,1 M KH2PO4,2.5 mM 
benzamidine hydrochloride), most of histone octamers were precipitated out and 
then re-dissolved into 10 ml of 2M KCI, 0.2 M K2HPO4,0.2 M KH2PO4. Then the 
histone octamer sample was loaded onto a S100 size exclusion column to run at 0.6 
ml/minute flow rate for 500 ml (1.5 column volume) with 2M KCI, 0.2 M K2HPO4,0.2 
M KH2PO4. This is the chromatogram of the S100 size exclusion. 
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From previous experiments it was known that the middle part of the main 
peak of this size exclusion contains the most pure histone octamers. So only the 
central part of the main peak shown in Figure 2.1 was selected for histone octamers 
production and further histone dimers and tetramers purification. A sample was taken 
from this selected histone octamer sample and loaded onto a 20% SDS-PAGE gel, 
the result is shown in Figure 2.3. 
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Figure 2.2 Histone dimers and tetramers fractionated by cation exchange 
chromatography 
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The chick histone octamer sample was loaded on to four series of 5-ml Sephadex 
SP columns (HightrapTM, fast flow, G. E. Healthcare) running with a salt gradient from 
0.1 M KCI, 0.05 M K2HPO4,0.05 M KH2PO4 (buffer A) to 2M KCI, 0.05 M K2HPO4, 
0.05 M KH2PO4 (buffer B). The first peak is eluted with 30% buffer B which is pure 
chick histone dimer and the second peak is eluted with 40% buffer B which is pure 
chick histone tetramer. SDS-PAGE of each fraction is shown in Figure 2.4. 
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Figure 2.3 20% SDS-PAGE of pure chick histone octamer sample selected from 
Figure 2.1 
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This is a 20% SDS-PAGE of pure chick histone octamer sample selected from Figure 
2.1 b. Four bands from top to bottom are histone H3, H2A, H2B and H4. 
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Figure 2.4 20% SDS-PAGE of pure chick histone dimers and tetramers selected 
from Figure 2.2 
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This is a 20% SDS-PAGE of pure chick histone dimers and tetramers fractionated by 
cation exchange chromatography described in Figure 2.2. 
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Conclusions and discussion 
Very pure histone octamers were produced by removing cePNE1 proteins 
(Chapter 3) before the lysis of cell nuclei, the removal of cePNE2 proteins by 
precipitation and careful selection of fractions from the size-exclusion S100 column. 
A second fractionation after concentrating the fractions chosen from the first column 
gave even purer histone octamers. 
Histone dimers and tetramers were very clearly separated by using four SP 
5ml, fast flow, Hitrap cation-exchange columns in series. 
In the next section, 2.2, it is shown how histone octamers, dimers and 
tetramers were set up for crystallisation and X-ray diffraction. Our native pure histone 
tetramers were the first product to produce the specific complexes with NAP1 -a 
histone chaperone - in collaboration with Dr. John McGeehan and Dr. Emily 
Newman from Portsmouth University. This is discussed in section 2.3. 
100 
2.2 Crystallisation of Chick Histone Octamers, Dimers and Tetramers 
Introduction 
When the chick histone octamers, dimers and tetramers had been purified, 
the next step of study was to try to crystallise them. Our group has successfully 
crystallised chick histone octamers in 2M KCI/1.35 M phosphate pH 6.9 at 2.15 A 
resolution (Lambert et al., 1999; Chantalat et al., 2003) and at 1.9 A resolution 
(Wood et al., 2005). The crystals of chick histone dimers and tetramers have not 
been crystallised in any research so far. The aim of this experiment was firstly to try 
to crystallise histone octamers to achieve even higher resolution by using the extra 
pure histone octamer samplesproduced by the new purification method developed; 
secondly to try to crystallise chick histone dimers and tetramers and study their 
structures by X-ray crystallography. This enabled us to appreciate the very different 
solubilities of histone dimers and tetramers in KCI/phosphate. 
Methods: 
The chick histone octamers, dimers and tetramers samples used for 
crystallisation were purified in our laboratory and the methods were described in 
chapter 2.1. Dialysis technology (chapter 1.8.2) was used for the crystallisation trials 
of chick histone octamers, dimers and tetramers. The crystallisation conditions were: 
Crystallisation solutions: 
1. Octamer crystallisation buffer a: 2M KCI, 0.675 M K2HPO4,0.675 M KH2PO4, 
2.5 mM benzamidine hydrochloride, pH 6.8. 
2. Octamer crystallisation buffer b: 1.6 M KCI, 0.8 M K2HPO4,0.8 M KH2PO4,2.5 
mM benzamidine hydrochloride, pH 6.8. 
3. Dimer crystallisation buffer a: 1M KCI, 0.5 M K2HP04,0.5 M KH2PO4,2.5 mM 
benzamidine hydrochloride, pH 6.8. 
4. Dimer crystallisation buffer b: 0.9 M KCI, 0.45 M K2HP04,0.45 M KH2PO4,2.5 
mM benzamidine hydrochloride, pH 6.8. 
5. Dimer crystallisation buffer c: 0.8 M KCI, 0.4 M K2HPO4,0.4 M KH2PO4,2.5 
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mM benzamidine hydrochloride, pH 6.8. 
6. Dimer crystallisation buffer d: 0.7 M KCI, 0.35 M K2HP04,0.35 M KH2PO4,2.5 
mM benzamidine hydrochloride, pH 6.8. 
7. Dimer crystallisation buffer e: 0.6 M KCI, 0.3 M K2HPO4,0.3 M KH2PO4,2.5 
mM benzamidine hydrochloride, pH 6.8. 
8. Dimer crystallisation buffer f: 0.5 M KCI, 0.25 M K2HPO4,0.25 M KH2PO4,2.5 
mM benzamidine hydrochloride, pH 6.8. 
9. Tetramer crystallisation buffer a: 1M KCI, 0.5 M K2HPO4,0.5 M KH2PO4,2.5 
mM benzamidine hydrochloride, pH 6.8. 
10. Tetramer crystallisation buffer b: 0.9 M KCI, 0.45 M K2HPO4,0.45 M KH2PO4, 
2.5 mM benzamidine hydrochloride, pH 6.8. 
11. Tetramer crystallisation buffer c: 0.8 M KCI, 0.4 M K2HPO4,0.4 M KH2PO4,2.5 
mM benzamidine hydrochloride, pH 6.8. 
12. Tetramer crystallisation buffer d: 0.7 M KCI, 0.35 M K2HPO4,0.35 M KH2PO4, 
2.5 mM benzamidine hydrochloride, pH 6.8. 
13. Tetramer crystallisation buffer e: 0.6 M KCI, 0.3 M K2HPO4,0.3 M KH2PO4,2.5 
mM benzamidine hydrochloride, pH 6.8. 
14. Tetramer crystallisation buffer f: 0.5 M KCI, 0.25 M K2HPO4,0.25 M KH2PO4, 
2.5 mM benzamidine hydrochloride, pH 6.8. 
Procedures: 
20 ml of 1 mg/ml pure chick histone octamers sample was concentrated down 
to 1 ml (20 mg/ml). Six 10 ml bottles were prepared and labeled, three of them 
contained 10 ml of octamer crystallisation buffer a (2 M KCI, 0.675 M K2HPO4, 
0.675 M KH2PO4,2.5 mM benzamidine hydrochloride, pH 6.8), three of them 
contained 10 ml of crystallisation buffer b (1.6 M KCI, 0.8 M K2HPO4,0.8 M 
KH2PO4,2.5 mM benzamidine hydrochloride, pH 6.8). The crystallisation buffer a 
was used by Chantalat et al. (2003) for chick histone octamer crystallisation and 
they successfully obtained chick histone octamer crystals at 2.15 A. 
0.05 ml of chick histone octamers sample was loaded onto a crystallisation 
button, then covered by a piece of dialysis membrane and sealed with rubber 
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rings. The sealed buttons were put into each bottle containing octamer 
crystallisation buffer a&b and the bottles were sealed and stored at 4 °C fridge. 
Each chick histone dimers and tetramers in 100 mM KCI, 50 mM K2HPO4,50 
mM KH2PO4,2.5 mM benzamidine hydrochloride were concentrated down to 20 
mg/mi. Three 10ml bottles were prepared for each different conditions (dimer 
crystallisation buffer a to e and tetramer crystallisation buffer a to e) and 0.05 ml 
of samples were loaded to the crystallisation buttons, sealed and stored at 4 °C 
fridge. All the buttons were checked under the microscope in every 7 days. 
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Results and discussion 
The chick histone octamers formed many crystals in octamer crystallisation 
buffer b (1.6 M KCI, 0.8 M K2HPO4,0.8 M KH2PO4,2.5 mM benzamidine 
hydrochloride, pH 6.8) (Figure 2.5 a and b), X-ray diffraction analysis showed 
crystals giving the highest resolution, 1.8 A (Figure 2.6 a and b, Table 2.1). No 
crystals but a lot of protein precipitations formed in octamer crystallisation buffer a. 
The Author prepared the histone octamers and produced the crystals. The X-ray 
diffraction on beam line at the National Light Source Diamond was carried out by Dr. 
James Nicholson, a member of Liverpool John Moores University group and of the 
Diamond Source. 
The dimers did not form any crystals or precipitations in any dimer 
crystallisation buffers. They seem to have very high solubility even in high ionic 
strength buffer as 1M KCI, 0.5 M K2HPO4,0.5 M KH2PO4, pH 6.8, and much higher. 
The tetramers did not form any crystals in all the tetramer crystallisation buffers, but 
a lot of protein precipitations were formed in tetramer crystallisation buffer a (1 M KCI, 
0.5 M K2HP04,0.5 M KH2PO4,2.5 mM benzamidine hydrochloride, pH 6.8. ) and b 
(0.9 M KCI, 0.45 M K2HPO4,0.45 M KH2PO4,2.5 mM benzamidine hydrochloride, 
pH 6.8) (Figure 2.7a). A suspected tetramer crystal was formed in tetramer 
crystallisation buffer b but the analysis showed that it was just a salt crystal (Figure 
2.7b). 
In a later chapter (chapter 3), where soluble proteins were prepared by direct 
lysis of chick-erythrocyte nuclei, HMG proteins, linker histones and histone dimers 
were produced in 1.6 M KCI, 1.22 M equimolar phosphate, but no histone tetramers. 
Further experiments at high KCI/phosphate, will be made to try to crystallise histone 
dimers, but internationally it is appreciated that histone tetramers are unlikely to 
crystallise on their own. 
The pis calculated for histone dimers and tetramers are 10.58 and 11.42 
respectively and the total numbers of lysines or arginines in each case are 54 and 
112 respectively. It therefore is remarkable that the dimers and tetramers differ in 
their precipitation conditions. However, this maybe correlated with synchrotron- 
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radiation circular dichroism studies of the dimers and tetramers of an earlier 
colleague, Dr. Sirirath Sodngam (Sodngam, 2007). The percentage a helix of the 
tetramers was appreciately less than calculated from the octamer structure, 
suggesting changes in the aN helix of the tetramers when isolated from the histone 
dimers. 
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Figure 2.5a The chick histone octamer crystal formed in 1.6 M KCI, 0.8 M K2HP04, 
0.8 M KH2PO4,2.5 mM benzamidine hydrochloride, pH 6.8. The crystal is at liquid 
nitrogen temperature and mounted in the loop for insertion into the X-ray diffraction 
camera 
ýýý um 
ý_ 
1, ' ri, 
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Figure 2.5b Examples of chick histone octamer crystals in crystallisation cells 
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Several images are showing the chick histone octamer crystals growing in 1.6 M KCI, 
0.8 M K2HPO4,0.8 M KH2PO4,2.5 mM benzamidine hydrochloride, pH 6.8. 
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Figure 2.6 An oscillation image of the chicken histone octamer crystal recorded on 
the CCD detector at Diamond 
a. 
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b. 
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Details of an X-ray diffraction image of the chick histone octamer crystals grown from 
1.6 M KCI, 0.8 M K2HP04,0.8 M KH2PO4,2.5 mM benzamidine hydrochloride, pH 
6.8. There are a few diffractions that show the crystal has a resolution higher than 
2.0 A, with some reaching 1.8 A spacing, which has never been achieved before. 
Although images of diffraction spots are "noisy" for the highest resolution spots, 
computer methods enable remarkably accurate determinations of spot intensities. 
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Table 2.1 Details of the X-ray diffraction studies of four chick histone octamer 
crystals at Diamond 
Strategies to resolution 2.00 A 
Run Predicted Predicted Predicted Predicted # of Total Total Maximum Description 
# completeness I/sigma I/sigma multiplicity images exposure collection resolution (A) 
(%) (overall) time time 
(min: sec) (min: sec) 
1 100.0 1.9 24.3 3.0 532 3: 39 25: 49 2.07 Standard 
Anomolous 
Dataset 
Multiplicity=3 
I/sig=2 
Maxlifespan=2 
83s 
2 100.0 2.0 32.3 5.1 520 4: 07 25: 47 2.00 Standard 
Native Dataset 
Multiplicity=3 
I/sig=2 
Maxlifespan=2 
83 s 
100.0 2.1 34.6 11.8 800 3: 37 36: 57 2.03 strategy with 
target 
multiplicy=16, 
target I/sig=2 
Maxlifespan=2 
83 s 
4 100.0 2.0 17.4 2.9 134 0: 34 6: 09 2.29 Gentle: Target 
Multiplicity=2 
and target 
I/Sig 2 and 
Maxlifespan=2 
8 
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Figure 2.7a The protein precipitation of pure histone H3-H4 tetramers in 0.9 M KCI, 
0.45 M K2HPO4,0.45 M KH2PO4,2.5 mM benzamidine hydrochloride, pH 6.8 
This picture shows the protein precipitation of pure histone H3-H4 tetramers in 0.9 M 
KCI, 0.45 M K2HP04,0.45 M KH2PO4,2.5 mM benzamidine hydrochloride, pH 6.8. 
Although there are no crystals growing, a lot of protein precipitation formed under 
this condition, which means this condition is close to where crystals would form if 
that was possible. 
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Figure 2.7b A suspected chick histone tetramer crystal obtained from 0.9 M KCI, 0.45 
M K2HPO4,0.45 M KH2PO4,2.5 mM benzamidine hydrochloride, pH 6.8 
A crystal formed in 0.9 M KCI, 0.45 M K2HPO4,0.45 M KH2PO4,2.5 mM 
Benzamidine hydrochloride, pH 6.8 histone H3-H4-tetramer crystallisation tray. 
However, further analysis showed that this was a salt crystal. 
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2.3 The studies of NAPI-histone tetramer complex in collaboration with 
Portsmouth group 
Introduction 
As described in chapter 1.7, histone chaperones are negatively charged 
molecules that bind to histone proteins and facilitate nucleosome formation (Tyler, 
2002). Previously, histone chaperones were considered as simple histone binding 
proteins which were involved in histone transport into the nucleus and in nucleosome 
assembly. Later experiments indicated that they help to maintain a delicate balance 
between nucleosome assembly and partial or complete disassembly (Figure 1.25; 
Table 1.3). Recently, histone chaperones have been implicated in histone removal 
and exchange in addition to their traditional role of aiding nucleosome assembly. 
Their role in maintaining chromatin structure and dynamics in non-replicating cells is 
increasingly recognized. 
Many molecules can act as histone chaperones in vitro by shielding the basic 
charge of histone proteins from DNA to mediate the process of chromatin assembly. 
Such molecules include pectin, RNA, polyglutamic acid and even salt. Most of these 
molecules just have little or even no relevance for the assembly of chromatin in the 
cell. However, some histone chaperones still can be identified by using cell free 
chromatin assembly system coupled to ongoing DNA replication. Histone 
chaperones have traditionally been grouped into chaperones that are 'specific' for 
H2A-H2B (e. g. NAP1, FACT, Chzl, nucleophosmin, nucleoplasmin, nucleolin), or 
H3-H4 (e. g. Asf1, Spt6, HIRA, or CAF1) (Table 1.3). Some chaperones are really 
specific such as Chzl, which preferentially bind H2A. Z/H2B over H2A-H2B. However, 
some other chaperones, like NAP1, bind all histones including H1 with high affinity. 
Histone chaperone NAPI 
NAP1 (nucleosome assembly protein 1) family proteins interact with a wide 
range of other molecules to carry out multi functions including histone shuttling 
(Mosammaparast et al., 2002), cell-cycle control (Kellogg et al., 1995), transcriptional 
regulation (Walter et al., 1995), histone variant exchange (Okuwaki et al., 2005) and 
facilitating nucleosome sliding (McQuibban et al., 1998). The crystal structure of 
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Saccharomyces cerevisiae NAP1 (yNAP1) was obtained by Park and Luger in 2006 
(Park and Luger, 2006). The yNAP1 contains unstructured N- and C-terminal regions 
and a central region with two functional domains, I and II, where domain I consists of 
three a-helices and domain II consists of an anti-parallel ß-sheet, a protruding 0- 
hairpin and three a-helices. The central domain has been shown to be necessary for 
both histone binding and nucleosome assembly (Fujii-Nakata et al., 1992). 
Studies of NAPI-H3-H4 tetramer complex in collaboration with Portsmouth 
rou 
In collaboration with LJMU and Dr. Emily Newman and Dr. John MeGeehan in 
Portsmouth University, they have produced complex of histone chaperone NAP1 
with our pure native chick histones H3-H4 tetramers and studied the structure of the 
NAP1-H3-H4 tetramer complex by protein NMR. The complex was first successfully 
obtained by using our high yield and high purity native H3-H4 tetramers made in this 
thesis work and their recombinant NAP1. This allowed them to find the correct 
conditions for forming a meaningful structure allowing a whole range of structure 
studies of the low resolution NAP1-H3-H4 tetramer complex. In this work, the 
histones H3-H4 tetramers were intact and with all its native post translational 
modifications. This is quite different from other studies (English et al., 2006) when 
they studied the complex of histone H3-H4 tetramers with the histone chaperone 
Asf1. In the studies of English et al. (2006), the a-helix and the whole N-terminal tail 
of histone H3 were not present. Based on these results, the Portsmouth group has 
produced a complex of NAP1 and their recombinant histones H3-H4 tetramers and 
compared the complexes containing native intact histones H3-H4 tetramers and 
recombinant tetramers. 
In comparing the complex obtained with native histones H3-H4 with those 
from the recombinant histones, they showed in the size-exclusion on a Superose 6 
column, that the elution profiles are similar but there is a slight shift of the maximum 
between the native and recombinant NAP1-tetramer structure (Figure 2.8). This 
suggests that the native and recombinant histones form complexes with NAP1 with 
similar hydrodynamic radii. It also indicates that the presence of PTMs on the 
histones do not inhibit the formation of large NAP/histone assemblies. 
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Figure 2.8 The size exclusion chromatography (superpose 6) comparing the 
difference between NAP1-native histones and NAP 1 -recombinant histones 
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This diagram shows the size exclusion chromatography results of NAP1- 
recombinant histones (xNAP1-xH2A-H2B, xNAP1-xH3-H4) and NAP1-native 
histones (xNAP1-gH2A-H2B, xNAP1-gH3-H4) (Newman, 2011). 
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Chapter 3 
Chick erythrocyte nucleoproteins studies by using 
the "Forward technology" 
Introduction 
The development of technologies to break open cell nuclei and extract their 
proteins has been part of the research at the JMU Laboratory for a number of years. 
This is an important technology because it allows the proteins to be purified and 
studied in detail, particularly to determine structures and remodelling of a protein. 
The most important proteins are the histone proteins (H2A, H2B, H3, H4 and 
H1) and the high-mobility-group (HMG) proteins (HMGB, HMGN and HMGA). These 
molecules are called "architectural proteins", because they package the DNA in 
higher organisms (eukaryotes). This packaging of the DNA by histones and HMGs 
also protects the DNA from any action by other proteins. When cells go through the 
cell cycle particular proteins and groups of proteins have to get through this 
protection to access the DNA sequence (chapter 1). The cell cycle is well explained 
in reviews and on the internet. Some of the intricate mechanisms requiring access to 
the DNA sequence include transcription, cell-cycle check points, DNA replication and 
repair, mitosis, planned cell death (apoptosis), changes in cell development 
(epigenetics), etc. 
The histone proteins and the HMGs are remodelled in well defined ways and 
at precisely defined positions in the total DNA sequence of the species being studied. 
So for example individual sequences of DNA within specific genes can be 
transcribed to produce mRNA at particular instants in the timing of the cell cycle. 
This intricate control of DNA access to particular proteins involves three types 
of remodelling: 
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a. Changes in structure of individual nucleosomes or groups of nucleosomes 
(this is done with the use of remodelling enzymes with energy provided by 
ATP) (Thomas, 2001); 
b. Use of slightly changed aminoacid sequences of HMG or histone molecules 
(called variants, e. g. use of H2A. Z in place of the usual H2A), inserted in 
specific nucleosomes in specific genes. The variant proteins are put in place 
of the usual proteins at specific places on the DNA, at specific times and in 
very specific mechanisms. Many enzymes are involved in the insertion of 
variants which themselves are derived from mRNA from their own genes. 
c. Detailed changes (modifications) to proteins by adding specific groups to 
particular aminoacid residues in an HMG or histone protein, after the 
molecules have been made at the ribosomes in the cytoplasm. So a methyl 
group (methylation) or an acetyl group (acetylation) may be added to a lysine 
residue, a phosphoryl group may be added covalently to a serine or threonine 
amino-acid residue and there are several other modifications. The 
modifications occur in different groups positioned at particular sites in patterns 
that are correlated with different functions of nucleosomes within a gene (e. g. 
within histone H3 during transcription). The modifications are effected using 
enzymes (acetyl transferases, histone deacetylases (HDACs), methyl 
transferases, kinases that phosphorylate, phosphatases that dephosphorylate. 
Modification patterns, at specific proteins and places on the DNA, occur at 
specific times and to enable very specific mechanisms (Chapterl, Kouzarides, 
2008; Turner, 2001). 
The remodelling described above is fundamental to the ways in which cells 
work in disease (cancer cells, cells in sepsis etc. ) and in health, so studies of the 
remodelling in all sorts of situations in the cell cycle are a major study in molecular 
biology. It is amazingly intricate and detailed in the control and even the existence of 
cells, organelles in the cells, whole organs and complete species. 
Studies of the remodelling of histone proteins and HMG proteins form part of the 
fields of proteomics and biomolecularstructure determination. This project will take 
these studies forward to develop efficient ways of extracting and purifying groups of 
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connected proteins from cell nuclei: The proteins that enable the remodelling of 
nucleosomes come in groups that are connected by lots of weak connections (i. e. 
non-covalently connected) and the proteins in a connected group have closely- 
related functions. For example one group is called the "enhanceosome", which 
contains among its proteins histone acetyl transferases. 
In the LJMU Chromatin Research Group, two major technologies are used for 
these nucleoprotein studies, one called the "Forward technology" and the other 
called the "Reverse technology". The "Forward technology" means to separate 
nucleoproteins step by step into small groups by increasing the KCI/phosphate salt 
concentration in the extraction buffer, and then do further purification or studies on 
each of them. "Reverse technology" means to target a group of high-salt soluble 
proteins, separate them from most of the other proteins in the very first several steps 
by a relatively high KCI/phosphate extraction buffer to make sure that we can purify 
the target proteins in the minimum of time. "Forward technology" lyses nuclei at 
relatively lower concentrations of phosphate/salt buffers compared with the "Reverse 
technology". This allows most of the nucleoproteins, including histones, HMGs, etc., 
to be separated from DNA/RNA and dissolved into the lysing buffer. They can then 
be separated into each group of proteins, step by step, in later purification 
procedures (Figure 3.1). 
A lysing buffer with high phosphate salt concentration is used in a single step 
in the "Reverse technology". Under this condition, only proteins with the highest 
solubility, such as HMGs, would remain in the lysing buffer after nuclei lysis. All the 
other components would be precipitated out with the DNA/RNA pellet. 
In the studies of chick erythrocyte nucleoproteins by using the "Forward 
technology" (the preparation of pure chick erythrocyte nuclei is attached as Appendix 
1), the first group of proteins separated from the nuclei is called "cePNEI" proteins. 
When the chick nuclei were produced (Appendix 1) with a low salt buffer (100 
mM KCI, 50 mM K2HPO4,50 mM KH2PO4,3.5 mM MgC12,2.5 mM benzamidine 
hydrochloride), some protein on the surface of the nuclei and inside the nuclei which 
are soluble under the low salt conditions, could be dissolved into the buffer and 
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washed out from the nuclei. During this process, a certain amount of MgCI2 was 
present in the washing buffer to keep the nuclei intact by stabilising the nuclear 
membrane. These proteins washed out from the chick nuclei are called cePNE1 
(chick erythrocyte Proteins Nuclear Extraction) proteins. 
A long SDS-PAGE plate-gel of cePNE1 proteins is given in Figure 3.2 and the 
proteins were analysed by mass spectrometry (Appendix 2), before the work of the 
Author commenced. There are some quite important proteins involved in this group 
(Table 3.1), so some further purification was decided to be applied to this group of 
proteins. First the cePNE1 sample was directly loaded onto a cation-exchange 
chromatography column to try to separate the proteins. Then another experiment 
was done which was to precipitate out some proteins from the cePNE1 proteins first 
and then to run both cation-exchange and anion-exchange to try to separate the 
proteins remaining soluble after precipitation. These two experiments are explained 
in chapter 3.1. Then, after the lysis of nuclei, another group of proteins are 
precipitated out with the DNA/RNA as "cePNE3". Then during the purification of 
histone octamers, dimers and tetramers (Chapter 2), "cePNE2", "cePNE4" (Chapter 
4.1) and "cePNE5" (Chapter 4.2) are separated step by step and further purification 
and studies were introduced to these groups of proteins (Figure 3.1). The results of 
these studies are given in each sections of this chapter. 
120 
Figure 3.1 Purification of nucleoproteins by using the "Forward technology" 
Lysis in 2.5 M KCI, 0.5 M 
equimolar phosphate, 2.5 
mm benzamidine 
hydrochloride buffer; 
centrifuge; concentrate and 
load the supernatant onto 
S100 column to separate 
cePNE4 (Chapter 4) 
1 
5x1012 pure erythrocyte nuclei were extracted 
from 10 L of chick blood in 10 mM NaCl, 10 mM 
Tris, 3.5 mM MgCl2,2.5 mM benzamidine 
hydrochloride. 
The nuclei were washed and centrifuged with 
100 mM KCI, 100 mM equimolar phosphate, 3.5 
mM MgCl2,2.5 mM benzamidine hydrochloride; 
The supernatant was taken as cePNE1 
(Chapter 3); cePNE1 depleted nuclei were left 
as the pellet. 
1 
The cePNE1 depleted nuclei were lysed with 
2.5 M KCI, 0.5 M equimolar phosphate, 2.5 mM 
benzamidine hydrochloride buffer; centrifuged; 
the pellet with DNA/proteins was taken as 
cePNE3; the supernatant was concentrated. 
1 
The concentrated supernatant was precipitated 
(Chapter 4) and centrifuged. The pellet was 
collected as cePNE2; the supernatant was 
precipitated and centrifuged again in a higher 
KCI/phosphate buffer. The supernatant was 
collected as cePNE5 (Chapter 4). The pellet 
was dissolved in 2M KCI, 0.4 M equimolar 
phosphate buffer. 
1 
The dissolved sample was loaded onto a S100 
size-exclusion column and the main peak was 
taken as pure histone octamers (Chapter 2). 
1 The pure histone octamers were loaded onto 
four SP FF cation-exchange chromatography 
column and pure histone dimers and tetramers 
were separated (Chapter 2). 
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Figure 3.2 An SDS-PAGE of cePNE1 proteins 
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A 175 mm long plate SDS-PAGE gel of the proteins present in the fractions obtained 
after washing in HMG extraction buffer (100 mM potassium chloride, 100 mM 
equimolar mono and dibasic potassium phosphate, 3.5 mM magnesium chloride). 
The sample was precipitated with TCA, washed in acetone and dissolved in sample 
buffer containing 2-mercaptoethanol. Lane 1: Chick erythrocyte histone standard. 
Lane 2: High-range molecular-weight marker (from top to bottom myosin 205000 Da, 
(3-galactosidase 116000 Da, phosphorylase b 97400 Da, albumin bovine 66000 Da, 
albumin egg 45000 Da and carbonic anhydrase 29000 Da). Lane 3: Sample. Lane 
4 Low molecular weight marker (from top to bottom albumin bovine 66000 Da, 
albumin egg 45000 Da, glyceraldehydes-3-phosphate dehydrogenase 36000 Da, 
carbonic anhydrase 29000 Da, trypsinogen 24000 Da, trypsin inhibitor 20000 Da, (X- 
lactalbumin 14200 Da, aprotinin 6500 Da). The HMG proteins were clearly within the 
molecular weight range ca. 17,000 to 27,000Da. All the proteins in cePNE1 group 
were identified by mass spectrometry (Table 3.1, Appendix 2) (Gel did by previous 
student Joanne Bebbington, bands identified by mass spectrometry). 
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Table 3.1 Some important proteins identified in cePNE1 
ID Name MWt (Da) 
GI 63556 Lamin A 73120 
G153130784 Elongation factor 1 alpha 50107 
GI 63494 HMG 2a (HMGB3) 23056 
GI 211929 HMG 2 (HMGB2) 23755 
GI 4140289 HMG Type 1 (HMGB1) 24893 
GI 50760614 Tau protein 80076 
G160098519 SAP domain protein 23448 
G113992475 FK506 binding protein 3 25016 
G153127480 Endothelial differentiation factorl 16354 
G153128101 
Translation Initiation factor 2 subunit 
1 alpha 
33038 
G150756492 Coronin 1C (hCRNn4 homologue) 140645 
G110178878 Translation initiation factor 2 beta 38412 
GI 53126116 Apoptosis inhibitor 5 58573 
G1600913563 
DEK oncogene protein (DNA 
binding) 42138 
G1833613 HMG 14a 11350 
G178692236 
Proliferation 
1 
associated protein 
G1515838 D-box DNA binding protein 
This table listed some important proteins identified in cePNE1 group proteins. A full 
list of all the proteins in cePNE1 group identified by nano-spray mass spectrometry 
at the Sanger Laboratory, Cambridge, is attached in Appendix 2. 
The mass spectrometry of these proteins, in table 3.1, was done by Professor 
Hornby's group at Sheffield University using MALDI-TOF. 
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3.1 Cation-exchange of cePNE1 proteins 
Cation-exchange chromatography of cePNE1 proteins was carried out using 
the following buffers (benzamidine hydrochloride was added and kept freshly at 4 °C 
before use; all buffers were filtered by 0.4 micron filters before use): 
1. Nuclei washing buffer: 1L of 10 mM KCI, 5 mM K2HPO4,5 mM KH2PO4, 
3.5 mM MgCI2,2.5 mM benzamidine hydrochloride. 
2. cePNE1 extraction buffer: 200 ml of 80 mM KCI, 40 mM K2HPO4,40mM 
KH2PO4,3.5 mM MgCI2,2.5 mM benzamidine hydrochloride. 
3. Cation-exchange running buffer: 
Buffer A: 1L of 80 mM KCI, 80 mM KH2PO4, pH 4.5. 
Buffer B: 1L of 1M KCI, 80 mM K2HPO4, pH 8. 
Four tubes (about 160 ml) of chick-erythrocyte nuclei were thawed in the cold 
room, then the chick nuclei were partitioned into four centrifuge tubes, balanced and 
centrifuged at 2000 rpm (Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) (650 
xg) for 20 minutes. The supernatants were discarded and the nuclei pellets were 
mixed with an equal volume of nuclei washing buffer (10 mM KCI, 5 mM K2HPO4,5 
mM KH2PO4,3.5 mM MgCI2,2.5 mM benzamidine hydrochloride), dispersed and 
made up to 160 ml in four tubes, each containing 40 ml. The samples were 
centrifuged at 1,500 rpm (Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) (359 
xg) for 15minutes, the supernatants were discarded. 
An equal volume of cePNE1-extraction buffer (80 mM KCI, 40 mM K2HP04, 
40 mM KH2PO4,3.5 mM MgCl2,2.5 mM benzamidine hydrochloride) was added to 
each nuclei pellet and the mixture was homogenised with a submerged plastic 
pipette. The suspensions were then transferred to two separate tubes through a 22- 
gauge syringe needle to disperse the nuclei and prevent clumping. The tubes were 
then centrifuged at 1,500 rpm (Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) 
for 20 minutes and the supernatants were retained. 
This cePNE1 wash was repeated twice, the supernatants of all three runs 
were combined as cePNE1 sample. The combined sample was then ultracentrifuged 
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at 100,000 xg (Beckman OPTIMATM L-80 preparative ultracentrifuge, Ti 70 rotor) 
overnight with six tubes in the Ti 70 rotor to avoid any DNA/RNA remaining in the 
sample. 
Extracting the proteins three times with a small amount of PNE1 extracting 
buffer allowed the ionic strength to be increased slowly and to keep the 
concentration of protein in the supernatant as high as possible. One wash with a 
large volume of extraction buffer to extract as many proteins as possible would have 
led to a much larger dilution of proteins in the supernatant. 
The cePNE1 proteins were dialysed against cation-exchange buffer A (80 mM 
KCI, 80 mM KH2PO4) and then concentrated down to 40 ml (4 mg/ml, 160 mg of total 
proteins). The sample after dialysis and concentration was then loaded onto four SP 
cation-exchange columns (5-mis each column, Hitrap, Fast Flow, G. E. Healthcare) 
and run at 3 ml per minute with a linear gradient between buffer A and elution buffer 
B. The chromatogram is shown in Figure 3.3; seven peaks were observed in the 
chromatogram, including a non-bound fraction. 20% SDS-PAGE gels (Figure 3.4a) 
were taken of all the fractions as defined in Figure 3.3. Some of the bands in the 
lanes of the SDS-PAGE (Figure 3.4b) were identified by mass spectrometry. 
The areas under the seven peaks in Figure 3.3 show that the proteins in 
peaks 3 and 4 are quite abundant in view of the large quantity of proteins extracted 
by one-step removal of proteins from nuclei from 10 litre of blood (-1 g). Heat-shock 
protein 70 (Hsp70) is very abundant. The peptides from the Hsp70 mass 
spectrometry show that they come from the N-terminal half of the protein as listed in 
the NCBI data for chick erythrocytes (residues 1 to 390). This was clear from 
mapping the mass spectrometry peptides against the NCBI database for Hsp70 
Peak 5 in Figure 3.3 contains mainly HMGB proteins, which are therefore 
abundant in the cePNE1 proteins, at a preparative level. 
There are no histones in the cePNE1 proteins except a very small quantity of 
H2Az histone shown up in the nanospray mass spectrometry. 
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Figure 3.3 The cation-exchange chromatogram of cePNE1 proteins 
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The colour code in this Figure refers to the A280 (blue), % buffer B (green) and pH 
(grey). The chick erythrocyte nuclei were prepared as described in Appendix 1 in 10 
mM Tris pH 7.5,10 mM NaCl, 3.5 mM MgCI2,2.5 mM benzamidine hydrochloride. 
The nuclei were washed three times in 80 mM KCI, 40 mM K2HPO4,40 mM KH2PO4, 
3.5 mM MgCl2,2.5 mM benzamidine hydrochloride, centrifuging at 1,500 rpm 
(Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) in a Beckman JS 13.1 swing- 
out rotor each time. The supernatants were retained, containing chick erythrocyte 
protein nuclei extract 1 (cePNE1 proteins). The nuclei remained intact and were later 
used for histone isolation and purification, so the procedure was an important 
purification step for this in removing the cePNE1 proteins. The cePNE1 proteins 
themselves were dialysed into filtered 80 mm KCI, 80 
mM KH2PO4 as buffer A in cation-exchange chromatography, with buffer B being 
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- Legend to Figure 3.3 continued- 
filtered 1M KCI, 80 mM K2HPO4. The cation-exchange resin was four 5-ml Sephadex 
SP columns (Hitrap, fast flow, G. E. Healthcare). The binding volume was four column 
volumes and the chromatography was monitored by measuring the elution solution 
A280, the elution solution pH and the percentage of buffer B in the elution 
fractionation. The flow rate was 3 ml/minute and final elution conditions were 100% 
buffer B, pH 7.8. Seven peaks were observed in the chromatogram, including a non- 
bound fraction. 20% SDS-PAGE gels (Figure 3.4) were taken of all the fractions as 
defined in the above Figure. Some of the bands in the lanes of the SDS-PAGE 
(Figure 3.4) were identified by mass spectrometry, it being a major task to identify all 
the bands. 
Fractions that were combined to represent the peaks in the chromatogram were as 
follows: 
Sample 1: A2-A8 
Sample 2: B12-B8 
Sample 3: B7-B4 
Sample 4: B3-B2 
Sample 5: B1-C5 
Sample 6: C6-C10 
Sample 7: C11-D9 
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Figure 3.4a 20% SDS-PAGE of the proteins selected from cePNE1 cation-exchange 
chromatography (Figure 3.3) 
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This is a 20% SDS-PAGE of the samples selected from the cation-exchange of 
cePNE1 proteins (Figure 3.3). Lanes 1 to 7 refer to peaks 1 to 7 in Figure 3.3 (lane 
5b is a lower loading of the original lane 5 which was slightly overloaded). Some 
bands were cut out and sent for mass spectrometry, the results are shown in Figure 
3.4b. 
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Figure 3.4b The bands which were cut from the gel shown in Figure 3.4a and 
analysed by mass spectrometry 
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3.2 Cation-exchange and anion-exchange chromatography of cePNEI proteins 
soluble in high KCI/phosphate 
The buffers used for this high KCI/phosphate extraction of soluble nucleoproteins 
were: 
1. Precipitation buffer: 2x2L of 2M KCI, 0.65 M K2HP04,0.65 M KH2PO4,5 
mM EDTA, 2.5 mM benzamidine hydrochloride. 
2. Cation-exchange buffer A: 100 mM KCI, 100 mM KH2PO4 (pH 4.5). 
3. Cation-exchange buffer B: 2M KCI, 92 mM K2HPO4i 8 mM KH2PO4 (pH 8). 
4. Anion-exchange buffer A: 10 mM KCI, 9.2 mM K2HPO4,0.8 mM KH2PO4 
(pH8). 
5. Anion-exchange buffer B: 1M KCI, 9.2 mM K2HPO4,0.8 mM KH2PO4 (pH8). 
The experiment started with 40 ml of concentrated cePNE1 sample which was 
washed out from chick-erythrocyte cell nuclei with 100 mM KCI, 50 mM K2HPO4,50 
mM KH2PO4,3-5 MM MgCl2 and 2.5 mM benzamidine hydrochloride without lysing 
(section 3.1). The concentration of the sample was 11.2 mg/ml and the total volume 
was 40 ml. Total protein in this sample was 450 mg. The cePNE1 sample was then 
dialysed against precipitation buffer (2 M KCI, 0.65 M K2HPO4,0.65 M KH2PO4,5 
mM EDTA and 2.5 mM benzamidine hydrochloride) overnight. 
The dialysed cePNE1 sample was centrifuged at 12,000 rpm (Beckman Acanti® 
J-26 XP centrifuge, JS 13.1 rotor) for 20 minutes to remove precipitation. The 
supernatant was taken as sample P2. The concentration was 6.13 mg/ml, the 
volume was 10 ml, and total protein was 61 mg. The majority of the total 450 mg had 
therefore precipitated, leaving the 61 mg of soluble proteins in the supernatant, 
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mostly HMG proteins. 
Sample P2 was then split into two parts each contained 5 ml labelled as sample 
P3 and P4. P3 was dialysed against cation-exchange buffer A (100 mM KCI, 100 mM 
KH2PO4, pH 4.5) and P4 was dialysed against anion-exchange buffer A (10 mM KCI, 
9.2 mM K2HPO4,0.8 mM KH2PO4, pH 8.0) overnight. 
Cation-exchange chromatography of the high KCl/phosphate supernatant 
After dialysis, UV spectrophotometry was taken for P3 as well as SDS-PAGE 
(Figure 3.5). The concentration was 2.6 mg/ml, the volume was 6.5 ml and total 
protein was 17 mg. The HMG proteins have gone from being a significant minority in 
the P1 sample to the majority in the soluble fraction of the P3 sample. 
P3 was bound to four 5 MI SP-Sephacryl cation-exchange columns 
(G. E. Healthcare) with binding buffer (buffer A): 100 mM KCI, 100 mM KH2PO4, pH 
4.5 and elution buffer (buffer B): 2M KCI, 92 mM K2HPO4,8 mM KH2PO4, pH 8.0. 
Five peaks were separated as samples C1-C5 (Figure 3.6). They were then dialysed 
against distilled water and freeze-dried for SDS-PAGE (Figure3.7). The UV 
spectrophotometry was taken for each sample, C1-C5, after dialysis against distilled 
water (Table 3.2). 
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Figure 3.5 20% SDS-PAGE of the sample P3, selected for cation-exchange 
chromatography from the soluble fraction of cePNE1 
P3 
Some bands were cut from this gel and analysed by mass spectrometry. The results 
are shown in this Figure (bands identified by compared with the histone marker). 
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Figure 3.6 The chromatogram of sample P3 using cation-exchange chromatography 
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The colour code in this Figure refers to the A280 (blue), % buffer B (green) and pH 
(grey). The precipitated cePNE1 sample was dialysed against cation-exchange 
buffer A (100 mM KCI, 100 mM KH2PO4, pH 4.5) and loaded onto four series of 5 ml 
SP Fast Flow columns to run cation-exchange chromatography. The binding buffer 
was also buffer A and the elution buffer (buffer B) was 2M KCI, 92 mM K2HPO4,8 
mM KH2PO4 (pH 8.0). The chromatography was run from 0% buffer B to 100% buffer 
B. Note that the sharp rise of at elution volume 135 mis may caused by blockage of 
pump B. The buffering was therefore not stabilised with phosphate at this pH. 
Five peaks/shoulders were taken separately and labeled as sample C1 to C5: 
Cl: Fractions 3-4,20m1 
C2: Fractions 6-9,40m1 
C3: Fraction 14,10ml 
C4: Fractions 15-17,30m1 
C5: Fractions 18-20,30m1 
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Figure 3.7 20% SDS-PAGE of cation-exchange fractions C1-C5 
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This Figure shows the 20% SDS-PAGE of cation-exchange fractions C1-C5 of the 
cation-exchange chromatogram (Figure 3.6). These samples were dialysed against 
distilled water overnight and then freeze-dried. Before the gel was run, a little bit of 
powder of each sample was taken and put into five 1ml tubes labelled C1-C5.20 µl 
of 1.0 M Tris-HCI buffer (pH 6.8) was added to each tube. If the powder in the tube 
was not fully dissolved, another 20 µl of 1.0 M Tris-HCI buffer (pH 6.8) was added 
until the powder was just dissolved. Then the 3X Laemmli buffer with a half volume 
of the sample was added to each sample and they were mixed and denatured in 
900Cwater bath for 2 minutes (Appendix 3). After that 20 pl of each sample was 
loaded onto the gel. Note the strong HMG bands in gel lanes C4 and C5. The 
proteins in the C4 and C5 peaks are the majority of proteins in the supernatant after 
precipitation procedure (Figure 3.6 and Table 3.2) (bands identified by compared 
with the histone marker). 
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Anion-exchange chromatography of the high KCI/phosphate supernatant 
Sample P4 was dialysed against anion-exchange buffer A (10 mM KCI, 9.2 mM 
K2HPO4,0.8 mM KH2PO4) and an UV spectrophotometry was taken for it (Table 3.2). 
Then P4 was loaded onto four series of 5m1 DEAE anion-exchange columns and the 
chromatography was run with binding buffer (buffer A): 10 mM KCI, 9.2 mM K2HP04, 
0.8 mM KH2PO4 and elution buffer (buffer B): 1M KCI, 9.2 mM K2HPO4,0.8 mM 
KH2PO4. Eight peaks were separated as samples Al-A8 (Figure3.8). They were 
dialysed against distilled water and freeze-dried for SDS-PAGE (Figure 3.9a). 
Some bands from the gels were cut out and analysed by mass spectrometry 
(Figure 3.9a and b), as in the legend to Figure 3.9a. 
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Figure 3.8 The chromatogram of sample P4 using anion-exchange 
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The colour code in this Figure refers to the A280 (blue), % buffer B (green) and pH 
(grey). The precipitated cePNE1 sample was dialysed against anion-exchange buffer 
A (10 mM KCI, 9.2 mM KH2PO4,0.8 mM KH2PO4, pH 8) and loaded onto four series 
of 5ml DEAE anion-exchange columns and run. The binding buffer (buffer A) of this 
anion-exchange was 10 mM KCI, 9.2 mM K2HPO4,0.8 mM KH2PO4 (pH 8); the 
elution buffer (buffer B) was 1M KCI, 9.2 mM K2HPO4,0.8 mM KH2PO4 (pH 8). The 
chromatography was run from 0% buffer B to 100% buffer B. 
Eight peaks were taken separately and labeled as sample Al to A8: 
Al: Fractions 2-5,40ml 
A2: Fractions 9-10,20ml 
A3: Fraction 11,10ml 
A4: Fraction 12,10ml 
A5: Fraction 13,10ml 
A6: Fraction 14,10ml 
A7: Fractions 15-16,20m1 
A8: Fractions 30-31,20m1 
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Figure 3.9a 20% SDS-PAGE of sample Al-A8 
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The 20% SDS-PAGE of samples Al-A8. Samples A1-A8 were from the eight peaks 
of anion-exchange chromatography (Figure 3.8). The samples were dialysed against 
distilled water overnight and then freeze-dried. They were treated the same as 
described in Figure 3.7 and 20 µl of each sample was loaded onto the gel. 
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Figure 3.9b The bands analysed by mass spectrometry from gel 3.9a 
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These Figures show the bands cut from gel 3.9a. They were analysed by mass 
spectrometry and the results are shown in the Figure. 
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Table 3.2 The yield of samples in each step of the experiment 
Sample Protein Volume Concentration Yield (mg) 
Description (MI) (mg/ml) 
Pi cePN E1 40 11.2 447 
P2 Supernatant 10 6.13 61.3 
after precipitation 
P3 Sample P2 in 6.5 2.6 17 
buffer A cation- 
exchange 
P4 Sample P2 in 9 2 18 
buffer A anion- 
exchange 
C1 Fraction 1, 23 0.043 1 
cation-exchange 
C2 Fraction 2, N/A N/A N/A 
cation-exchange 
C3 Fraction 3, N/A N/A N/A 
cation-exchange 
C4 Fraction 4, 35 0.23 8.25 
cation-exchange 
C5 Fraction 5, 35 0.17 5.93 
cation-exchange 
Al Fraction 1, 40 0.1 4 
anion-exchange 
A2 Fraction 2, 20 0.02 0.4 
anion-exchange 
A3 Fraction 3, 10 0.06 0.6 
anion-exchange 
A4 Fraction 4, 10 0.15 1.5 
anion-exchange 
A5 Fraction 5, 10 0.27 2.7 
anion-exchange 
A6 Fraction 6, 10 0.16 1.6 
anion-exchange 
A7 Fraction 7, 20 0.1 2 
anion-exchange 
A8 Fraction 8, 20 0.044 0.89 
anion-exchange 
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3.3 Cross-Linking of cePNE1 proteins 
After some initial studies of the cePNE1 proteins, we found that there are 
hundreds of different proteins in this group. The most important proteins in this group 
for our studies are the HMG proteins, and a surprising quantity of the FK-binding 
protein 3, a peptidyl-prolyl isomerase. As described in the earlier chapters, HMGs 
play very important roles in nucleosome remodelling, in order to contribute to the 
regulation of DNA replication, transcription and repair. All these processes require 
interactions between HMGs and other proteins. So it was considered important to try 
to cross link these protein assemblies in the cePNE1 group and identify the cross- 
linked proteins by gel electrophoresis and mass spectrometry. 
Solutions: 
a. 2 ml aliquots of cePNE1 proteins in 100 mM KCI, 50 mM K2HP04,50 
mM KH2PO4. 
b. Cross-linking buffer without EDC: 500 mIs of 100 M KCI, 100 mM 
phosphate pH 7.5, by dilution from stock solution 3. 
c. Cross-linking buffer with EDC: dissolve 0.5 gm of EDC in 20 ml of 
cross-linking buffer, and make up to 25 MI. Freeze at -80°C in 1 ml 
aliquots. 
One 2 ml microfuge tube of cePNE1 proteins was thawed by leaving the tube 
in the cold room for one hour. The tube of cePNE1 proteins was then dialysed 
against cross-linking buffer (Working solution b) overnight. Meanwhile, the water 
bath was set at the correct temperature, 23 °C, and two electrophoresis gels were 
made up at the same time, one 20% acrylamide and one 12% acrylamide ready for 
loading, each with a 5% acrylamide stacking gel. 
Eight labelled microfuge tubes were prepared, each with 10 pl of 3X Laemmli 
buffer (Stock solution 2). 
0.5 ml of the dialysed sample of cePNE1 proteins was mixed with 0.5 ml of 
cross-linking buffer without EDC (Working solution b) and was put into water-bath 
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temperature, 23 °C. 20 pl of mixed sample was taken at time 0 minute, 15 minutes, 
30 minutes and 1 hour, immediately put into the 10 pl of hot 3X Laemmli buffers (the 
3X Laemmli buffer was heated to 100 °C just before mixing). These set of samples 
are the control of the experiment. 
0.5 ml of the dialysed sample of cePNE1 proteins was mixed with 0.5 ml of 
EDC cross-linking buffer (Working solution c) and was put into a 23 °C water-bath at 
the same time as the control. 20 pI from the sample with EDC buffer and 20 pl from 
the sample without EDC buffer were taken. This was done at time t=0 minutes, 15 
minutes, 30 minutes and 1 hour, immediately put into the 10 pl of 3X Laemmli buffer 
at 95 °C. 
All the two sets of samples were then loaded onto the 20% and 12.5% 
electrophoresis gels and run (Figure 3.1Oa and Figure 3.1Ob). 
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Figure 3.10a 20% SDS-PAGE of cePNE1 cross linking 
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Cross-linking buffer with EDC Cross-linking buffer without EDC 
The 20% gel of cePNE1 cross-linking results. The lanes from left to right are: time 
0.15 min, 30 min, and 1 hr with EDC; time 0,15 min, 30 min, and 1 hr without EDC 
(bands identified by compared with the histone marker). 
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Figure 3.10b 12.5% SDS-PAGE of cePNE1 cross linking 
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Cross-linking buffer with EDC Cross-linking buffer without EDC 
The 12.5% gel of cePNE1 cross-linking results. The lanes from left to right are time 0, 
15 min, 30 min, and 1 hr with EDC, time 0,15 min, 30 min, and 1 hr without EDC 
(bands identified by compared with the histone marker). 
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Conclusion and discussion 
The first part of the experiment in this Chapter describes the direct separation 
of the cePNE1 proteins by cation-exchange chromatography. In this experiment, the 
cePNE1 proteins were separated into several not very well separated peaks. The 
SDS-PAGE and mass spectrometry results show that a group of proteins containing 
the heatshock protein 70, eluted at the early stage of the cation-exchange 
chromatography. Then a group of proteins containing the important peptidyl-prolyl 
isomerase FKBP3 were eluted in peak/shoulder 3 and 4. Finally a group of proteins 
enriched in HMGBs were washed out in peak/shoulder 5 and 6. 
Heatshock protein 70 is a highly conserved protein family with multiple 
fundamental functions. Their main functions include enhancing cell survival by its 
ability to catalyse the reassembly of damaged ribosomal protein (Pelham, 1984) and 
preventing proteins from degradation. These functions are important for cancer 
studies. The peptidyl-prolyl isomerase FKBP3 and HMG proteins which were 
introduced in Chapter 1 are also very important. So this experiment provided a 
potential purification method for these functionally important proteins. Also this 
cation-exchange chromatography for native chick nucleoproteins showed that the 
FKBP3 is not co-fractionated with any HMG proteins, which related to some issues 
about the work, did by Leclercq et al. (2000), and this is explained later in this 
conclusion. 
The second part of this Chapter is a further experiment extended from the first 
part. The cePNE1 proteins were first precipitated in a high KCI/phosphate buffer, only 
the most soluble proteins remained in the solution. After that both cation-exchange 
and anion-exchange chromatography were applied. Unfortunately, some mass 
spectrometry results for this part of work have not been completed. From the SDS- 
PAGE and mass spectrometry results available, it seems that the major proteins 
remaining after precipitation are the HMGBs. This experiment may lead to some 
future work for extraction and studies of pure HMGB proteins. 
The final part of this Chapter is an experiment of chemical cross-linking of the 
cePNE1 proteins. The method of cross linking was a valuable training in the control 
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of protein cross linking experiments and the use of controls of the PhD. of the Author. 
As mentioned earlier, the method used by Cato, et al., (2008) was in the presence of 
Dithiothreitol (DTT). Therefore in their experiments, the disulphide bridges were not 
present. During the Author's cross linking experiment, it is seen that as time 
progressed the HMG protein bands disappeared and a new diffuse band was built up. 
This is described by Cato, et al., (2008). The gels confirm the work of a colleague 
working on the "reverse technology" in our laboratory that the FKBP3 pepitidyl-prolyl 
isomerase did not cross link to any proteins. This is clear in both 20% and 12.5% 
SDS-PAGES. There are publications (Leclercq et al., 2000) showing that HMG 
proteins and FKBP3 run together in the pH dimension of a2 dimensional 
electrophoresis gel (2DE). So these cross linking experiments did not confirm the 
presence of complexes of HMGs with FKBP3. 
Some other studies that have been done in our laboratory, suggested that in 
nuclear extracts, such as the linker histone rich extract from human cell culture, 
show more cross linking information. And it should be noted that linker histones are 
not present in cePNE1 extract described in this Chapter. It has been pointed out by 
Stros & Kolibalova (1987) and Stros (2010) that cross-linking of nucleoproteins to 
extract molecular assemblies must be done with native proteins rather than 
recombinant proteins which are without their PTMs or with acid-extracted proteins. 
Experiments have not been done in the presence of DTT as was done by 
Cato et al., (2008), and it is not clear that cross linking experiments between proteins 
without disulphide bridges are meaningful for the contacts. 
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Chapter 4 
Extraction and Studies of the cePNE4 and 
cePNE5 proteins from Chick-erythrocyte Nuclei by 
using the "Forward Technology" 
The "Forward Technology", as described in Chapters 2 and 3, is a very quick 
and efficient method to separate nucleoproteins into small groups. Each of these 
groups of proteins is enriched in some important nucleoproteins such as linker 
histones, core histones, HMG proteins, etc. After separation and further purification, 
studies can be applied to each group (named as cePNE1,2,3,4,5, etc. ). 
In this Chapter, some studies of these groups of proteins, which have been 
done by the Author in collaboration with project students, are described. The Author 
was pleased for the opportunity to share some research projects with students 
undergoing projects as a part of their honours degree programs (Mr Damien Long & 
Mr Arabarb Mirza), a taught MSc program (Mr Zhao) and new PhD program (Mr 
Hugh Smallman). I considered it is very useful to gain experience in training others in 
research methods. The projects of this Chapter were part of this work and include 
firstly, the fractionation and characterisation of high-molecular-weight proteins 
soluble with histone octamers in 2M KCI, 0.4 M equimolar phosphate (section 4.1) 
and secondly the analysis of proteins that were still soluble after the procedure of 
Chapter 2, where the histone octamers were precipitated (section 4.2). 
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4.1 Extraction of High Molecular Weight proteins (cePNE4) from chick nuclei 
During the preparation of histone octamers, dimers and tetramers, histone 
octamers were prepared and dissolved in 2M KCI, 0.4 M equimolar phosphate and 
loaded onto the S100 size-exclusion column. The histone octamers should be eluted 
first and then any linker histones, because linker histones are smaller than histone 
octamers. However, when we ran the SDS-PAGE for the fractions of the gel 
exclusion we found that there were some proteins eluted out before the main peak 
for histone octamers. That might be because some linker histones form complexes 
with other proteins to give them an increased molecular weight or that some high- 
molecular-weight proteins themselves were eluted. So it was decided to do the 
following experiment to try to work out which proteins may form complexes with 
linker histones and also which proteins fractionate before the histone octamers in 
this way. Because of the presence of high-molecular-weight proteins in the cePNE1 
extraction (Figure 3.1), these proteins were left in the nuclei before lysis so that they 
could be extracted with the histone-octamer lysis procedure. That is to say we leave 
out the nuclei in 100 mM KCI, 100 mM equimolar phosphate described earlier in the 
thesis. So we extract pure chick-erythrocyte nuclei in 2M KCI, 0.4 M equimolar 
phosphate. The procedures and results are given below: 
Buffers: 
(add benzamidine hydrochloride freshly, keep at 4°C before use) 
1. Nuclei washing buffer: 1L of 10 mM KCI, 5 mM K2HPO4,5 mM KH2PO4, 
3.5 mM MgCI2,2.5 mM benzamidine hydrochloride. 
2. Nuclei Lysing buffer: 400 ml of 2.5 M KCI, 0.25 M K2HPO4,0.25 M KH2PO4, 
2.5 mM benzamidine hydrochloride. 
3. Size-exclusion running buffer: 2L of 2M KCI, 0.2 M K2HP04,0.2 M 
KH2PO4. 
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Procedure: 
120 ml of pure chick erythrocyte nuclei (Appendix 1) were thawed in the cold 
room. After thawing, the chick nuclei were partitioned into four 50 ml centrifuge tubes, 
balanced, and centrifuged at 2,500 rpm (Beckman Acanti® J-26 XP centrifuge, JS 
13.1 rotor) for 20 minutes. The supernatant was discarded and the nuclei pellets 
were mixed with an equal volume of nuclei washing buffer (10 mM KCI, 5 mM 
K2HPO4,5 mM KH2PO4,3.5 mM MgCl2,2.5 mM benzamidine hydrochloride), 
dispersed by sucking in and out the suspension of nuclei with a submerged plastic 
Pasteur pipette. Then the suspension was made up to 75 ml with nuclei washing 
buffer, stirring in a beaker on ice. 60 ml of cold nuclei lysing buffer (2.5 M KCI, 0.25 M 
K2HPO49 0.25 M KH2PO4,2.5 mM benzamidine hydrochloride) was put into each of 
six Beckman Ti 45 centrifuge tubes on ice. 12.5 ml of nuclei sample were carefully 
layered on the top of the nuclei lysing buffer in each centrifuge tube using a syringe 
with 22-gauge needle. The centrifuge tubes were then capped and quickly shaken to 
mix up the nuclei and lysing buffer, making a uniform gel. The centrifuge tubes were 
then balanced and ultra centrifuged at 36,000 (Beckman OPTIMATM L-80 preparative 
ultracentrifuge, Ti 45 rotor) (100,000 xg) for 16 hours. 
After centrifugation, the DNA pellets were kept, the supernatant was 
concentrated down to 10 ml. The sample was then dialysed against gel exclusion 
running buffer (2 M KCI, 0.2 M K2HPO4,0.2 M KH2PO4) overnight and loaded onto 
an S100 column to run (Figure 4.1). 
The chromatogram shows a main peak and a clear shoulder before the main 
peak (Figure 4.1). The shoulder was collected and concentrated down to 10 ml and 
re-loaded to the S100 column for another size-exclusion under the same conditions 
as above. This time two clear peaks were given (Figure 4.2). Samples collected from 
the two peaks were dialysed against distilled water and freeze-dried. Then they were 
loaded onto a 20% SDS-PAGE gel. The first peak contains some high molecular 
weight proteins and the second peak contains mainly histone proteins (Figure 4.3a & 
4.3b). 
The sample from the first peak was sent to Sheffield University to be analysed 
by mass spectrometry (Table 4.1). 
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Figure 4.1 S100 Size-exclusion Chromatogram of chick erythrocyte nucleoproteins 
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This Figure shows the fractionation by size-exclusion chromatography of the lysate 
of chicken-erythrocyte nuclei. The chick erythrocyte nuclei were lysed by 2.5 M KCI, 
0.25 M K2HP04,0.25 M KH2PO4,2.5 mM benzamidine hydrochloride buffer and 
ultracentrifuged at 100,000 xg for 16 hours. The supernatant were collected and 
concentrated down to 10 ml, then dialysed in 2M KCI, 0.2 M K2HP04,0.2 M KH2PO4 
and loaded onto a S100 size-exclusion column to run with 2M KCI, 0.2 M K2HPO4, 
0.2 M KH2PO4 at 0.6 ml/minute flow rate for 500 ml (1.5 column volume). The 
shoulder before the main peak fractions (1-14) was selected and loaded on the gel 
exclusion column again under the same condition. 
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Figure 4.2 The chromatogram of the second gel exclusion using the sample selected 
from Figure 4.1 
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The shoulder selected from the first gel exclusion (Figure 4.1) was re-loaded onto 
the S100 column again under the same condition as described in Figure 4.1. The 
shoulder of first gel exclusion was further separated into two peaks. These samples 
was selected and loaded on SDS-PAGE with each pair of fractions as a lane on the 
gel. The results are shown in Figure 4.3a and Figure 4.3b. 
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Figure 4.3a 20% SDS-PAGE of proteins from peak 1 (cePNE4) of Figure 4.2 
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The gel of the proteins from the first peak in Figure 4.2 fractionated from the S100 
size-exclusion column. Each pair of fractions as a lane loaded on the gel from start 
to the end of the peak (Figure 4.2). It shows mainly some high-molecular-weight 
proteins in this peak. Some linker histone and histone octamer proteins remain in the 
sample but these are minimal compared with the high-molecular-weight proteins. 
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Figure 4.3b 20% SDS-PAGE of proteins from peak 2 of Figure 4.2 
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The gel of the second peak fractionated from S100 gel exclusion column. Each pair 
of fractions as a lane loaded on the gel from start to the end of the peak (Figure 4.2). 
It shows that the high molecular weight proteins are decreasing and mainly histone 
proteins are in this peak. 
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The results of mass spectrometry are in Table 4.1 where the proteins of fractions 
2-20 in Figure 4.2 were combined and freeze-dried and sent for electrospray mass 
spectrometry at Sheffield University (Ms Helen Phillips and Dr. Mark Dickman). The 
analysis was a total result for the combined proteins, not for selected band from the 
electrophoresis. 
The molecular mass of each protein was given in the second column in the Table 
4.1. Therefore some indication of where the proteins are positioned for example in 
lane 6 of Figure 4.3a. 
The initial analysis of the mass spectrometry identified many "unnamed gallus 
gallus protein product". The Author therefore entered the peptide sequences from 
these products and entered them into the NCBI BLAST-search routine comparing 
with the NCBI gallus gallus data bank. In doing this, three further proteins were 
identified. The first 12 proteins in the list therefore are clearly identified and the final 
column of the table gives a short description of the function of the proteins (Table 
4.1). 
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Table 4.1 The mass spectrometry results of the proteins in the first peak of the 
second gel exclusion run (cePNE4) (Figure 4.3a) 
Protein Mass Score 
Queries 
matched 
emPAI Description Function 
SMC1 protein 
Regulation of the 
giJ29837126 142904 2988 154 4.85 cohesin subunit 
separation of sister 
chromatids during [Gallus gallus] cell division 
chondroitin sulfate SMC3, regulation of 
giJ45383139 141482 2493 168 4.95 
proteoglycan 6 
(bamacan) [Gallus 
the separation of 
sister chromatids 
gallus] during cell division 
A eukaryotic 
nucleolar 
nucleolin [Gallus phosphoprotein, 
is 
giJ63711 75594 1240 75 4.27 gallus] 
involved in the 
synthesis and 
maturation of 
ribosomes 
Cuts both strands of 
topoisomerase the DNA helix 
giJ45384180 183131 800 28 0.27 
(DNA) II beta 
180kDa [Gallus 
simultaneously in 
order to manage 
gallus] DNA tangles and 
supercoils 
FACT complex Affects eukaryotic 
gij53128417 79976 581 35 1.24 subunit SSRP1 
RNA polymerase II 
[Gallus gallus] 
(Pol II) transcription 
elongation 
Spectrin alpha An actin crosslinking 
chain, brain and molecular 
gil134800 285188 418 28 0.22 
(Spectrin, non- scaffold protein that 
erythroid alpha links the plasma 
chain) (Fodrin membrane to the 
alpha chain) actin cytoskeleton 
similar to 
giI60302806 152988 387 28 0.35 KIAA0648 protein Gallus allus 
PREDICTED: An actin crosslinking 
similar to spectrin and molecular 
giJ50757376 287699 374 26 0.17 alpha chain, brain 
scaffold protein that 
- chicken [Gallus 
links the plasma 
gallus] membrane to the actin cytoskeleton 
sister chromatid 
giJ60098709 143760 344 34 0.29 
cohesion protein 
Regulator of 
cohesion PDS5 homolog A 
[Gallus gallus] maintenance 
PREDICTED: Abundant in 
giJ50810565 56972 232 12 0.31 
similar to type II keratinocytes in the 
alpha-keratin IIC cornified layer of the 
[Gallus gallus] epidermis 
PREDICTED: 
similar to THO part of the TREX 
giJ5074599 186901 211 13 0.10 complex subunit 2 (transcription/export) 
(Tho2) [Gallus complex 
allus 
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SMC2 structural 
A subunit of 
maintenance of 
condensin I and 11, 
giJ45382553 134857 184 12 0.23 chromosomes 2- 
large protein 
complexes involved like 1 [Gallus in chromosome gallus] condensation 
type II alpha- 
giI46399073 62423 164 8 0.10 keratin IIA [Gallus 
allus 
heterogeneous 
nuclear 
giI60302824 36633 112 3 0.09 ribonucleoprotein 
H3 (2H9) [Gallus 
galfus] 
PREDICTED: 
giJ5080677 84352 98 6 0.08 similar to keratin 6 
irs3 [Gallus gallus] 
PREDICTED: 
similar to 
KIAA0097 gene 
giJ50748121 153598 96 4 0.06 product; colonic 
and hepatic tumor 
over-expressed 
Gallus gallus] 
PREDICTED: 
gij50760853 96952 81 3 0.07 
similar to type I 
hair keratin KA31 
[Gallus gallus] 
PREDICTED: 
similar to H2B 
giJ50728598 20946 80 5 0.15 histone family, 
member F [Gallus 
allus 
PREDICTED: 
similar to 
giJ50745996 188082 72 5 0.05 hypothetical 
protein [Gallus 
gallus] 
formin binding 
giJ15636898 119483 72 3 0.05 protein 
11-related 
protein [Gallus 
gallus] 
unnamed protein 
giJ63448 13946 70 4 0.52 product [Gallus 
allus 
PREDICTED: 
giJ50728590 49063 68 4 0.13 
similar to germinal 
histone H4 gene 
Gallus allus 
giJ45383996 32612 60 5 0.32 nucleophosmin Gallus gallus] 
PREDICTED: 
0150748796 27914 58 2 0.11 similar to Mthfdl- 
prov protein 
[Gallus gallus] 
gi1571460 90179 54 2 0.07 protein 
kinase 
Gallus allus 
serine/arginine 
giJ7189561 100744 48 4 0.06 repetitive matrix 1 
Gallus allus 
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PREDICTED: 
giJ50760887 82798 48 3 0.04 similar to keratin 
K12 [Gallus gallus] 
PREDICTED: 
similar to 
hypothetical 
giJ50749292 314115 47 10 0.04 
protein FLJ10839; 
cell-cycle and 
apoptosis 
regulatory protein 
1 [Gallus gallus] 
PREDICTED: 
similar to 
Desmoplakin (DP) 
giJ50734049 199324 47 5 0.02 
(250/210 kDa 
paraneoplastic 
pemphigus 
antigen) [Gallus 
gallus] 
PREDICTED: 
gi15073108 342733 45 3 0.01 similar to ATM 
Gallus gallus] 
PREDICTED: 
similar to Arginase 
II, mitochondrial 
giJ50748318 43531 45 3 0.07 
precursor (Non- 
hepatic arginase) 
(Kidney-type 
arginase) [Gallus 
allus 
PREDICTED: 
giJ50738743 84848 43 2 0.04 
similar to 
KIAA1469 protein 
Gallus gallus] 
ubiquitin protein 
gi171896647 124068 42 2 0.03 ligase E3C [Gallus 
gallus] 
PREDICTED: 
similar to ninein 
isoform 2; GSK3B- 
interacting protein; 
ninein 
gi15074908 249733 42 3 0.01 centrosomal 
protein; glycogen 
synthase kinase 3 
beta-interacting 
protein [Gallus 
gallus] 
PREDICTED: 
similar to cis-Golgi 
giJ50757442 42 2 matrix protein 
GM130 [Gallus 
gallus] 
PREDICTED: 
similar to cadherin 
giJ50758915 192581 42 1 0.02 
22 precursor; 
ortholog of rat PB- 
cadherin [Gallus 
allus 
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PREDICTED: 
giJ50748243 32054 41 3 0.21 similar 
to RIKEN 
cDNA 2610015JO1 
[Gallus gallus] 
PREDICTED: 
giJ50740806 89979 40 1 0.03 similar 
to kinesin- 
related protein 3A 
[Gallus gallus] 
PREDICTED: 
giJ50759167 203960 39 1 0.02 similar to MEGF6 
[Gallus gallus] 
PREDICTED: 
similar to ring 
gi150756669 87623 38 3 0.04 finger protein 10 
[Gallus gallus] 
describtion 
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Conclusions and discussion 
By using the method described in this section, a group of native proteins with 
a relatively high molecular weight are extracted. The functions of the proteins with 
highest scores in this group are given in Table 4.1. These include: SMC1 and SMC3, 
subunits of the cohesin complex, which regulate the separation of sister chromatids 
during cell division; nucleolin, which is involved in the synthesis and maturation of 
ribosomes; topoisomerase (DNA) II, which cuts both strands of the DNA helix 
simultaneously in order to manage DNA tangles and supercoils; FACT complex 
subunit SSRP1, which affects eukaryotic RNA polymerase II (Pol II) transcription 
elongation; etc. 
These are all fundamental proteins with important functions. The method 
described in this section, is able to produce a significant amount of these proteins in 
their native state within less than 48 hours. This gives a potential to introduce further 
purification and studies of these proteins. 
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4.2 Extraction and studies of cePNE5 proteins 
During the extraction and purification of chick erythrocyte histone octamers, 
dimers and tetramers, another group of proteins produced is the cePNE5. This group 
of proteins is extracted during the last stage of precipitation of pure histone octamer 
(chapter 2). After centrifugation, the histone octamers precipitate out as a pellet, 
meanwhile the supernatant are collected as the cePNE5 proteins. 
Previous work in the LJMU Group concerned proteins that were soluble in high 
KCI/phosphate solutions, above precipitation conditions for histone octamers 
(Snijders et al., 2008). Some cation-exchange-chromatography fractionation of a 
similar protein extract produced in one step by lysing total chick nuclei (without 
removing cePNE1 proteins) was carried out by Mr Larus Foulger (Foulger L. F. Ph. D. 
thesis, submitted). The Author took part in some of this work that was carried out by 
sweeping the elution-buffer pH from a low value to pH 8.0. 
Work was undertaken on the group of proteins of Snijders et al. (2008) with Mr 
Hugh Smallman who was at an early stage of his Ph. D. The objectives were to carry 
out the cation-exchange chromatography at a stable pH of 6.8 and to identify 
proteins that co-eluted with the majority proteins in each peak of the chromatogram. 
The first part of the procedure is described in Chapter 2, where core-histone- 
enriched protein was precipitated in 2M KCI, 1.5 M equimolar phosphate, pH 6.8. 
About 80 mg of precipitated protein, pelleted after ultracentrifugation, was dissolved 
in "octamer maintenance buffer" for size-exclusion chromatography to produce about 
30 mg of pure histone octamers (chapter 2). 
The supernatant from the ultracentrifugation (cePNE5) contained about 100 mg 
of protein and was dialysed into 0.1 M KCI, 0.1 M equimolar phosphate pH 6.8 for 
analysis in the present work with Mr Smallman. 
Four 5-ml SP sephadex, HITRAP, Fast-flow cation-exchange columns were 
equilibrated with buffer A (100 mM KCI, 50 mM K2HP04,50 mM KH2PO4). The 40-ml 
sample of cePNE5 was introduced into the loading loop of the AKTA liquid 
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chromatography equipment. 
Cation-exchange chromatography was carried out with a linear gradient of the 
elution-buffer B (1 M KCI, 50 mM K2HPO4,50 mM KH2PO4). The chromatogram is in 
Figure 4.4. Six well-resolved peaks were assigned and the major proteins in each 
peak were as follows: Peak M (mystery peak) - to be determined; Peak 3- linker 
histones 1a and 1 b; Peak 4- linker histone H1b; Peak 5- core histone dimers; Peak 
6- linker histone H5; Peak 7- residual histone tetramers that are insoluble at the 
high salt before dialysis into buffer A. 
Fractions from Peak 6 were combined and concentrated to seven mis in an 
Amicon pressurised-ultrafiltration cell with a 10 kDa cut-off molecular weight. Ultra- 
violet spectrophotometry of this solution gave a yield of Peak 6, histone H5, of 
approximately 23 mg. 
Each peak of the chromatogram of Figure 4.4, were then dialysed into distilled 
water and freeze dried, so that SDS-PAGE could be carried out as in Figure 4.5. 
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Figure 4.4 The chromatogram of the cePNE5 proteins using cation exchange 
300 SP CATION EXCHANGE pH 6.8 
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This diagram is showing the chromatogram of the cation exchange of cePNE5.40 ml 
of cePNE5 sample was dialysed against cation exchange buffer A (100 mM KCI, 50 
mM K2HP04,50 mM KH2PO4) and then loaded to four series of 5m1 SP sephadex, 
HITRAP, Fast-flow cation-exchange columns. The chromatography was carried out 
with elution buffer B (1 M KCI, 50 mM K2HP04,50 mM KH2PO4). Seven well- 
resolved peaks were assigned as follows: Peak N is the non-binding protein (not 
shown in this Figure), Peak M (mystery peak) and peaks 3,4,5,6 and 7. 
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Figure 4.5 20% SDS-PAGE of peaks M, 3,4,5,6 and 7 
A. 20% SDS-PAGE of the cePNE5 cation exchange peaks M, 3,4,5,6 and 7. 
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This Figure shows the 20% SDS-PAGE of the cePNE5 proteins cation exchange 
peaks M, 3,4,5,6 and 7, compare with histone marker and pure histone octamer 
sample. Sample 3,4,5 and 6 are very heavily loaded to show all the proteins in the 
samples, but this caused some bands to spill over to other lanes. So two other 20% 
SDS-PAGE (Figure 4.5B and C) were run to decrease the loading of these 
overloaded samples and gaps were left in between each lane to avoid any possible 
spill over. 
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A 20% SDS-PAGE re-run of the cePNE5 cation exchange peaks M and 3 with a 
higher loading of M and a lower loading of 3. Gaps were left in between each lane. 
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A 20% SDS-PAGE re-run of the cePNE5 cation exchange peaks 4,5 and 6 with a 
lower loading. Gaps were left in between each lane. This indicates that a linker 
histone like band of sample 5 in Figure 4.5A was actually a spill over from sample 4 
(bands identified by compared with the histone marker). 
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Conclusion and discussion 
The work described in this section 4.2 has not yet been completed with mass 
spectrometry data from the bands on Figure 4.5. However, in discussion with co- 
workers on this project we may summarise the interpretation of the results at this 
stage of work as follows: 
In the Figures the lane labelled M corresponding to the small peak of the 
chromatogram contains a prominent protein and in comparison with Figure 3.4. It is 
very likely that this protein is heatshock protein 70, by comparing two gels and the 
molecular weight of these two proteins. Future work will be needed to establish why 
this protein fractionates under wildly different conditions in the chromatograms of 
Figures 3.4 and 4.6. This could be due to the modification of the protein, for example, 
or two different variants of the protein. 
The gel lanes in Figure 4.6 suggest that the HMGs co-fractionate with the peak 
in the chromatogram in Figure 4.4 corresponding to histone dimers. However, 
although there are some bands below the H1 histones and H5 histone in the Figures, 
they do not appear to be in the region expecting for HMGBs. 
Although recent literature makes almost no note of the possibility for H2A-H2B 
interacting with HMGBs, older papers of Bernues et al. (1983 and 1986) detect 
chemical crosslinking of the two components in free solution. It is clear from Figure 
4.5 that the H2A-H2B dimers are in large excess compared with the HMGs. It will be 
of some interest in future experiments to see if specific modifications or variants of 
the HMGs bind to the histone dimers. It is noticeable in the chromatogram of Figure 
4.4 that peak 5 corresponding to histone dimers (and also peak 6 for histone H5) is 
not symmetrical and it will be interesting in future experiments to run gels from the 
individual fractions across those peaks. If there are significant differences it will be 
useful to re-fractionate by cation-exchange chromatography different regions of peak 
5 (and also peak 6). 
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Chapter 5 
Extraction and Studies of Nucleoproteins from 
Human-Leukocyte and Human Tissue-culture 
Nuclei by using the "Forward Technology" 
As described in Chapter 3, the two main technologies that are used in the 
LJMU chromatin research group to purify and study nucleoproteins are called 
"forward technology" and "reverse technology". The "forward technology" enables the 
separation of a small group of proteins (PNE1) from the cell nuclei without lysing 
them. Then nucleoproteins are separated from the nuclei lysate progressively by 
increasing its KCI/phosphate concentration (Chapter 2 and 3). The "reverse 
technology" involves the direct lysis of the nuclei by high KCI/phosphate "histone 
octamer precipitation conditions", which precipitate out most nucleoproteins including 
histone octamers in the very beginning first step. Only the most soluble proteins such 
as HMGs remained in the solution. Further fractionation, purification and analysis 
were then applied to these soluble proteins. Both technologies were applied to chick- 
erythrocyte nuclei and discussed in chapter 3. How the "forward technology" was 
applied to human-leukocytesand human cancer cell line (tissue-culture) nuclei is 
described in this chapter. The Author collaborated with supervisors in the 
development of this work and with Dr. James Nicholson of STFC Daresbury 
laboratory, where finances and laboratory facilities were available. The majority of 
the laboratory work was done by the Author. 
The first step in studying human-leukocyte nucleoproteins was to obtain pure 
human-leukocyte cells which were separated from human buffy coats by 
centrifugation. Then the pure human-leukocyte cells were lysed by cell-lysis buffer 
containing detergent and the nuclei were separated from the other cell components 
by centrifugation and washing. This step of the experiment is described in section 
5.1. 
After the pure human-leukocyte nuclei were obtained, they were washed by 
PNE1 washing buffer to remove a group of proteins through the nuclear membrane, 
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called the huPNE1 (hu = human) proteins (see chapter 3.1 for the studies of the 
cePNE1 proteins). This step was done while the nuclei were kept intact by inclusion 
of MgCI2 in the PNE1 washing buffer. The human-leukocyte nuclei were then lysed 
and the "forward technology" and the "reverse technology" were applied to study the 
nucleoproteins. The technologies were developed from the studies of chick- 
erythrocyte nucleoproteins, but some difficulties occurred and the technologies were 
slightly altered while applying them to the human-leukocyte nucleoproteins studies. 
The studies of human-leukocyte nuclei were mainly using the "forward technology" 
as described in section 5.2. 
The "forward technology" was also applied to HT29 (human colon 
adenocarcinoma) human tissue-culture cell nuclei. The tissue-culture cells were 
harvested and lysed to produce nuclei by colleagues Dr. Katie Evans, Dr. Elaine 
Hemers and their project students. The nucleoproteins were then extracted from the 
nuclei by using the "forward technology". This is described in section 5.3. 
The objective of this experiment was to apply the methods developed in the 
studies of chick-erythrocyte nucleoproteins to human-leukocyte nucleoproteins, to 
extract and enrich certain groups of proteins separately such as histone octamers 
(Carcia et al., 2007; Kornberg and Thomas, 1974), linker histones and HMGs (Davey 
et al., 2002) from human-leukocyte nuclei. Thus, methods for studying human 
nucleoproteins (Hake et al., 2006; Khan and Krishnamurthy, 2005; Nightingale et al., 
2006) related to human disease such as cancer could be undertaken by using 
leukocytes from patients with disease in comparison with healthy people. 
169 
5.1 Extraction and purification of nuclei from human-leukocyte cells and 
human HT29 tissue-culture cells 
Introduction 
The human-leukocyte cells and nuclei were prepared from human buffy coat. 
Because it is a human product, an ethics approvement was needed. The ethics 
approved for this project was obtained from the Cheshire Research Ethics 
Committee. The work was carried out with the Science and Technology Facilities 
Council laboratory at Daresbury, Cheshire, where a safety risk assessment was 
carried out. The buffy coats had been tested for diseases and were purchased for 
non-clinical use. At least 24 hours delay was incurred for disease-testing of the blood 
before it was available from the National Blood Service. 
The human HT29 tissue-culture cells were prepared and harvested and the 
nuclei from them were extracted and purified by colleagues Dr. Katie Evans, Dr. 
Elaine Hemers and their project students. For the cell culture, HT-29 cells 
(purchased from ATCC) were used and cultured in a `full' growth medium consisting 
of 500 ml of advanced RMPI media 1640 (Sigma-Aldrich), 50 ml foetal bovine serum 
(FBS or FCS, where C is short for calf), 5 ml penicillin/streptomycin (pen/step) and 5 
ml L-glutamine- 200 mM (Gibco cat # 25030). The cells were maintained in a 95% 02, 
5% CO2 humidified atmosphere at 37°C. The cells were grown until there were 16 
confluent flasks in total from which the nuclear HMGs could be extracted. Trypsin- 
EDTA (Sigma-Aldrich) was used to divide the cells in to culture flasks. CCD18 cells 
(myofib rob lasts) were also cultured using this media and grown for stimulation with 
varying HMGB1 doses. The procedure used to produce nuclei from HT29 tissue 
culture was similar to that from human-leukocyte cells described below. 
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Methods for Producing Human Leukocyte-cells and Cell Nuclei: 
Buffers: 
(Benzamidine hydrochloride was added freshly and keptat 4 °C before use; all 
buffers were filtered by 0.4 pm filters before use) 
Stock solutions: 
1.1 M Tris, pH 7.5,1 M NaCl, 100 ml. 
2.10% Triton-X-100,100 ml. 
3.1M MgCI2. 
4. Complete protease-inhibitor pills (Roche), 1 tablet per 40 mis of protein 
solution. 
Working solutions: 
1. Cell-lysis buffer: 100 ml of 10 mM Tris pH 7.5,10 mM NaCl, 1.1 % Triton 
X100,3.5 mM MgCl2: add 1 ml of stock solution 1,11 ml of stock solution 2, 
and 0.35 ml of stock solution 3 to distilled water and made up to 100 ml, 
followed by mixing the total solution thoroughly. The solution was made up 
immediately before use and filtered. 20 ml of this solution was used for the 
cell lysis, containing one dissolved protease-inhibitor tablet. 
Procedure: 
Immediately after arrival, two buffy coats were transferred to a beaker 
containing two Roche protease-inhibitor tablets and stirred untill the tablets 
dissolved. The blood was then transferred into two 50 ml Falcon tubes (about 45 ml 
per tube). The tubes were centrifuged at 3,500 rpm (Beckman Acanti® J-26 XP 
centrifuge, JS 13.1 rotor) for 8 minutes. This speed and time was determined by 
colleagues Prof. J. Baldwin and Dr. K. Evans, which is short enough so that the red 
cells were intact and the white cells not contaminated or tinged with red cells. The 
profile of cells (Figure 5.1) allows separation of the white cells and platelets with 
plasma at the top. Under this was a fairly thick layer of white cells (leukocytes) 
distributed in the plasma, then a thin layer of platelets with clearly-defined top and 
bottom boundaries. The thick bottom layer of red cells, at 8 minutes, was separated 
from the other layers. Note that the plasma was cloudy (containing white cells still). 
The platelet layer had sharp boundaries and was narrow (Figure 5.1). 
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Figure 5.1 Buffy coats centrifuged at 3,500 rpm (Beckman Acanti® J-26 XP 
centrifuge, JS 13.1 rotor) for 8 minutes 
i 
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Red blood 
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The buffy coats (about 45 ml) with a pill of complete protease inhibitor were 
centrifuged at 3,500 rpm (Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) for 8 
minutes immediately after arrival. The centrifugation conditions were critical so that 
the blood was separated into three main layers after centrifugation. The cloudy top 
layer was plasma still mixed with white blood cells; the middle thin layer of platelets 
had clearly-defined top and bottom boundaries; the bottom thick layer was non- 
nucleated red blood cells. 
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The cloudy plasma layers containing the white cells in each Falcon tube were 
carefully removed down to the top of the platelet layers and put into two 50 ml Falcon 
tubes that were balanced. The two Falcon tubes were centrifuged at 3,500 rpm 
(Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) for 25 minutes and the white- 
cell region at the bottom of the tubes was retained while removing the clear plasma 
layer above (Figure 5.2). 
In principle, the initial centrifugation could have been even shorter, so that the 
erythrocytes were at the bottom of the centrifugation tube and the leukocytes and 
platelets still distributed in the plasma for later removal. Then the plasma containing 
leukocytes and platelets could be centrifuged exactly as described in the previous 
paragraphs to separate platelets from plasma containing leukocytes. 
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Figure 5.2 The mixture of plasma and white blood cells were then centrifuged at 
3,500 rpm (Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) for 25 minutes 
Clear plasma 
White blood 
cells 
Remaining red 
blood cells 
The mixture of plasma and white blood cells was centrifuged at 3,500 rpm for 25 
minutes. The white blood cells were pelleted to the bottom of the tube. The clear top 
layer supernatant was the plasma. The small red region down the bottom of the tube 
was a small amount of red blood cells remaining in the sample, or more probably 
residual platelets. 
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The remaining leukocytes at the bottom of the tube were transferred to be 
dispersed in 20 ml of cell lysis buffer, stirring in a small beakerfor 30 minutes to lyse 
the cells. The lysed cells were partitioned into two fresh 15 ml Falcon tubes, 
balanced and centrifuged at 2,500 rpm (Beckman Acanti® J-26 XP centrifuge, JS 
13.1 rotor) for 25 minutes. The two supernatants of cytoplasmic material were 
retained for the extraction of cytoplasmic proteins. The two white pellets of pure 
human-leukocyte nuclei at the bottom of the tubes were then ready for the next step 
of the experiment (Figure 5.3). 
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Figure 5.3 Preparation of the pure human-leukocyte nuclei 
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The lysed human-leukocyte cells were centrifuged at 2,500 rpm (Beckman Acanti® 
J-26 XP centrifuge, JS 13.1 rotor) for 25 minutes, and then the pure nuclei were 
obtained at the bottom of the tube. 
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5.2 Extraction of nucleoproteins from human-leukocyte nuclei by using the 
"forward technology" 
After the pure human leukocyte nuclei were obtained, the next step was to 
extract nucleoproteins from them. The "forward technology", which was developed 
from the studies of chick-erythrocyte nuclei, was applied to these human nuclei. In 
the "forward technology", the first step was to extract a group of proteins called 
"PNE1" from the nuclei by low KCI/phosphate buffer with MgCl2 to keep the nuclei 
intact. Following that, the nuclei were then lysed in high ionic strength KCI/phosphate 
nuclei lysis buffer to remove histones and other nucleoproteins from the DNA. These 
nucleoproteins were then separated into small groups by further purifications 
(Chapters 2 and 3). When this "forward technology" was applied to human nuclei, the 
high KCI/phosphate nuclei lysis buffer (2 M KCI, 0.2 M K2HP04,0.2 M KH2PO4,2.5 
mM benzamidine hydrochloride) was used in attempt to lyse the nulcei, but the 
results showed that much of the human nuclei kept intact under this condition (Figure 
5.4). Meanwhile, the low KCI/phosphate PNE1 extraction buffer (70 mM KCI, 35 mM 
K2HPO4,35 mM KH2PO4,3.5 mM MgCI2,2.5 mM benzamidine hydrochloride), 
developed from the study of chick-erythrocytes, was introduced to the human nuclei; 
but the results showed that the human nuclei lysed under this low KCI/phosphate 
condition even when MgCI2 was present (Figure 5.5). Therefore, a new technology 
had to be established for these human nuclei. From a series of experiments, we 
found that although the low KCI/ phosphate condition could lyse the nuclei, the ionic 
strength was not high enough to dislodge the histones in which case the histones 
remained with the DNA. Finally, a new "forward technology" was established by 
lysing the nuclei under the low KCI/phosphate conditions while the histones still 
remained with DNA as a chromatin gel. Then the lysate was centrifuged through a 
second high ionic strength KCI/phosphate buffer to remove the histones from the 
DNA. 
Another problem that occurred in these experiments was that of protein 
degradation. As with chick-erythrocytes, histones and other chromatin-fibre 
architecture proteins are subject to degradation due to endogenous proteases. One 
of these proteases has been identified by the group of Kouzarides. It cleaves the tail 
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of histone H3 (Santo-Rosaet al., 2008). Therefore it was important to use 2.5 mM 
benzamidine hydrochloride or the complete protease-inhibitor cocktail from the 
company "Roche". Since the latter is expensive and we found that the cost could be 
minimized by using our method of leukocyte preparation. 
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Figure 5.4 The human-leukocyte nuclei were lysed in high ionic strength 
KCI/phosphate buffer 
Intact nuclei after 
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bottom of the tube 
This Figure shows that the human-leukocyte nuclei only partially lysed under the 
high ionic strength KCI/phosphate condition (2 M KCI, 0.2 M K2HPO4,0.2 M KH2PO4, 
2.5 mM benzamidine hydrochloride). The top pellet was the nuclei which remained 
intact after lysis and centrifugation. The bottom pellet was the DNA from the nuclei 
which were lysed. 
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Figure 5.5 The nuclei lysed under the low ionic strength KCI/phosphate conditions 
This Figure shows the pure human-leukocyte nuclei mixed with PNE1 extraction 
buffer (80 mM KCI, 40 mM K2HP04,40 mM KH2PO4,3.5 mM MgCI2,2.5 mM 
benzamidine hydrochloride) and centrifuged at 2,000 rpm (Beckman OPTIMATM L-80 
preparative ultracentrifuge, Ti 70 rotor) for 15 minutes. The nuclei were lysed under 
this low ionic strength condition and chromatin formed in the tube. 
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Figure 5.4 shows that the human-leukocyte nuclei were just partially lysed 
under the high ionic strength KCI/phosphate lysing condition developed for chick- 
erythrocyte nuclei (Chapters 2 and 3). On the other hand, Figure 5.5 shows that they 
were lysed under the low ionic strength KCI/phosphate condition usually used to 
extract the PNEI proteins without nuclei lysis. The Author helped to supervise two 
project students, Mr. Arabarb Mirza and Mr. Damien Long, in their experiments with 
chick-erythrocyte cell nuclei. These showed that the cePNE1 proteins (Chapter 3) 
could be extracted without nuclei lysis at lower KCI/phosphate ionic strength than 0.9 
M KCI, 0.45 M K2HPO4,0.45 M KH2PO4. Their experiments also showed that nuclei 
lysis at a relatively lower ionic strength (0.2 M KCI, 0.1 M K2HPO4,0.1 M KH2PO4) 
were possible. In that case, linker histones were released into solution, while core 
histones remained attached to DNA. 
Conditions close to this proved effective in isolating huPNE1 proteins, linker 
histones and core histones separately from cell-culture cells. The results showing 
this are in section 5.3. 
Work on the leukocytes needs to be continued to reproduce the conditions of 
section 5.3. However, working in a laboratory outside the John Moores University, 
necessary for safety containment and ethics approved, does present problems of 
access and this has been particularly difficult because of changes to the CCLRC 
Daresebury Laboratory. However, the work on human leukocytes will continue at the 
Diamond Light Source Laboratory near Oxford, where new ethics approval and 
safety conditions have just been completed. 
So while nucleoproteins can be released from DNA-phosphate interactions by 
competition with an increased KCI/phosphate concentration, histone octamers in a 
highly enriched form remain attached to the DNA. They can then be removed by acid 
or salts in a highly enriched form. 
According to the results and conclusions made above, a new "forward 
technology" was developed and applied to human-leukocyte nuclei. This time 8 ml of 
new nuclei-lysis buffer (125 mM KCI, 62.5 mM K2HPO4,62.5 mM KH2PO4,3.5 mM 
MgCl2,2.5 mM benzamidine hydrochloride) were placed into a 10 ml Ti 70 Beckman 
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centrifuge tube. The 2 ml of nuclei, now well dispersed in cell-lysis buffer (10 mM tris 
pH 7.5,10 mM NaCl, 1.1 % Triton X100,3.5 mM MgCl2), were gently layered on top 
of the new-nuclei lysis buffer, using a glass Pasteur pipette (Figure 5.6). The tube 
was then carefully sealed without disturbing the layering and then shaken suddenly 
to lyse the nuclei. Sudden shaking instantly distributes the nuclei uniformly before 
the lysis. The centrifuge tube was balanced against a second tube containing buffer 
and centrifuged at 36,000 rpm (Beckman OPTIMAT" L-80 preparative ultracentrifuge, 
Ti 70 rotor) (100,000 xg) for 18 hours. 
After centrifugation, the supernatant containing the nucleoproteins extracted 
from the human-leukocyte nuclei was collected. Approximately 30 mg of total 
proteins were extracted from 2 ml of the nuclei. The supernatant was then dialysed 
against distilled water and freeze-dried. The sample was then re-dissolved into 1M 
Tris-HCI, pH 6.8 buffer and 20% SDS-PAGE was run for it (Figure 5.7). 
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Figure 5.6 The lysis of human-leukocyte nuclei 
a. b. 
The 2 ml of human-leukocyte nuclei suspension was dispersed (a) and layered on 
the top of the nuclei lysis buffer (125 mM KCI, 62.5mM K2HPO4,62.5 mM KH2PO4,5 
mM EDTA) with a glass Pasteur pipette (b). A sudden shaking was then applied to 
the tube to lyse the nuclei. After that the tube was balanced and centrifuged at 
36,000 rpm (Beckman OPTIMATM L-80 preparative ultracentrifuge, Ti 70 rotor) for 18 
hours. The supernatant was then taken and a SDS-PAGE was run for it (Figure 5.7). 
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Figure 5.7 20% SDS-PAGE of the nucleoproteins extracted from the human- 
leukocyte nuclei 
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This Figure shows a 20% SDS-PAGE of the nucleoproteins extracted from the 
human-leukocyte nuclei. Core-histone octamers and linker histones were extracted 
out from the nuclei (bands identified by compared with the histone marker), but the 
yield was not as high as expected. That was because the major part of core histones 
still remained attached to DNA as explained above and in section 5.3. This problem 
will be solved by applying a further altered "forward technology" to the human 
leukocyte nuclei as for HT29 tissue-culture cell nuclei (section 5.3). 
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5.3 Extraction of nucleoproteins from human tissue-culture-cell nuclei by 
using the "forward technology" 
The "forward technology", developed from chick-erythrocyte nuclei, was also 
applied to HT29 human tissue-culture cell nuclei. During the experiments described 
above (Figure 5.4 and 5.5), we found that the human nuclei did not lyse under high- 
ionic-strength nuclei-lysis buffer in contrast to chick-erythrocyte nuclei. The human 
nuclei could be lysed under a low ionic strength KCI/phosphate buffer, but the major 
part of the histones were not extracted out and remained bound to DNA. Based on 
that, a new "forward technology", altered from the previous one for chick-erythrocyte 
nuclei described in Chapters 2 and 3, was established for these human HT29 tissue- 
culture cell nuclei. In this new technology, the nuclei were first lysed under the low 
KCI/phosphate condition while the histones still remained with DNA as a chromatin 
gel. Then the lysate was centrifuged through a second high ionic strength 
KCI/phosphate buffer to dislodge out the histones. 
The human HT29 tissue-culture cells were harvested and the nuclei were 
extracted as described in section 5.1. The nuclei were stored in 50 ml Falcon tubes 
at -80 °C in glycerol maintenance buffer (-40 ml in each tube). The nuclei were 
thawed at 4 °C before use, and then centrifuged at 3,000 rpm (Beckman Acanti® J- 
26 XP centrifuge, JS 13.1 rotor) for 15 minutes to remove the glycerol. After 
centrifugation, the supernatant was removed, a volume of nuclei washing buffer (10 
mM tris, 10 mM NaCl, 3.5 mM MgCl2, and 2.5 mM benzamidine hydrochloride) equal 
to that of the nuclei was added to the tube and thoroughly mixed with the nuclei by a 
submerged Pasteur pipette. The total volume was then made up to 40 ml and the 
nuclei were centrifuged at 2,000 rpm (Beckman Acanti® J-26 XP centrifuge, JS 13.1 
rotor) for 15 minutes. The supernatant was removed and the nuclei were washed 
again with nuclei washing buffer and pelleted by centrifugation. Approximately 2 ml 
of nuclei in each tube were then kept in 4 °C cold room before use. 
A tube of nuclei (2 ml) was used for an acid extraction to provide a control to 
examine the total protein in the nuclei. The nuclei were dispersed in nuclei washing 
buffer through a 22-gauge needle and an equal volume of 1N sulphuric acid was 
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added to the tube. The tube was shaken well to mix and left on ice for an hour to let 
the acid extraction take place. After that the mixture was centrifuged at 13,000 rpm 
(Beckman OPTIMATM L-80 preparative ultracentrifuge, Ti 70 rotor) for 20 minutes, 
the supernatant was collected and dialysed against distilled water. Then the protein 
concentration of the supernatant was measured by UV spectrophotometry (0.93 
mg/ml, total protein = 3.71 mg). The proteins were then freeze-dried and ready for 
SDS-PAGE gel analysis (Figure 5.8 and 5.10). 
Then, the huPNE1 proteins were extracted from another tube of nuclei, 
dispersed in PNE1 extraction buffer (75 mM KCI, 75 mM equimolar potassium 
phosphate, 3.5 mM MgCI2,2.5 mM benzamidine hydrochloride). The mixture was 
then centrifuged at 2,000 rpm (Beckman OPTIMATM L-80 preparative ultracentrifuge, 
Ti 70 rotor) for 10 minutes; the supernatant was collected as the huPNE1 proteins. 
The PNE1 extraction procedure was repeated twice and three supernatants were 
combined together and ultra-centrifuged at 35,000 rpm (Beckman OPTIMAT" L-80 
preparative ultracentrifuge, Ti 70 rotor) for 18 hours to remove any small amount of 
RNA which may have leaked through the nuclear membrane. The supernatant was 
then dialysed against distilled water and the protein concentration was measured by 
UV spectrophotometry (0.33 mg/ml, total protein = 3.77 mg). The huPNE1 sample 
was then freeze-dried and ready for SDS-PAGE gel analysis (Figure 5.8). 
The PNE1-depleted nuclei were re-suspended in 1 ml of PNE1 extraction 
buffer and gently layered on top of 4 ml of nuclei lysis buffer 1 (0.2 M KCI, 0.2M 
equimolar potassium phosphate, 2.5 mM benzamidine hydrochloride). The tube was 
then shaken vigorously and the nuclei lysed in about 30 seconds. After that, the 
nuclei lysate was dispersed and carefully layered on top of 5 ml of nuclei lysis buffer 
2 (2 M KCI, 0.4 M equimolar potassium phosphate, 2.5 mM benzamidine 
hydrochloride) (Figure 5.9). Then the tube was directly ultra-centrifuged at 35,000 
rpm (Beckman OPTIMATM L-80 preparative ultracentrifuge, Ti 70 rotor) for 18 hours 
without disturbing the two layers. After centrifugation, the supernatant was taken and 
separated as the top layer, the middle layer and the bottom layer (the layers were not 
clearly defined, 3 ml of each layer was taken). The three samples were then dialysed 
against distilled water and the protein concentrations were measured by UV 
spectrophotometry (top: 0.36 mg/ml, total protein = 2.0 mg; middle: 0.41 mg/ml, total 
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protein = 1.32 mg; bottom: 0.47 mg/ml, total protein = 3.49 mg). The samples were 
then freeze-dried and ready for SDS-PAGE gel analysis (Figure 5.8 and 5.10). 
The above sample procedure allows separation (enrichment) of the important 
chromatin architectural proteins: HMGs, linker histones and core histones in a simple 
procedure, and allows the analysis of nucleoproteins for proteomics of cell-culture 
nucleoproteins. The methods should be directly transferable to leukocyte 
nucleoproteins to determine their yields and proteomics, with further enrichment of 
nucleoproteins by the methods described in chapter 2 and 3. 
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Results: 
Figure 5.8 The 20% SDS-PAGE of the huPNE1 proteins which were extracted from 
the HT29 human tissue-culture nuclei 
Histone H1aýymensvimm_ 
Histone H1b 
Histone H5--ýý 
Histone H3 
Histone H2A 
Histone H2B 
Histone H4-- 
Histone 
Marker 
DNA 
Pellet Acid 
Extraction 
DNA 
Pellet Acid 
Extraction 
DNA 
Pellet Acid 
Extraction 
DNA 
Pellet Acid 
Extraction I lul'NL: I 
This Figure shows the 20% SDS-PAGE of the huPNE1 proteins which were 
extracted from the HT29 human tissue-culture nuclei (in 75 mM KCI, 75 mM 
equimolar phosphate extraction buffer), and compare with the histones acid 
extracted from the pellet after centrifugation that is composed of pure core histones 
(bands identified by compared with the histone marker). 
IIuI'NIiI 
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Figure 5.9 The lysate of nuclei lysed in nuclei lysis buffer 1 (0.2 M KCI, 0.2 M 
equimolar phosphate) was then carefully layered on top of the nuclei lysis buffer 2 (2 
M KCI, 0.4 M equimolar phosphate) 
This Figure shows that how the lysate of nuclei lysed in nuclei-lysis-buffer 1 (0.2 M 
KCI, 0.2 M equimolar phosphate) was then carefully layered on top of the nuclei- 
lysis-buffer 2 (2 M KCI, 0.4 M equimolar phosphate). This tube was then ultra- 
centrifuged at 35,000 rpm (Beckman OPTIMATM L-80 preparative ultracentrifuge, Ti 
70 rotor) for 18 hours without disturbing these two layers. 
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Figure 5.10 The 20% SDS-PAGE of the three layers of nucleoproteins which were 
extracted from the HT29 human tissue-culture nuclei 
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This Figure shows 20% SDS-PAGE of the top layer, the middle layer and the bottom 
layerof the nucleoproteins extracted from the HT29 human tissue-culture nuclei. 
Note that the HMG proteins were enriched in the HuPNE1 fraction (lane 2), the linker 
histones were enriched in the supernatant after nuclei lysis and ultracentrifugation 
(lane 3,4 and 5), and while the core histones remained attached to the DNA pellet to 
be acid extracted (lane 6) bands identified by compared with the histone marker. 
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Conclusions and discussion 
HT29 Cell-Culture Cells: 
Figures 5.8 and 5.10 showed the complete extraction of HMG proteins in the 
huPNE1 fraction. 3.8 mgs of total huPNE1 contains HMGs, probably about 300 ng, 
sufficient for both 2DE and mass spectrometry analysis. However, this yield is low 
and may be due to precipitation during the dialysis into 10 mM tris pH 7.5. In future, 
the solution can be dialysed against volatile buffers of 10 mM ammonium bi- 
carbonate (high pH), 10 mM ammonium acetate (pH 7) or ammonium formate (low 
pH). Then direct freeze drying could be done including any precipitation, to extract all 
the proteins. 
A high yield of linker histones and some of the other proteins, but including a 
tiny quantity of core histones, were extracted completely and exclusively in the 
supernatant from the nuclei lysis, after ultra-centrifugation through the high-KCI- 
phosphate cushion (Figure 5.10). The total yield of proteins was 6.8 mg. The linker 
histones can be purified by cation-exchange chromatography in future experiments. 
Core histones (3.5 mg) were exclusively targeted by acid extraction from the 
chromatin pellet after ultracentrifugation. Histone dimers and tetramers can be 
extracted by cation-exchange chromatography for further targeting. The chromatin 
pellet can be cut and the proteins can be extracted in KCI/phosphate, rather than 
acid extraction. The yield would be lower, but there would be plenty of extract for 
2DE and PTM analysis, without exposure to acid conditions. 
Remarkably the core histones were not degraded at all. This indicated that the 
expensive complete protease inhibitors are not necessary to extract tissue culture 
proteins intact. Benzamidine hydrochloride was enough to protect histones from the 
various proteases. The procedure therefore opens the door for a very efficient, fast 
and inexpensive identification of PTMs and variants of selective core histones, 
selective linker histones and selected HMG proteins and many other nucleoproteins. 
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Human Blood Leukocytes: 
In the work explained in this chapter, the isolation of cells from human blood 
from the National Blood Services was completed without using any solvents, except 
the introduction of heparin by the National Blood Services to prevent blood clotting. 
The procedure was simply to use low speed centrifugation and careful separation to 
extract leukocytes dispersed in the blood plasma, leaving the platelets layer and 
erythrocytes as clear bands. This is a fast, efficient procedure which in our opinion 
compares well with other existing methods (Graziani-Bowering et al., 1997; Okuzaki 
et al., 2011). 
There are many strategies for separating blood components using 
centrifugation and others have also used the principle of distributing platelets and 
leukocytes in blood plasma allowing separation from the bottom red cells component 
(Internet: OnFocus Recipe Box, 2009). In our procedure we have started with human 
buffy-coats from the National Blood Services. If we started from whole blood it would 
be possible to allow the red cells to fractionate to the bottom of the tube allowing the 
platelets and leukocytes to be extracted, distributed in the plasma. It would be 
dangerous to remove any plasma top layer in case of losing the platelets and 
leukocytes distributed in that layer. Then the procedure outlined in this chapter would 
be very efficient for obtaining pure platelets and pure leukocytes without exposing 
the components to any solvents except for the heparin introduced initially into the 
blood, to prevent clotting. The leukocytes could then be fractionated into the 
component cells (Neutrophils, most abundant; Eosinophils, 2-4%; Basophils, 1%; 
Lymphocytes, 25%; and Monocytes, 3-8%) using density gradient centrifugation, 
using, for example, percol or "Optiprep" as density gradient media (Axis- 
Shielddensitygradientmedia, "nicomed" Application Sheet C43; 3rd, July 2011). We 
are aware that pure plasma after high speed centrifugation could be used as a 
density gradient media and this would mean that there would be no intervention by 
any outside solutions since the collection of blood apart from the addition of heparin. 
Human leukocytes were extracted in one experiment and tissue-culture cells 
in the second one. Nuclei were produced as described in this chapter, based on 
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early papers by Garrard and Hancock (Garrard and Hancock, 1978) and by Hancock, 
Faber and Fakan (Hancock et al., 1977). The methods have been developed in 
many laboratories (Simon and Felsenfeld, 1979; Moudrianakiset al., 1985; Goodwin 
et al., 1979) including the LJMU Chromatin Research Group (Prof. J. Baldwin) with 
experience from work with colleagues at Portsmouth University (Suau et al., 1979). 
Comparing each of these technologies developed by others we believe that our 
method is unique in the use of phosphate combined with KCI. Indeed this 
combination established conditions for crystallisation of intact histone octamers. The 
crystals with space group P65 are unique to the LJMU Chromatin Research Group 
and are discussed in chapter 2 (Chantant et al., 2003; Wood et al., 2005). 
In our method of extracting cell nuclei from human buffy coat, only one 
solution is required reduce which is the time of the experiment by using one cell lysis 
stage. After centrifugation, the nuclei were simply taken up in buffer and proteins are 
extracted as described earlier. 
In the procedures described in this chapter, we were able to produce the 
huPNE1 proteins (enriched in HMG proteins), separate from a supernatant after 
centrifugation enriched in linker histones. Again separately, core histones were 
extracted from the sedimented chromatin pellet. The procedure for the tissue-culture 
cells can be a standard procedure for enriching this group of proteins greatly 
reducing the clutter of spots in 2D gel electrophoresis and enabling directly mass 
spectrometry determination of the enriched proteins separately in each of the three 
extractions. 
The methods for cePNEI-proteins extraction and purification of HMGs from 
chick erythrocytes have been described in chapter 3. Shechter et al. (2007) have 
reviewed isolation, purification and analysis of histone proteins particularly applied to 
mass spectrometry and other studies in the group of Allis (Shechter et al., 2007). The 
method described in this chapter allows core histones, linker histones, HMG proteins 
and other proteins such as peptidylprolylisomerases to be studied by mass 
spectrometry, following one extraction from human tissue-culture cells or human 
leukocytes. 
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The procedures developed in this chapter could be used to study biomarkers 
of diseases, by studying proteins from diseased cells in comparison with normal cells 
used as control. 
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Conclusion and Discussion 
The major target of this thesis work was to develop a fast and efficient 
technology to extract, purify and study nucleoproteins from chick and human cell 
nuclei. Proteins were extracted by successively increasing the ionic strength of 
KCI/phosphate solution to high values. The methods together are called the "forward 
technology" to distinguish them from procedures where proteins are extracted 
abruptly at very high ionic strengths to produce only the most soluble nucleoproteins. 
In Chapter 2, ultra-pure histone octamers, dimers and tetramers were 
extracted from chick erythrocyte nuclei within 3 days by using this "forward 
technology". The pure histone octamers were crystallised to reach the highest 
resolution, 1.8 A. The pure histone H2A-H2B dimers and (H3-H4)2 tetramers were 
complexed with histone chaperone NAP1 in collaboration with Dr. Emily Newman 
and Dr. John MeGeehan of Pothmouth University. 
In Chapter 3, the "forward technology" was used to enrich important 
nucleoporteins such like HMGs, into small groups, to allow further purification and 
studies of these proteins. A group of proteins rich in HMGs was extracted from chick 
erythrocyte nuclei by the "forward technology" called cePNE1 proteins. Ion-exchange 
chromatography was applied to the cePNE1 proteins to fractionate them. During 
these experiments, an important peptidyl prolyl isomerase, FKBP3, was found to be 
co-fractionated with HMGB1 which may indicate a potential complex between them. 
In Chapter 4, two other groups of proteins were extracted from chick 
erythrocyte nuclei called cePNE4 and cePNE5 proteins. CePNE4 proteins mainly 
contain some high molecular weight proteins including some functionally important 
ones such as DNA topoisomerase II. CePNE5 proteins contain mainly linker histones. 
Cation exchange chromatography was used to fractionate this group of proteins. 
Results showed that some histone dimers co-fractionated with HMGB proteins. This 
indicates complexes between HMGB proteins and histone dimmers (H2A-H2B) 
which could be purified further for crystallography and other structural studies. 
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In Chapter 5, the "forward technology", developed from chick nuclei, was 
applied to human-leukocyte and human-tissue-culture nuclei. Pure human tissue- 
culture nuclei were produced in a fast and efficient manner. HMG proteins were 
enriched in the huPNE1 group proteins and human core histones were acid 
extracted (Figure 5.8). 
These works will lead to a wide range of further studies of nucleoproteins: 
The complex between HMGBs and FKBP3 will need to be purified. Following 
that, further extraction, purification, crystallization and other functional or disease 
related studies can be carried out for this complex. 
The same can be done for the complex between HMGBs and histone H2A- 
H2B dimers. Crystallization of the ultra-pure histone dimers and tetramers, which 
have never been achieved, should be carried out. 
The methods of extracting and studying of human nucleoproteins in this thesis 
need to be extended, particularly for structural studies of nucleoprotein assemblies. 
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Appendix 1 
Isolation of chick erythrocyte nuclei 
Introduction 
Chick erythrocyte cell nuclei are one of the main resources of our experiment. 
Although chick's cells and nuclei may behave differently compared with mammalian's 
cells and nuclei, there are still many advantages to use chick erythrocyte nuclei. 
Firstly chick erythrocyte cells contain nuclei which mammalian erythrocyte cells don't, 
and the yield of erythrocyte cells is much greater than leukocyte cells. Secondly the 
nucleosome structure and histone proteins which we are focusing on are stably 
inherited in different species. Finally chick blood as the resource of erythrocyte cells 
is very cheap and easy to obtain which allow us to do large amount of works on it. 
Chick erythrocyte nuclei preparation is the first step of our purification of chick 
histone octamers, dimers, tetramers and other associated nuclei proteins. Our group 
developed this method to purify the nuclei from fresh chick blood collected from 
chicken farm. 
Method: 
Buffers: 
(All buffers stored at 4°C before use) 
1. Chick blood anti clotting buffer: 2L of 10% Tris-sodium Citrate. 
2. Cell lysis buffer: 20 L of 10 mM Tris-HCI pH 7.4,10 mM NaCl, 3.5 mM 
MgCI21 1.25% Triton X-100. 
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3. Detergent nuclei washing buffer: 30 L of 10 mM Tris-HCI pH 7.4,10 mM 
NaCl, 3.5 mM MgCl2,0.5% Triton X-100. 
4. Nuclei washing buffer: 30 L of 10 mM Tris-HCI pH 7.4,10 mM NaCl, 3.5 
mM MgCI2. 
5. Nuclei freezing buffer: 10 mM Tris-HCI pH 7.4,10 mM NaCl, 3.5 mM 
MgCl2,50% glycerol. 
Procedure: 
Twelve litres of chicken blood was collected from the chicken farm. 10% Tris- 
sodium citrate was added into the blood at a ratio of 100 ml buffer per litre of blood to 
stop the blood clotting and the blood was allowed to cool slowly on the way to the 
laboratory. Then the blood was filtered through two layers of butter muslin which pre- 
wetted with 10% Tris-sodium citrate to filter out most of the leukocyte cells. Then the 
blood was partitioned into twelve 1 litre centrifuge tubes and centrifuged at 3000 rpm 
(Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) for 15 minutes to separate the 
cells. After centrifugation the bully coat was sucked off , 
the erythrocytes were pool 
together and lysed in cell lysis buffer (10 mM Tris-HCI pH 7.4,10 mM NaCl, 3.5 mM 
MgCl2,1.25% Triton X-1 00) to a final volume of 20 litres. The erythrocytes with lysis 
buffer were stirred at 4 °C for one hour to allow the cells to be lysed. 
After lysis the lysed cells were centrifuged at 2500 rpm (Beckman Acanti® J- 
26 XP centrifuge, JS 13.1 rotor) for 15 minutes to separate the nuclei and other 
materials. Then the supernatant was sucked off down to the pellet, the nuclei pellets 
were pool together and washed in detergent nuclei washing buffer (10 mM Tris-HCI 
pH 7.4,10 mM NaCl, 3.5 mM MgCl2,0.5% Triton X-100) with a ratio of 1/3 nuclei to 
2/3 buffer and then the nuclei were centrifuged at 2000 rpm (Beckman Acanti® J-26 
XP centrifuge, JS 13.1 rotor) for 15 minutes and the supernatant was removed. This 
stage is to lyse any unlysed cells remain in the nuclei pellet; it might be repeat one or 
two more times to lyse all the cells, each time the nuclei pellets were dispersed by 
squirting through the nozzle of a 20 ml syringe. 
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Then the nuclei were washed with nuclei washing buffer (10 mM Tris-HCI pH 
7.4,10 mM NaCl, 3.5 mM MCI2,2.5 mM benzamidine hydrochloride) by suspend the 
nuclei into the buffer with a ratio of 1/3 nuclei to 2/3 buffer and then the nuclei were 
centrifuged at 2000 rpm (Beckman Acanti® J-26 XP centrifuge, JS 13.1 rotor) for 15 
minutes and the supernatant was removed. This step is to remove the haemoglobin 
remain in the nuclei; it might be repeated several times until the nuclei pellets 
become pure white. Then the nuclei were dispersed by squirting through the nozzle 
of a 20 ml syringe and mixed with an equal volume of nuclei freezing buffer. Finally 
the nuclei were partitioned into 50 ml tubes and flash freezed by liquid N2. They can 
then be stored in -80 °C freezer ready for further purification of nuclei proteins. 
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Appendix 2 
cePNEI-protein identification by nanospray mass 
spectrometry 
Note that our methods extract gram quantities of the mixture of proteins so that 
purification of significant quantities of the most abundant proteins will be possible for 
mass spectrometry and structural studies. 
C 
Proteins (accession number/molecular weight/score/queries matched/name) 
ategory 
of 
protein 
1 i 63556 Mass: 73120 Score: 3820 Queries matched: 409 19 
unnamed protein product [Gallus gallus] lamin A 
2. 050748706 Mass: 545623 Score: 2901 Queries matched: 99 2 
PREDICTED: similar to Dynein heavy chain, cytosolic (DYHC) (Cytoplasmic dynein heavy chain 1) (DHC1) 
(Gallus gallus) 
37 i 50751217 Mass: 267232 Score: 2829 Queries matched: 87 9 
PREDICTED: similar to Tpr [Gallus gallus] 
4. W153136476 Mass: 100168 Score: 2576 Queries matched: 95 2 
hypothetical protein [Gallus gallus] methylenetetrahydrofolate dehydrogenase 
5. 113384736 Mass: 531690 Score: 2403 Queries matched: 83 17 
dynein, cytoplasmic, heavy chain I [Mus musculus] 
6. i 25162 Mass: 81360 Score: 2262 Queries matched: 100 2 
muCL [Gallus gallus] 
g1137690083 Mass: 69870 Score: 1942 Queries matched: 86 3 
heat shock protein Hsp70 [Gallus gallus] 
8. i0 Mass: 67900 Score: 1919 Queries matched: 96 19 
unnamed protein product [Gallus gallus] lamin B2 
9. i 91717 Mass: 97146 Score: 1907 Queries matched: 84 10 
eukaryotic translation initiation factor 2C, 2 [Homo sapiens] 
10. W1160731932 Mass: 96379 Score: 1873 Queries matched: 84 10 
PREDICTED: similar to eukaryotic translation Initiation factor 2C, 2; argonaute 2 [Gallus gallus] 
11. i 45 3 Mass: 70827 Score: 1707 Queries matched: 68 3 
heat shock protein [Numida meleagris] 
12. nuffl-zou Mass: 51044 Score: 1654 Queries matched: 80 9 
similar to eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked [Gallus gallus] 
13. 9URUM Mass: 33038 Score: 1622 Queries matched: 97 10 
eukaryotic translation Initiation factor 2, subunit I alpha, 35kDa [Gallus gallus] 
14. i7 Mass: 60125 Score: 1597 Queries matched: 452 10 
Elongation factor 1-alpha I (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) 
15. i1157529974 Mass: 68573 Score: 1596 Queries matched: 69 13 
apoptosis inhibitor 5 (Gallus gallus] 
16, 2W7 Mass: 51033 Score: 1538 Queries matched: 71 10 
eukaryotic translation Initiation factor 2, subunit 3, structural gene X. linked (Mus musculus] 
17. 9UKHM Mass: 167812 Score: 1429 Queries matched: 48 
PREDICTED: similar to Microtubule-actin crosslinking factor 1, isoforms 11213 (Actin cross-linking family 
protein 7) (Macrophin 1) (Trabeculin-alpha) (620 kDa actin-binding protein) (ABP620) (Gallus gallus) 
1 
18. IT7 Mass: 74889 Score: 1371 Queries matched: 49 2 
PREDICTED: similar to Mthfdl -prov protein [Gallus gallus] - 
t ý] 
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19. i 45382971 Mass: 38412 Score: 1366 Queries matched: 64 10 
eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa [Gallus gallus] 
20. gi156377788 Mass: 50123 Score: 1361 Queries matched: 347 9 
elongation factor-1 alpha (EF-lalpha) (Pelodiscus sinensis) 
21. 014758256 Mass: 36089 Score: 1359 Queries matched: 84 10 
eukaryotic translation initiation factor 2, subunit I alpha, 35kDa [Homo sapiens] 
22. W17242148 Mass: 51098 Score: 1280 Queries matched: 54 10 
eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked [Mus musculus] 
23. 153136508 Mass: 53174 Score: 1275 Queries matched: 87 1 
hypothetical protein [Gallus gallus] coronin, actin binding protein, IC 
24. al 171896353 Mass: 76972 Score: 1253 Queries matched: 44 7 
heterogeneous nuclear ribonucleoprotein M [Gallus gallus] 
25. i 45383133 Mass: 145766 Score: 1253 Queries matched: 32 2 
SMC4 structural maintenance of chromosomes 4-like 1 [Gallus gallus] 
26. ail27881747 Mass: 51265 Score: 1252 Queries matched: 53 10 
Eif2s3-prov protein [Xenopus laevis] 
277 W15076809 Mass: 40824 Score: 1239 Queries matched: 67 24 
PREDICTED: similar to proliferation-associated protein 1, partial [Gallus gallus] 
28. i 50759864 Mass: 282157 Score: 1220 Queries matched: 34 1 
PREDICTED: similar to Microtubule-actin crosslinking factor 1, isoform 4 [Gallus gallus] 
29. 2iI50745996 Mass: 188082 Score: 1212 Queries matched: 47 12 
PREDICTED: similar to hypothetical protein [Gallus gallus] stromal antigen 2 
30. i 1362713 Mass: 67266 Score: 1206 Queries matched: 57 2 
calpain (EC 3.4.22.17) large chain I- chicken (fragment) 
31. a11617957 0 Mass: 68512 Score: 1175 Queries matched: 75 1 
radixin [Gallus gallus] 
32. 1 5075986 Mass: 170652 Score: 1169 Queries matched: 48 1 
PREDICTED: similar to Microtubule-actin crosslinking factor 1. Isoform 4 [Gallus gallus] 
33. 1160302698 Mass: 105393 Score: 1151 Queries matched: 42 2 
34. 
TAO kinase 3 [Gallus gallus] 
4114273778 Mass: 613652 Score: 1128 Queries matched: 39 1 
35. 
trabeculln-alpha (Homo sapiens] 
q1150758833 Mass: 388014 Score: 1114 Queries matched: 33 9 
PREDICTED: similar to PPAR-alpha interacting complex protein 285 [Gallus gallus] 
36. d160098709 Mass: 143760 Score: 1088 Queries matched: 43 
hypothetical protein [Gallus gallus] PDS6, regulator of cohesion maintenance, homolog B 
37. i 11 9 Mass: 105224 Score: 1087 Queries matched: 41 
KFC [Gallus gallus] 
38. 1 5075 2 Mass: 59229 Score: 1085 Queries matched: 28 
PREDICTED: similar to Nucleolar protein NOPS (Nucleolar protein 5) (NOP58) (HSPC120) [Gallus gallus] 
8 
39. p112832596 Mass: 72326 Score: 1077 Queries matched: 80 
OTTHUMP00000028920 [Homo sapiens] 
40. p1129435310 Mass: 36152 Score: 1034 Queries matched: 51 10 
Eukaryotic translation Initiation factor 2, subunit 1 alpha (Danlo redo) 
41. I7 Mass: 669735 Score: 1024 Queries matched: 36 1 
macrophin I Isoform 4 [Homo sapiens] 
42. 2 Mass: 41768 Score: 1023 Queries matched: 54 1 
43. 
beta-actin [Monopterus aibus] 
g11637111 Mass: 75594 Score: 1019 Queries matched: 41 8 
unnamed protein product [Gallus gallus] nucleolin 
44. Mass: 46614 Score: 988 Queries matched: 49 
PREDICTED: similar to PTB-associated splicing factor (Gallus gallus) 
45. i Mass: 51010 Score: 969 Queries matched: 33 
46. 
kappa-B motif-binding phosphoprotein - mouse 
Mass: 188642 Score: 968 Queries matched: 29 18 
PREDICTED: similar to Nup210 protein (Gallus gallus) 
47. Mass: 118615 Score: 966 Queries matched: 39 
hypothetical protein [Gallus gallus]ublquitin specific peptidase 48 
2 
48. 17 Mass: 66027 Score: 959 Queries matched: 69 19 
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k eratin I [Homo sapiens] 
49. p 1171896565 Mass: 87658 Score: 947 Queries matched: 30 2 
s imilar to Putative pre-mRNA splicing factor RNA helicase (DEAN box protein 15) [Gallus gallus] 
50.8 1133415848 Mass: 41752 Score: 928 Queries matched: 56 1 
c ytoplasmic actin type 5 [Rana lessonae] 
51.8 1146048916 Mass: 25016 Score: 921 Queries matched: 50 12 
F K506 binding protein 3,25kDa [Gallus gallus) 
52. p 1150749186 Mass: 29826 Score: 905 Queries matched: 28 
P REDICTED: similar to DnaJ homolog, subfamily C, member 9; DnaJ protein SB73 [Gallus gallus] 
53.8 1171896967 Mass: 23448 Score: 901 Queries matched: 112 
h ypothetical protein LOC426068 [Gallus gallus] 
54. 160098563 Mass: 42138 Score: 897 Queries matched: 48 
h ypothetical protein [Gallus gallus] DEK oncogene (DNA binding) 
55. p 1174004805 Mass: 49853 Score: 882 Queries matched: 277 10 
P REDICTED: similar to eukaryotic translation elongation factor 1 alpha 1 [Canis familiaris] 
56. i 55956899 Mass: 62027 Score: 876 Queries matched: 57 19 
k eratin 9 [Homo sapiens] 
57. 81150755234 Mass: 126319 Score: 871 Queries matched: 46 9 
PREDICTED: similar to transcription elongation regulator 1; transcription factor CA150; TATA box binding 
protein (TBP)-associated factor, RNA polymerase II, S, 15OkD; TATA box-binding protein-associated factor 
2S [Gallus gallus] 
58. W15815432 Mass: 24778 Score: 868 Queries matched: 184 5 
high mobility group protein HMG1 [Gallus gallus] 
59. 063494 Mass: 23056 Score: 860 Queries matched: 251 5 
HMG2a [Gallus gallus] 
60. 81150750688 Mass: 60638 Score: 858 Queries matched: 26 2 
PREDICTED: similar to Protein disulfide Isomerase A5 precursor (Protein disulfide Isomerase-related 
protein) (Gallus gallus] 
61. a1163658 Mass: 66490 Score: 858 Queries matched: 23 19 
unnamed protein product [Gallus gallus] lamin B1 
62. a11391636 Mass: 22914 Score: 858 Queries matched: 281 5 
HMG-1 (Gallus gallus) 
63. i11531 26280 Mass: 89269 Score: 855 Queries matched: 24 
hypothetical protein [Gallus gallus] 
64. i4 6902 Mass: 46803 Score: 854 Queries matched: 23 10 
translation Initiation factor [Homo sapiens] 
65. p1157530393 Mass: 33962 Score: 849 Queries matched: 24 9 
similar to transcription elongation factor IIS - mouse [Gallus gallus] 
66. gfl§0746121 Mass: 41423 Score: 846 Queries matched: 34 
PREDICTED: similar to hypothetical protein FU20534 [Gallus gallus] hypothetical protein 
67. I 1097989 Mass: 104127 Score: 837 Queries matched: 37 
adaptor-related protein complex 2, alpha 2 subunit [Gallus gallus] 
68. 1716 7277 Mass: 47249 Score: 836 Queries matched: 32 7 
hypothetical protein LOC426616 (Gallus gallus]heterogeneous nuclear ribonucleoprotein K 
69. gfl! QZAM Mass: 141198 Score: 833 Queries matched: 22 
PREDICTED: similar to KIAA0017 protein (Gallus gallus] 
70. g1161704 021 Mass: 68976 Score: 832 Queries matched: 53 
LOC398649 protein [Xenopus laevis] 
71. 81145382027 Mass: 22399 Score: 810 Queries matched: 53 2 
peptidylprolyl isomerase B (cyclophilin B) [Gallus gallus] 
72. 02606056 Mass: 23900 Score: 801 Queries matched: 52 2 
calpain small subunit (Gallus gallus] 
73. 118 Mass: 104108 Score: 800 Queries matched: 34 
Adaptor protein complex AP-2, alpha 2 subunit [Rattus norvegicus] 
74. 11115Z624964 Mass: 50164 Score: 797 Queries matched: 20 
RuvB-like 1 (Gallus gallus) 
75. i1 Mass: 48972 Score: 787 Queries matched: 31 2 
hypothetical protein (Gallus gallus]Spliceosome RNA hellcase BAT1 (DEAD box protein UAP56) (66 We U2AF65-associated protein). 
76. 
L_ 
1627 7 Mass: 88891 Score: 787 Queries matched: 22 
I 
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Chain C, VcpP97 COMPLEXED WITH ADP 
77. gi157529634 Mass: 65852 Score: 786 Queries matched: 25 2 
phenylalanine-tRNA synthetase-like, beta subunit [Gallus gallus] 
78. gi153129083 Mass: 42956 Score: 772 Queries matched: 28 2 
hypothetical protein [Gallus gallus] flap structure-specific endonuclease 1 
79. i 5453842 Mass: 43785 Score: 771 Queries matched: 40 24 
proliferation-associated 2G4,38kDa [Homo sapiens] 
80. i 50756645 Mass: 40435 Score: 756 Queries matched: 21 
PREDICTED: similar to GTP-binding protein [Gallus gallus] 
81. 060748121 Mass: 153598 Score: 746 Queries matched: 29 15 
PREDICTED: similar to KIAA0097 gene product; colonic and hepatic tumor over-expressed [Gallus gallus] 
82. i 50806270 Mass: 284058 Score: 739 Queries matched: 44 20 
PREDICTED: similar to ankyrin [Gallus gallus] 
83. 0600761 Mass: 24848 Score: 729 Queries matched: 141 5 
high mobility group I protein 
84. ai145382755 Mass: 23813 Score: 726 Queries matched: 88 5 
non-histone chromosomal protein [Gallus gallus]chicken HMGB2 
85. a1112004634 Mass: 51155 Score: 718 Queries matched: 22 
reptin [Xenopus laevis] 
86. 050758733 Mass: 236832 Score: 716 Queries matched: 21 2 
PREDICTED: similar to transglutaminase y [Gallus gallus] 
87. i 28317 Mass: 59492 Score: 711 Queries matched: 31 
unnamed protein product [Homo sapiens] 
88. i 55741612 Mass: 50151 Score: 710 Queries matched: 37 10 
thymopoletin [Gallus gallus] 
89. 050747 69 Mass: 117573 Score: 694 Queries matched: 20 
PREDICTED: similar to chromosome condensation protein G, partial [Gallus gallus] 
90. a114098678 Mass: 210415 Score: 690 Queries matched: 61 9 
C1 transcription factor [Mus musculus] 
91. 145383053 Mass: 82432 Score: 686 Queries matched: 20 
DEAD (Asp-Glu-Ala-Asp) box polypeptide I [Gallus gallus] 
92. a114139170 Mass: 49079 Score: 685 Queries matched: 264 10 
elongation translation factor I alpha [Cyanophora paradoxa] 
93. 9I L23712 Mass: 45220 Score: 682 Queries matched: 34 12 
myoblast antigen 24.1 D5 [Homo sapiens] 
94. 14699 Mass: 16325 Score: 879 Queries matched: 71 4 
Chain D, R-State Form Of Chicken Hemoglobin D 
95. i4 489 1 Mass: 35681 Score: 676 Queries matched: 20 2 
glyceraldehyde-3-phosphate dehydrogenase [Gallus gallus] 
96. 15 2067 Mass: 45150 Score: 673 Queries matched: 181 10 
elongation factor-1 alpha [Chloreuptychia arnaca]Eukaryotic translation elongation factor I alpha 1 
97. a1171895845 Mass: 54033 Score: 669 Queries matched: 29 5 
similar to non-POU domain containing, octamer-binding; Nuclear RNA-binding protein, 54-kD; non-Pou 
domain-containing octamer (ATGCAAAT) binding protein; non-POU-domain-containing, octamer-binding [Gallus gallus] 
98, I1 
=L21 
Mass: 23755 Score: 646 Queries matched: 70 5 
high-mobility group-2 protein 
99. 17 9 Mass: 51136 Score: 641 Queries matched: 19 
similar to BAG-family molecular chaperone regulator-5 (BAG-5) [Gallus gallus] 
100. 157 2 813 Mass: 37256 Score: 640 Queries matched: 34 
BUB3 budding uninhibited by benzimidazoles 3 homolog (Gallus gallus] 
101. 14 0 61 Mass: 244392 Score: 629 Queries matched: 17 
US snRNP-specific protein, 200 kDa [Mus musculus] 
102. 9"2 7 Mass: 41203 Score: 623 Queries matched: 128 10 
translation elongation factor 1-alpha [Saccharomyces cerevislae] 
103. i17 Mass: 271672 Score: 614 Queries matched: 20 20 
Iln I [Gallus gallus] 
104. I7 Mass: 353T4 Score: 813 Queries matched: 27 1 PREDICTED: similar to plectin, partial [Gallus gallus] 
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105. 9i150755565 Mass: 17015 Score: 610 Queries matched: 39 
PREDICTED: similar to G10 protein homolog (EDG-2) [Gallus gallus] 
106. äi160302704 Mass: 56901 Score: 604 Queries matched: 15 18 
nucleoporin 93kDa [Gallus gallus) 
107. äi171896957 Mass: 64463 Score: 602 Queries matched: 19 
similar to CDA02 protein [Gallus gallus] 
108. äi150760614 Mass: 80076 Score: 591 Queries matched: 155 17 
PREDICTED: similar to microtubuie-associated protein tau; Tau microtubule-associated protein [Gallus 
gallus] 
109. äi158865420 Mass: 93243 Score: 588 Queries matched: 16 18 
nucleoporin 93 (predicted) [Rattus norvegicus] 
110. i 63524 Mass: 53607 Score: 576 Queries matched: 34 12 
unnamed protein product [Gallus gallus] Ig gamma chain (clone 36) - chicken (fragment) 
111. i 50748193 Mass: 177312 Score: 567 Queries matched: 14 
PREDICTED: similar to pincher; pinocytic chaperone [Gallus gallus] 
1120 81127436951 Mass: 67647 Score: 560 Queries matched: 33 19 
lamin B2 [Homo sapiens] 
113. W171897265 Mass: 59796 Score: 560 Queries matched: 16 8 
hypothetical protein LOC426574 [Gallus gallus] nucleolar protein 5A (56kDa with KKE/D repeat) 
114. W160302806 Mass: 152988 Score: 560 Queries matched: 19 
similar to KIAA0648 protein [Gallus gallus] 
115. ä1150758110 Mass: 36944 Score: 559 Queries matched: 13 2 
PREDICTED: similar to malate dehydrogenase, mitochondrial; malate dehydrogenase 2; Malate dehydrogenase 2 NAD (mitochondrial) [Gallus gallus] 
116. i 71895795 Mass: 20837 Score: 552 Queries matched: 11 
hypothetical protein LOC428588 [Gallus gallus] hypothetical protein LOC428588 
117. i 181402 Mass: 65825 Score: 552 Queries matched: 18 19 
epidermal cytokeratin 2 [Homo sapiens] 
118. f 71897251 Mass: 45199 Score: 551 Queries matched: 46 
MHC B-G antigen isoform 2 precursor [Gallus gallus] 
119. i 50749292 Mass: 314115 Score: 546 Queries matched: 22 
PREDICTED: similar to hypothetical protein FLJ10839; cell-cycle and apoptosis regulatory protein 1 [Gallus 
gallus] 
13 
120. g11126090 Mass: 46645 Score: 544 Queries matched: 14 19 
Keratin, type I microfibrlllar 48 kDa, component 8C-1 (Low-sulfur keratin) 
121. g1140788963 Mass: 94570 Score: 642 Queries matched: 13 
KIAA0095 [Homo sapiens) 
122. i 3127674 Mass: 70507 Score: 531 Queries matched: 14 
hypothetical protein [Gallus gallus]chicken hypothetical protein 
123. i 3136 20 Mass: 66365 Score: 629 Queries matched: 13 
hypothetical protein [Gallus gallus]chicken hypothetical protein 
124. aII9709893 Mass: 47399 Score: 527 Queries matched: 13 
BRG11brm-associated factor 53A [Mus musculus] 
125. 145382 Mass: 50121 Score: 525 Queries matched: 17 
tubulin, beta 3 (Gallus gallus) 
126. g1153133424 Mass: 49519 Score: 520 Queries matched: 13 2 
hypothetical protein (Gallus gallus] Phenylalanyl-tRNA synthetase alpha chain (Phenylalanine - tRNA Ilgase alpha chain) (PheRS). 
127, a1127124646 Mass: 65045 Score: 517 Queries matched: 26 3 
heat shock protein 70 [Crassostrea gigas] 
128. q111098573 Mass: 41885 Score: 515 Queries matched: 25 1 
actin 
129. aII52130645 Mass: 15685 Score: 512 Queries matched: 21 
adult alpha D globin (Gallus gallus] 
130. a1161857876 Mass: 54596 Score: 509 Queries matched: 11 
PREDICTED: similar to hair type II keratin Intermediate filament protein [Bos taurus] 
19 
131. Mass: 23978 Score: 504 Queries matched: 1857 
trypsin (EC 3.4.21.4) precursor - bovine 
2 
132. I Mass: 49847 Score: 601 Queries matched: 13 
alpha-tubulln (Xenopus laevis] 
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133. g i1453 22329 Mass: 19518 Score: 501 Queries matched: 29 15 
t umor protein, translational ly-control led 1 [Gallus gallus] 
134. p 1171896527 Mass: 72006 Score: 500 Queries matched: 26 8 
s 
( 
imilar to Double-strand-break repair protein rad2l homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) 
SCC1 homolog) [Gallus gallus] 
135. a 1146048671 Mass: 22072 Score: 498 Queries matched: 14 21 
c alcium-binding protein [Gallus gallus] 
136.8 1157525242 Mass: 16354 Score: 497 Queries matched: 84 
e ndothelial differentiation-related factor 1 [Gallus gallus] 
137. i 127095 Mass: 35614 Score: 490 Queries matched: 15 
Myeloid protein I precursor (p33) 
138. p 115881792 Mass: 41825 Score: 490 Queries matched: 29 1 
a ctin [Artemia franciscana] 
139. W150755 11 Mass: 350958 Score: 488 Queries matched: 18 
PREDICTED: similar to mitotic checkpoint protein [Gallus gallus] 
140. W165932 Mass: 33061 Score: 486 Queries matched: 11 2 
malate dehydrogenase (EC 1.1.1.37), mitochondrial - pig 
141. W171896 11 Mass: 61158 Score: 486 Queries matched: 16 
similar to MGC68847 protein [Gallus gallus] 
W. i 1703106 Mass: 41705 Score: 485 Queries matched: 37 1 
Actin-1 
143. 038453896 Mass: 51422 Score: 485 Queries matched: 197 10 
translation elongation factor I alpha [Nematostella vectensis] 
144. 04530086 Mass: 41190 Score: 481 Queries matched: 156 10 
elongation factor 1-alpha [Semibalanus balanoides]Eukaryotic translation elongation factor I alpha 1 
145. 163359 Mass: 11703 Score: 478 Queries matched: 13 14 
cytochrome C [Gallus gallus] 
146. W 1630i4 Mass: 15419 Score: 477 Queries matched: 44 
alpha-A globin [Gallus gallus] 
147. 1 50750 19 Mass: 124958 Score: 474 Queries matched: 21 
PREDICTED: similar to melanoma differentiation associated protein-5; DEAD/H (Asp-Glu-Ala-Asp/His) bo 
polypeptide [Gallus gallus] 
x 
148. 15 751020 Mass: 165461 Score: 473 Queries matched: 14 
PREDICTED: similar to complement component factor h (Gallus gallus) 
149. p119725 Mass: 17837 Score: 470 Queries matched: 36 
unnamed protein product [Manduca sexta] 
150. i4 078 Mass: 177965 Score: 465 Queries matched: 12 
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 [Gallus 
gallus] 
151. 11171895651 Mass: 109408 Score: 461 Queries matched: 14 7 
similar to 116 kDa U5 small nuclear ribonucleoproteln component (US snRNP-specific protein, 116 kDa) (US- 
116 kDa) (Gallus gallus] 
152. I Mass: 269665 Score: 461 Queries matched: 14 
talin [Mus musculus] 
153. i 2741 4 Mass: 37063 Score: 460 Queries matched: 13 
Hnrpa3 protein [Mus musculus] 
154. 77 Mass: 60782 Score: 460 Queries matched: 27 10 
P 
( 
REDICTED: similar to eukaryotic translation Initiation factor 2, subunit 3 gamma, 62kDa 
Strongylocentrotus purpuratus] 
155. 1 Mass: 76846 Score: 460 Queries matched: 14 
h ypothetical protein (Gallus gallus] Kinesin-like protein KIF2A 
156. Mass: 199631 Score: 459 Queries matched: 10 15 
P REDICTED: similar to hypothetical protein FLJ40597 [Gallus gallus] similar to Baggressive lymphoma 2B 
157. Mass: 166171 Score: 458 Queries matched: 14 
h ypothetical protein LOC419128 [Gallus gallus] hypothetical protein LOC419128 
158. Mass: 35686 Score: 456 Queries matched: 13 2 
g lycaraldehyde-3-phosphate dehydrogenase (phosphorylating) (EC 1.2.1.12) - pig 
159. a111334733 Mass: 48143 Score: 455 Queries matched: 15 12 
unnamed protein product [Gallus gallus] Ig mu chain C region. 
160. Mass: 211721 Score: 453 Queries matched: 12 
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P REDICTED: similar to zinc finger protein 27 [Gallus gallus] 
161. i 10719701 Mass: 19471 Score: 452 Queries matched: 35 22 
u biquitin [Scyliorhinus torazame] 
162.0 38648948 Mass: 88588 Score: 452 Queries matched: 16 2 
P hosphofructokinase, platelet [Xenopus tropicalis] 
163. W 141400364 Mass: 66010 Score: 448 Queries matched: 11 23 
R Nase L inhibitor; HP68; RLI [Macaca fascicularis] 
164. a 1173980410 Mass: 33004 Score: 447 Queries matched: 181 10 
P REDICTED: similar to eukaryotic translation elongation factor 1 alpha I Isoform 5 [Canis famlliaris] 
165. W 150755457 Mass: 477902 Score: 446 Queries matched: 24 9 
P REDICTED: similar to transformation/transcription domain-associated protein [Gallus gallus] 
166. i 22597134 Mass: 36010 Score: 446 Queries matched: 198 10 
e longation factor-1 alpha [Eubosmina coregoni]Eukaryotic translation elongation factor I alpha 1 
167. g 1162658950 Mass: 475622 Score: 446 Queries matched: 17 
P REDICTED: similar to KIAA0614 protein [Rattus norvegicus] 
168. g 1150759301 Mass: 34397 Score: 443 Queries matched: 13 
( 
PREDICTED: similar to DNA fragmentation factor alpha subunit (DNA fragmentation factor 45 kDa subunit) 
DFF-45) (Inhibitor of CAD) (ICAD) [Gallus gallus] 
169. a1160762325 Mass: 269190 Score: 441 Queries matched: 14 9 
PREDICTED: similar to transcriptional regulator (Gallus gallus] 
170. i 45331057 Mass: 53850 Score: 436 Queries matched: 17 3 
70 kDa heat shock protein [Megachile rotundata] 
171. 1 55420740 Mass: 45177 Score: 435 Queries matched: 161 10 
elongation factor-1 alpha [Neomaenas monachus]Eukaryotic translation elongation factor I alpha I 
172. 16467317 Mass: 29963 Score: 432 Queries matched: 62 
elongation factor 1-a [Diphyllobothrium stemmacephalum] 
173. W150762650 Mass: 125697 Score: 429 Queries matched: 17 
PREDICTED: similar to mSin3A [Gallus gallus] 
174. i 45383564 Mass: 38449 Score: 425 Queries matched: 12 
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) [Gallus gallus] 
1 55. 15 751518 Mass: 22300 Score: 424 Queries matched: 21 
PREDICTED: similar to peroxiredoxin 1 [Gallus gallus] 
176. p11561 2338 Mass: 37691 Score: 423 Queries matched: 130 10 
elongation factor-1 alpha [Maculinea arion]Eukaryotic translation elongation factor I alpha 1 
177. g112030263 5 Mass: 45145 Score: 423 Queries matched: 167 10 
elongation factor-1 alpha [Antherina suraka]Eukaryotic translation elongation factor I alpha I 
178. 11171895487 Mass: 69161 Score: 421 Queries matched: 10 
similar to Retinoblastoma binding protein 6 [Gallus gallus] 
179. "122L4 Mass: 71440 Score: 417 Queries matched: 20 3 
heat shock protein 70 [Cryptosporldium andersoni] 
180. 127 19 Mass: 61219 Score: 416 Queries matched: 12 
RuvB-like 2 [Danio rerio] 
181. alI89882 Mass: 63647 Score: 416 Queries matched: 9 19 
keratin, type II, component 7c, cytoskeletal - sheep (tentative sequence) 
182. 1211 14 Mass: 15378 Score: 412 Queries matched: 39 
alpha-giobin-A 
183. 9HUMM Mass: 39784 Score: 409 Queries matched: 29 
PREDICTED: similar to DEAD box polypeptide 17 Isoform 3 [Gallus gall us] 
184. 1397 74 Mass: 27240 Score: 409 Queries matched: 14 
eIF-2gA (Homo sapiens] 
185. i7 Mass: 147292 Score: 407 Queries matched: 12 
PREDICTED: similar to Eukaryotic translation Initiation factor 6B (eIF-6B) (Translation initiation factor IF-2) 
(Gallus gallus] 
10 
186. a114557469 Mass: 104486 Score: 403 Queries matched: 21 
adaptor-related protein complex 2, beta 1 subunit isoform b [Homo sapiens] 
187. 11 Mass: 37641 Score: 401 Queries matched: 13 
single stranded D box binding factor 2- chicken 
- 188. IgI157536 465 Mass: 69247 Score: 399 Queries matched: 15 
tyrosyl-tRNA synthetase [Gallus gallus] 
2 
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189. p1150728556 Mass: 238084 Score: 395 Queries matched: 11 18 
PREDICTED: similar to Nuclear pore complex protein Nup205 (Nucleoporin Nup205) (205 kDa nucleoporin) 
[Gallus gallus] 
190. pi171896753 Mass: 36962 Score: 392 Queries matched: 11 7 
similar to heterogeneous nuclear ribonucleoprotein A2IB1 Isoform 2 [Gallus gallus] 
191. W1410360 4 Mass: 107046 Score: 392 Queries matched: 9 
putative mitochondrial outer membrane protein import receptor [Homo sapiens] 
192. p1122597128 Mass: 35171 Score: 391 Queries matched: 155 10 
elongation factor-1 alpha [Simocephalus vetulus]Eukaryotic translation elongation factor I alpha I 
193. pi15670229 Mass: 30083 Score: 389 Queries matched: 138 10 
elongation factor 1 alpha [Cinara etsuhoe]Eukaryotic translation elongation factor 1 alpha 1 
194. p1163517257 Mass: 115553 Score: 387 Queries matched: 20 2 
PREDICTED: ubiquitin specific protease 48 [Mus musculus] 
195. 11156118984 Mass: 42619 Score: 384 Queries matched: 8 1 
ARPI actin-related protein I homolog A, centractin alpha [Gallus gallus] 
196. p1150759639 Mass: 29596 Score: 384 Queries matched: 14 
PREDICTED: similar to Dnajc8 protein [Gallus gallus] 
197. i 1575536 Mass: 123039 Score: 380 Queries matched: 10 
regulator of nonsense transcript stability [Homo sapiens] 
198. p1147420845 Mass: 52329 Score: 379 Queries matched: 13 
FUSITLS [Gallus gallus] 
199. pi150753682 Mass: 151122 Score: 373 Queries matched: 15 
PREDICTED: similar to retinoblastoma-like 2 (p130) [Gallus gallus] 
200. i 7657381 Mass: 55146 Score: 366 Queries matched: 13 
PRP19/PSO4 pre-mRNA processing factor 19 homolog [Homo sapiens] 
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Appendix 3 
Recipes of SDS-PAGE 
The SDS-PAGE gel was made up as the following table in LJMU chromatin research 
group: 
Resolving gel: 
Percentage 
gel 
5% 7.5% 10% 12.5% 15% 17.5% 20% 
30% 
Acrylamide 
2.5 ml 3.75 ml 5 ml 6.25 ml 7.5 ml 8.75 ml 10 ml 
1% Bis- 
acrylamide 
3.9 ml 2.6 ml 1.95 ml 1.56 ml 1.3 ml 1.115 ml 0.975 ml 
1.5 M Tris- 
HCI pH 8.8 
3.75 ml 3.75 ml 3.75 ml 3.75 ml 3.75 ml 3.75 ml 3.75 ml 
20% SDS 0.15 ml 0.15 ml 0.15 ml 0.15 ml 0.15 ml 0.15 ml 0.15 ml 
Water 4.6 ml 4.35 ml 4.05 ml 3.19 ml 2.2 ml 1.135 ml 0.025 ml 
10% APS 0.1 ml 0.1 ml 0.1 ml 0.1 ml 0.1 ml 0.1 ml 0.1 ml 
TEMED 0.01 ml 0.01 ml 0.01 ml 0.01 ml 0.01 ml 0.01 MI 0.01 ml 
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Stacking gel: 
Percentage gel 5% 
30% Acrylamide 2.5 ml 
1% Bis-acrylamide 3.9 ml 
1.0 M Tris-HCI pH 6.8 3.75 ml 
20% SDS 0.15 ml 
1% bromophenol blue 0.6 ml 
Water 4.0 ml 
10% APS 0.1 ml 
TEMED 0.02 ml 
Running buffer: 
14.4 g Glysine, 3.03 g Tris base and 0.5 g SDS, dissolve in 500 ml distilled water. 
3X Laemmli sample buffer: 
1.875 ml of 1M Tris pH 6.8 (187.5 mM) 
0.6 g of SIDS 
3 ml of glycerol 
1.5 ml of 2-mercaptoethanol 
0.3 ml of 0.1% bromphenoblue 
Make up to 10 ml with distilled water 
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